Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Bladder Cancer, January 2013

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1716 articles:
HTML format


 

Single Articles

  1. ZHANG Y , Wang X, Zhang W, Gong S, et al
    An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
    Tumour Biol. 2012.
    Abstract     Related articles   

  2. DEGRAFF DJ , Robinson VL, Shah JB, Brandt W, et al
    Current pre-clinical models for the advancement of translational bladder cancer research.
    Mol Cancer Ther. 2012.
    Abstract     Related articles   

  3. OTA H , Ohtsuru M, Komai T, Katayama T, et al
    [Surgical treatment for gall bladder cancer with a confluence stone-a case report].
    Gan To Kagaku Ryoho. 2012;39:2131-3.
    Abstract     Related articles   

  4. CAGILTAY E , Tuncel T, Yonem A, Ozdemir G, et al
    Pioglitazone causing urinary bladder cancer? While waiting for the result of the debate, suggestions for physicians.
    Eur J Intern Med. 2012 Dec 22. pii: S0953-6205(12)00308.
    Abstract     Related articles   

  5. SCHEFFER AR , Holdenrieder S, Kristiansen G, von Ruecker A, et al
    Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?
    World J Urol. 2012.
    Abstract     Related articles   

  6. KOHAAR I , Porter-Gill P, Lenz P, Fu YP, et al
    Genetic Variant as a Selection Marker for Anti-Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer.
    J Natl Cancer Inst. 2012.
    Abstract     Related articles   

  7. BERNAL-PEREZ M , Souza DL, Romero-Fernandez FJ, Gomez-Bernal G, et al
    Estimation of Bladder Cancer Projections in Spain.
    Actas Urol Esp. 2012 Dec 19. pii: S0210-4806(12)00351.
    Abstract     Related articles   

  8. RESZKA E , Jablonowski Z, Wieczorek E, Gromadzinska J, et al
    Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males.
    Neoplasma. 2013;60:123-8.
    Abstract     Related articles   

  9. YIN X , Yu B, Tang Z, He B, et al
    Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.
    Cancer Gene Ther. 2012 Dec 21. doi: 10.1038/cgt.2012.
    Abstract     Related articles   

  10. YUN SJ , Moon SK, Kim WJ
    Investigational cell cycle inhibitors in clinical trials for bladder cancer.
    Expert Opin Investig Drugs. 2012.
    Abstract     Related articles   

  11. MOGHADDASI L , Bezak E, Marcu LG
    Current challenges in clinical target volume definition: tumour margins and microscopic extensions.
    Acta Oncol. 2012;51:984-95.
    Abstract     Related articles   

  12. LENZ P , Pfeiffer R, Baris D, Schned AR, et al
    Cell-cycle control in urothelial carcinoma: large-scale tissue array analysis of tumor tissue from Maine and Vermont.
    Cancer Epidemiol Biomarkers Prev. 2012;21:1555-64.
    Abstract     Related articles   

  13. RACHIOTIS G , Drivas S, Kostikas K, Makropoulos V, et al
    Respiratory tract mortality in cement workers: a proportionate mortality study.
    BMC Pulm Med. 2012;12:30.
    Abstract     Related articles   

  14. HUANG HS , Liu ZM, Chen PC, Tseng HY, et al
    TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
    Free Radic Biol Med. 2012;53:769-78.
    Abstract     Related articles   

  15. KOCH A , Hatina J, Rieder H, Seifert HH, et al
    Discovery of TP53 splice variants in two novel papillary urothelial cancer cell lines.
    Cell Oncol (Dordr). 2012;35:243-57.
    Abstract     Related articles   

  16. PANDITH AA , Siddiqi MA
    Burden of cancers in the valley of Kashmir: 5 year epidemiological study reveals a different scenario.
    Tumour Biol. 2012;33:1629-37.
    Abstract     Related articles   

  17. BOMMER NX , Hayes AM, Scase TJ, Gunn-Moore DA, et al
    Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam.
    J Feline Med Surg. 2012;14:527-33.
    Abstract     Related articles   

  18. HE HC , Ling XH, Zhu JG, Fu X, et al
    Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
    Mol Biol Rep. 2013.
    Abstract     Related articles   

  19. POWER NE , Kassouf W, Bell D, Aprikian AG, et al
    Natural history of pT3-4 or node positive bladder cancer treated with radical cystectomy and no neoadjuvant chemotherapy in a contemporary North-American multi-institutional cohort.
    Can Urol Assoc J. 2012;6:E217-23.
    Abstract     Related articles   

  20. FUJII T , Shimada K, Anai S, Fujimoto K, et al
    ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression.
    Cancer Sci. 2012 Dec 20. doi: 10.1111/cas.12089.
    Abstract     Related articles   

  21. MITTAL RD
    Gene Variants in Predicting BCG Response to Urinary Bladder Cancer.
    Indian J Clin Biochem. 2012;27:1-5.
    Abstract     Related articles   

  22. SCHOPS W , Jungmann O, Zumbe J, Zellner M, et al
    Assessment criteria for compensation of occupational bladder cancer .
    Front Biosci (Elite Ed). 2013;5:653-61.
    Abstract     Related articles   

  23. BRANCHEREAU J , Larue S, Vayleux B, Karam G, et al
    Prognostic Value of the Lymphovascular Invasion in High-Grade Stage pT1 Bladder Cancer.
    Clin Genitourin Cancer. 2012 Dec 28. pii: S1558-7673(12)00232.
    Abstract     Related articles   

  24. MARRA L , Cantile M, Scognamiglio G, Marra L, et al
    Deregulation of HOX B13 Expression in Urinary Bladder Cancer Progression.
    Curr Med Chem. 2012.
    Abstract     Related articles   

  25. SONG SO , Kim KJ, Lee BW
    Response: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).
    Diabetes Metab J. 2012;36:462-3.
    Abstract     Related articles   

  26. KIM SY
    Letter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).
    Diabetes Metab J. 2012;36:460-1.
    Abstract     Related articles   

  27. IWASAKI K , Obara W, Kato Y, Takata R, et al
    Neoadjuvant Gemcitabine Plus Carboplatin for Locally Advanced Bladder Cancer.
    Jpn J Clin Oncol. 2012.
    Abstract     Related articles   

  28. KRPINA K , Babarovic E, Dordevic G, Fuckar Z, et al
    The association between the recurrence of solitary non-muscle invasive bladder cancer and tumor infiltrating lymphocytes.
    Croat Med J. 2012;53:598-604.
    Abstract     Related articles   

  29. SPECK-PLANCHE A , Kleandrova VV, Luan F, Cordeiro MN, et al
    Unified Multi-target Approach for the Rational In silico Design of Anti-bladder Cancer Agents.
    Anticancer Agents Med Chem. 2012.
    Abstract     Related articles   

  30. LEE SJ , Cho SC, Lee EJ, Kim S, et al
    Interleukin-20 promotes migration of bladder cancer cells through ERK-mediated MMP-9 expression leading to NF-kB activation by inducing the up-regulation of p21WAF1 expression.
    J Biol Chem. 2012.
    Abstract     Related articles   

  31. WANG W , Fan Y, Xiong G, Wu J, et al
    Nitrate in drinking water and bladder cancer: A meta-analysis.
    J Huazhong Univ Sci Technolog Med Sci. 2012;32:912-8.
    Abstract     Related articles   

  32. EL KHOURY F , Jour I, Malaeb B, Assaf G, et al
    Bladder paraganglioma. A case report.
    J Med Liban. 2012;60:182-4.
    Abstract     Related articles   

  33. WANG C , Miyago N, Harada Y, Yasunaga Y, et al
    [Solitary fibrous tumor of the urinary bladder: a case report].
    Nihon Hinyokika Gakkai Zasshi. 2012;103:640-3.
    Abstract     Related articles   

  34. FANG Y , Yu Y, Hou Q, Zheng X, et al
    The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein XIAP.
    J Biol Chem. 2012;287:35234-43.
    Abstract     Related articles   

  35. SRIVASTAVA R , Arora VK, Aggarwal S, Bhatia A, et al
    Cytokeratin-20 immunocytochemistry in voided urine cytology and its comparison with nuclear matrix protein-22 and urine cytology in the detection of urothelial carcinoma.
    Diagn Cytopathol. 2012;40:755-9.
    Abstract     Related articles   

  36. JIANG XZ , Xu C, Zhang NZ, Xu ZS, et al
    Influence of clinical characteristics and tumor size on symptoms of bladder leiomyoma: a pooled analysis of 61 cases.
    Chin Med J (Engl). 2012;125:2436-9.
    Abstract     Related articles   

  37. STEINBERG PL , Ghavamian R
    Robotic-assisted radical cystectomy: current technique and outcomes.
    Expert Rev Anticancer Ther. 2012;12:913-7.
    Abstract     Related articles   

  38. MOHANTY NK , Kumar A, Vasudeva P, Jain M, et al
    Analysis of the perioperative and five-year oncological outcome of two hundred cases of open radical cystectomy: a single center experience.
    Indian J Cancer. 2012;49:96-101.
    Abstract     Related articles   

  39. VASCONCELOS-NOBREGA C , Colaco A, Lopes C, Oliveira PA, et al
    Review: BBN as an urothelial carcinogen.
    In Vivo. 2012;26:727-39.
    Abstract     Related articles   

  40. XING NZ , Song LM, Niu YN, Zhang JH, et al
    [A novel technique of ureterointestinal anastomosis for urinary diversion].
    Zhonghua Yi Xue Za Zhi. 2012;92:114-6.
    Abstract     Related articles   

  41. ERDOGAR N , Iskit AB, Mungan NA, Bilensoy E, et al
    Prolonged retention and in vivo evaluation of cationic nanoparticles loaded with Mitomycin C designed for intravesical chemotherapy of bladder tumours.
    J Microencapsul. 2012;29:576-82.
    Abstract     Related articles   

  42. HATTORI M , Nishimura Y, Toyonaga M, Kakinuma H, et al
    Cytological significance of abnormal squamous cells in urinary cytology.
    Diagn Cytopathol. 2012;40:798-803.
    Abstract     Related articles   

  43. OLSSON H , Hultman P, Monsef N, Rosell J, et al
    Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer.
    ISRN Urol. 2012;2012:379081.
    Abstract     Related articles   

  44. DAVIS SR , Tao X, Bernacki EJ, Alfriend AS, et al
    Evaluation of a bladder cancer cluster in a population of criminal investigators with the bureau of alcohol, tobacco, firearms and explosives-part 1: the cancer incidence.
    J Environ Public Health. 2012;2012:101850.
    Abstract     Related articles   

  45. MUTO S , Nakajima A, Horiuchi A, Inoue M, et al
    Maintenance Therapy with Intravesical Bacillus Calmette-Guerin in Patients with Intermediate- or High-risk Non-muscle-invasive Bladder Cancer.
    Jpn J Clin Oncol. 2013.
    Abstract     Related articles   

  46. LEE JS , Lee SY, Kim WJ, Seo SI, et al
    Efficacy and safety of hexaminolevulinate fluorescence cystoscopy in the diagnosis of bladder cancer.
    Korean J Urol. 2012;53:821-5.
    Abstract     Related articles   

  47. ERSOY H , Yaytokgil M, Karakoyunlu AN, Topaloglu H, et al
    Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.
    Drug Des Devel Ther. 2013;7:1-6.
    Abstract     Related articles   

  48. COVEY TM , Vira MA, Westfall M, Gulrajani M, et al
    Single cell network profiling assay in bladder cancer.
    Cytometry A. 2013 Jan 8. doi: 10.1002/cyto.a.22244.
    Abstract     Related articles   

  49. PRIZMENT AE , Anderson KE, Yuan JM, Folsom AR, et al
    Diabetes and risk of bladder cancer among postmenopausal women in the Iowa women's health study.
    Cancer Causes Control. 2013.
    Abstract     Related articles   

  50. UCHINO K , Takeshita F, Takahashi RU, Kosaka N, et al
    Therapeutic Effects of MicroRNA-582-5p and -3p on the Inhibition of Bladder Cancer Progression.
    Mol Ther. 2013 Jan 8. doi: 10.1038/mt.2012.
    Abstract     Related articles   

  51. YING L , Huang Y, Chen H, Wang Y, et al
    Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer.
    Mol Biosyst. 2013.
    Abstract     Related articles   

  52. PIRINCCI N , Gecit I, Gunes M, Yuksel MB, et al
    Serum adenosine deaminase, catalase and carbonic anhydrase activities in patients with bladder cancer.
    Clinics (Sao Paulo). 2012;67:1443-6.
    Abstract     Related articles   

  53. NOON AP , Catto JW
    Bladder cancer in 2012: Challenging current paradigms.
    Nat Rev Urol. 2013 Jan 8. doi: 10.1038/nrurol.2012.
    Abstract     Related articles   

  54. WANG SY , Zhou CW, Chen P, Shu -, et al
    [Laparoscopic radical cystectomy with orthotopic ileal neobladder in the treatment of invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2012;34:793-6.
    Abstract     Related articles   

  55. MIYACHIKA Y , Yamamoto Y, Matsumoto H, Nishijima J, et al
    Centrosome amplification in bladder washing cytology specimens is a useful prognostic biomarker for non-muscle invasive bladder cancer.
    Cancer Genet. 2013 Jan 2. pii: S2210-7762(12)00275.
    Abstract     Related articles   

  56. JENSEN JB
    Lymph node dissection in bladder cancer. Impact on staging and prognosis.
    Dan Med J. 2012;59:B4559.
    Abstract     Related articles   

  57. BRAUSI M , Olaru V
    Management of high-risk non-muscle invasive bladder cancer.
    Minerva Urol Nefrol. 2012;64:255-60.
    Abstract     Related articles   

  58. MULLER D , Tomasovic-Loncaric C, Galeic-Iljubanovic D, Heinzl R, et al
    Renal cell carcinoma with concurrent urothelial carcinoma of urinary bladder and non-Hodgkin lymphoma.
    Coll Antropol. 2012;36:1049-52.
    Abstract     Related articles   

  59. PERSEC Z , Bukovic D, Zupic JT, Pavic M, et al
    Clear cell variant of urothelial carcinoma in urinary bladder; a clinicopathological and immunohistochemical study--a case report.
    Coll Antropol. 2012;36:1045-7.
    Abstract     Related articles   

  60. PERSEC Z , Bukovic D, Persec J, Sovic T, et al
    Paraganglioma of the urinary bladder--clinicopathological, immunohistochemical and electron microscopy analysis--a case report.
    Coll Antropol. 2012;36:1041-3.
    Abstract     Related articles   

  61. DESMET M , Moubax K, Haerens M
    Multiple organ failure and granulomatous hepatitis following intravesical bacillus Calmette-Guerin instillation.
    Acta Clin Belg. 2012;67:367-9.
    Abstract     Related articles   

  62. TAGAMI K , Tanda S, Satake Y, Takeuchi A, et al
    [Successful chemotherapy with a docetaxel regimen for primary signet-ring cell carcinoma of the urinary bladder-a case report].
    Gan To Kagaku Ryoho. 2012;39:1737-41.
    Abstract     Related articles   

  63. NAGAYAMA T , Koyama A, Okoshi K, Oshima K, et al
    [Assessment of contracted bladder following intravesical instillation of BCG (Japan)].
    Gan To Kagaku Ryoho. 2012;39:1681-5.
    Abstract     Related articles   

  64. KOH DM , Sohaib A
    Diffusion-weighted imaging of the male pelvis.
    Radiol Clin North Am. 2012;50:1127-44.
    Abstract     Related articles   

  65. HEDGIRE SS , Pargaonkar VK, Elmi A, Harisinghani AM, et al
    Pelvic nodal imaging.
    Radiol Clin North Am. 2012;50:1111-25.
    Abstract     Related articles   

  66. RAZA SA , Jhaveri KS
    MR imaging of urinary bladder carcinoma and beyond.
    Radiol Clin North Am. 2012;50:1085-110.
    Abstract     Related articles   

  67. ZHAO X , Flynn EA
    Small cell carcinoma of the urinary bladder: a rare, aggressive neuroendocrine malignancy.
    Arch Pathol Lab Med. 2012;136:1451-9.
    Abstract     Related articles   

  68. GRUVER AM , Amin MB, Luthringer DJ, Westfall D, et al
    Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.
    Arch Pathol Lab Med. 2012;136:1339-46.
    Abstract     Related articles   

  69. THIND P , Jensen JB
    [Bladder Cancer Database].
    Ugeskr Laeger. 2012;174:2549.
    Abstract     Related articles   

  70. ROUGE-BUGAT ME , Herin F, Julien S, Oustric S, et al
    [Compensable occupational disease and cancer: how to improve the recognition rate? "Cursus Laboris" Project in Midi-Pyrenees: feasibility study].
    Bull Cancer. 2012;99:927-34.
    Abstract     Related articles   

  71. DENISET-BESSEAU A , Miannay FA, Laplace-Builhe C, Vielh P, et al
    A fluorescence-based assay for monitoring clinical drug resistance.
    J Clin Pathol. 2012;65:1003-7.
    Abstract     Related articles   

  72. KWON SY , Latchamsetty KC, Benson J, Carreno M, et al
    Inflammatory myofibroblastic tumor of the urinary tract following a TVT.
    Female Pelvic Med Reconstr Surg. 2012;18:249-51.
    Abstract     Related articles   

  73. COLMENERO JD , Sanjuan-Jimenez R, Ramos B, Morata P, et al
    Miliary pulmonary tuberculosis following intravesical BCG therapy: case report and literature review.
    Diagn Microbiol Infect Dis. 2012.
    Abstract     Related articles   

  74. RAZAVI SA , Sadigh G, Kelly AM, Cronin P, et al
    Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic.
    Acad Radiol. 2012;19:1134-40.
    Abstract     Related articles   

  75. KANAZAWA Y , Miyati T, Sato O
    Hemodynamic analysis of bladder tumors using T1-dynamic contrast-enhanced fast spin-echo MRI.
    Eur J Radiol. 2012;81:1682-7.
    Abstract     Related articles   

  76. SAID N , Frierson HF, Sanchez-Carbayo M, Brekken RA, et al
    Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
    J Clin Invest. 2013 Jan 16. pii: 64782. doi: 10.1172/JCI64782.
    Abstract     Related articles   

  77. LIN YL , Li ZG, He ZK, Guan TY, et al
    Clinical and Prognostic Significance of Protocadherin-10 (PCDH10) Promoter Methylation in Bladder Cancer.
    J Int Med Res. 2012;40:2117-23.
    Abstract     Related articles   

  78. DING MX , Wang HF, Wang JS, Zhan H, et al
    ppGalNAc T1 as a Potential Novel Marker for Human Bladder Cancer.
    Asian Pac J Cancer Prev. 2012;13:5653-7.
    Abstract     Related articles   

  79. ZABOLOTNEVA AA , Zhavoronkov A, Garazha AV, Roumiantsev SA, et al
    Characteristic patterns of microRNA expression in human bladder cancer.
    Front Genet. 2012;3:310.
    Abstract     Related articles   

  80. RUAN J , Wei B, Xu Z, Yang S, et al
    Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer.
    Med Oncol. 2013;30:445.
    Abstract     Related articles   

  81. AMBROSIO MR , Rocca BJ, Onorati M, Bellan C, et al
    Renal sinus pseudolymphoma in a patient with multiple carcinomas: a case report and a brief review of the literature.
    Histol Histopathol. 2012;27:1327-32.
    Abstract     Related articles   

  82. BARGHI MR , Rahjoo T, Borghei M, Hosseini-Moghaddam SM, et al
    Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses.
    Arch Iran Med. 2012;15:572-4.
    Abstract     Related articles   

  83. KWAN K , Bharadwaj S, Inderjeeth C
    Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette-Guerin unresponsive to DMARDs.
    Int J Rheum Dis. 2012;15:e73-5.
    Abstract     Related articles   

  84. TREIYER A , Saar M, Butow Z, Kamradt J, et al
    Robotic-assisted laparoscopic radical cystectomy: surgical and oncological outcomes.
    Int Braz J Urol. 2012;38:324-9.
    Abstract     Related articles   

  85. ABOUMARZOUK OM , Drewa T, Olejniczak P, Chlosta PL, et al
    Laparoscopic radical cystectomy: a 5-year review of a single institute's operative data and complications and a systematic review of the literature.
    Int Braz J Urol. 2012;38:330-40.
    Abstract     Related articles   

  86. LAUSS M , Aine M, Sjodahl G, Veerla S, et al
    DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.
    Epigenetics. 2012;7:858-67.
    Abstract     Related articles   

  87. LEE ST , Lawrentschuk N, Scott AM
    PET in Prostate and Bladder Tumors.
    Semin Nucl Med. 2012;42:231-46.
    Abstract     Related articles   

  88. SUN J , Tang DN, Fu T, Sharma P, et al
    Identification of human regulatory T cells in the setting of T-cell activation and anti-CTLA-4 immunotherapy on the basis of expression of latency-associated peptide.
    Cancer Discov. 2012;2:122-30.
    Abstract     Related articles   


  89. [Clonal origin of multiple foci of urinary bladder cancer].
    Arkh Patol. 2012;74:44-50.
    Abstract     Related articles   

  90. HUANG LP , Savoly D, Sidi AA, Adelson ME, et al
    CIP2A protein expression in high-grade, high-stage bladder cancer.
    Cancer Med. 2012;1:76-81.
    Abstract     Related articles   

  91. MAYR R , Burger M
    Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer.
    Curr Urol Rep. 2013.
    Abstract     Related articles   

  92. MITIN T , Shipley WU, Efstathiou JA, Heney NM, et al
    Trimodality Therapy for Bladder Conservation in Treatment of Invasive Bladder Cancer.
    Curr Urol Rep. 2013.
    Abstract     Related articles   

  93. HU HY , Hu ZL, Wang HQ, Liu C, et al
    [Nuclear matrix protein 22 and urinary cytology test in the diagnosis of bladder cancer: a meta-analysis].
    Zhonghua Wai Ke Za Zhi. 2012;50:1126-30.
    Abstract     Related articles   

  94. GAKIS G , Stenzl A, Renninger M
    Evolution of the concept of androgen-sensitive bladder cancer.
    Scand J Urol. 2013.
    Abstract     Related articles   

  95. CHEUNG G , Sahai A, Billlia M, Dasgupta P, et al
    Recent advances in the diagnosis and treatment of bladder cancer.
    BMC Med. 2013;11:13.
    Abstract     Related articles   

  96. NAIR R , Coker C
    'Stop going off on a tangent': a novel method for discriminating pathological from tangential fluorescence during photodynamic diagnosis cystoscopy.
    Ann R Coll Surg Engl. 2012;94:608.
    Abstract     Related articles   

  97. MARTIN LC , Abah U, Bean E, Gupta S, et al
    Metabolic acidosis: neo-considerations for general surgeons.
    Ann R Coll Surg Engl. 2012;94:e249-50.
    Abstract     Related articles   

  98. FRITSCHE HM , Aziz A, Eder F, Otto W, et al
    Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.
    Virchows Arch. 2012;461:655-61.
    Abstract     Related articles   

  99. NAKAGAWA T , Kanai Y, Nakanishi H, Komiyama M, et al
    Characteristics of lymph node metastases defining the outcome after radical cystectomy of urothelial bladder carcinoma.
    Jpn J Clin Oncol. 2012;42:1066-72.
    Abstract     Related articles   

  100. GUO KF , Zhang Z, Wang JY, Gao SL, et al
    Variation of urinary and serum trace elements (Ca, Zn, Cu, Se) in bladder carcinoma in China.
    Asian Pac J Cancer Prev. 2012;13:2057-61.
    Abstract     Related articles   

  101. BRASSESCO MS , Pezuk JA, Morales AG, de Oliveira JC, et al
    Cytostatic in vitro effects of DTCM-glutarimide on bladder carcinoma cells.
    Asian Pac J Cancer Prev. 2012;13:1957-62.
    Abstract     Related articles   

  102. KISS T , Bluth T, Heller A
    [Anesthesia in endourological and robot-assisted interventions.]
    Anaesthesist. 2012.
    Abstract     Related articles   

  103. HATINA J , Schulz WA
    Stem cells in the biology of normal urothelium and urothelial carcinoma.
    Neoplasma. 2012;59:728-36.
    Abstract     Related articles   

  104. LIU H , Shi J, Wilkerson ML, Lin F, et al
    Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas.
    Am J Clin Pathol. 2012;138:57-64.
    Abstract     Related articles   

  105. MAI KT , Belanger EC, Djordjevic B, Amin SM, et al
    Urinary bladder sinuses: a novel morphologic lesion with clinical and pathologic significance.
    Appl Immunohistochem Mol Morphol. 2012;20:494-500.
    Abstract     Related articles   

  106. LIN J , Wang YH, Zhang YH, Tian Y, et al
    [Proliferation effects of sirolimus, cyclosporine A and mycophenolate mofetil on human transitional cell carcinoma cells].
    Zhonghua Yi Xue Za Zhi. 2012;92:388-91.
    Abstract     Related articles   

  107. ZHANG XL , Geng J, Zhang XP, Peng B, et al
    Statin use and risk of bladder cancer: a meta-analysis.
    Cancer Causes Control. 2013.
    Abstract     Related articles   

  108. MUDULY DK , Satyanarayana Deo SV, Shukla NK, Kallianpur AA, et al
    Gall bladder cancer in a child: A rare occurrence.
    J Cancer Res Ther. 2012;8:653-4.
    Abstract     Related articles   

  109. YAN X , Al-Hayek S, Huang H, Zhu Z, et al
    Photodynamic effect of 5-aminolevulinic acid-loaded nanoparticles on bladder cancer cells: A preliminary investigation.
    Scand J Urol. 2013.
    Abstract     Related articles   

  110. KECK B , Merseburger AS, Stohr R, Fussel S, et al
    [Bladder cancer in focus : Update 2012 of the German Bladder Cancer Association.]
    Urologe A. 2013.
    Abstract     Related articles   

  111. JAGER T , Tschirdewahn S, Vom Dorp F, Piechotta G, et al
    [Siliconchiptechnology-based MMP-7 analysis in urine : An option for preoperative identification of lymph node metastasis in bladder cancer.]
    Urologe A. 2013.
    Abstract     Related articles   

  112. ZHU HB , Yang K, Xie YQ, Lin YW, et al
    Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells.
    World J Surg Oncol. 2013;11:22.
    Abstract     Related articles   

  113. LUO M , Li Z, Wang W, Zeng Y, et al
    Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression.
    Cancer Lett. 2013 Jan 24. pii: S0304-3835(13)00076.
    Abstract     Related articles   

  114. HAN B , Cui D, Jing Y, Hong Y, et al
    Estrogen receptor beta (ERbeta) is a novel prognostic marker of recurrence survival in non-muscle-invasive bladder cancer potentially by inhibiting cadherin switch.
    World J Urol. 2013.
    Abstract     Related articles   

  115. WU S , Li F, Huang X, Hua Q, et al
    The association of tea consumption with bladder cancer risk: a meta-analysis.
    Asia Pac J Clin Nutr. 2013;22:128-37.
    Abstract     Related articles   

  116. FERWANA M , Firwana B, Hasan R, Al-Mallah MH, et al
    Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.
    Diabet Med. 2013 Jan 28. doi: 10.1111/dme.12144.
    Abstract     Related articles   

  117. RASUL A , Bao R, Malhi M, Zhao B, et al
    Induction of Apoptosis by Costunolide in Bladder Cancer Cells is Mediated through ROS Generation and Mitochondrial Dysfunction.
    Molecules. 2013;18:1418-33.
    Abstract     Related articles   

  118. MYNAMPATI DK , Yaparpalvi R, Hong L, Kuo HC, et al
    Application of AAPM TG 119 to volumetric arc therapy (VMAT).
    J Appl Clin Med Phys. 2012;13:3382.
    Abstract     Related articles   

  119. WANG Z , Lu T, Du L, Hu Z, et al
    Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
    Int J Clin Exp Pathol. 2012;5:601-8.
    Abstract     Related articles   

  120. TERADA T
    Small cell carcinoma of the urinary bladder.
    Int J Clin Exp Pathol. 2012;5:596-600.
    Abstract     Related articles   

  121. AL-KASHWAN TA , Houshmand M, Al-Janabi A, Melconian AK, et al
    Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.
    BMC Res Notes. 2012;5:466.
    Abstract     Related articles   

  122. DEMELLAWY DE , Ahmed AD, Bora B, Bonin M, et al
    Plasmacytoid variant of urothelial carcinoma: a report of a rare case.
    Pathol Res Pract. 2012;208:561-4.
    Abstract     Related articles   

  123. CUI XB , Chen YZ, Li F
    [Recent advances on relationship between phospholipase C epsilon-1 gene and tumor].
    Zhonghua Bing Li Xue Za Zhi. 2012;41:213-6.
    Abstract     Related articles   

  124. SHIH CY , Lai CR, Huang CY, Twu NF, et al
    A challenge in the management of a patient with ovarian cancer associated with extensive endometriosis.
    Taiwan J Obstet Gynecol. 2012;51:324-5.
    Abstract     Related articles   

  125. CHANG CC , Tai CJ, Su TC, Shen KH, et al
    The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas.
    Ann Diagn Pathol. 2012;16:362-8.
    Abstract     Related articles   

  126. DEGENER S , Brandt AS, Lazica DA, von Rundstedt FC, et al
    [Imperative cystectomy in patients at risk. Ileal conduit or ureterocutaneostomy?].
    Urologe A. 2012;51:1220-7.
    Abstract     Related articles   

  127. COWAN NC
    CT urography for hematuria.
    Nat Rev Urol. 2012;9:218-26.
    Abstract     Related articles   

  128. VOGT AP , Cohen C, Siddiqui MT
    Fascin as an identifier of metastatic urothelial carcinoma: A retrospective study of fine-needle aspiration cell blocks and histologic tissue microarrays.
    Diagn Cytopathol. 2012;40:882-6.
    Abstract     Related articles   

  129. PARK B , Jeong BC, Choi YL, Kwon GY, et al
    Development and characterization of a bladder cancer xenograft model using patient-derived tumor tissue.
    Cancer Sci. 2013 Feb 6. doi: 10.1111/cas.12123.
    Abstract     Related articles   

  130. AJILI F , Kourda N, Darouiche A, Chebil M, et al
    Prognostic Value of Tumor-associated Macrophages Count in Human Non-muscle-invasive Bladder Cancer Treated by BCG Immunotherapy.
    Ultrastruct Pathol. 2013;37:56-61.
    Abstract     Related articles   

  131. GAKIS G , Stenzl A
    C-reactive protein in bladder cancer: where do we stand?
    Nat Rev Urol. 2013 Feb 5. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  132. FENNER A
    Bladder cancer: Bridging the gender gap in bladder cancer diagnoses.
    Nat Rev Urol. 2013 Feb 5. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  133. PEIRIS AN , Bailey BA, Manning T
    Relationship of vitamin d monitoring and status to bladder cancer survival in veterans.
    South Med J. 2013;106:126-30.
    Abstract     Related articles   

  134. BARLOW LJ , Benson MC
    Experience with Newer Intravesical Chemotherapy for High-Risk Non-Muscle-Invasive Bladder Cancer.
    Curr Urol Rep. 2013.
    Abstract     Related articles   

  135. MEIJER RP , Nieuwenhuijzen JA, Meinhardt W, Bex A, et al
    Response to induction chemotherapy and surgery in non-organ confined bladder cancer: A single institution experience.
    Eur J Surg Oncol. 2013 Jan 31. pii: S0748-7983(13)00005.
    Abstract     Related articles   

  136. SOFRA M , Fei PC, Fabrizi L, Marcelli ME, et al
    Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical Cystectomy: preliminary results.
    J Exp Clin Cancer Res. 2013;32:6.
    Abstract     Related articles   

  137. PIERRO GB , Gulia C, Cristini C, Fraietta G, et al
    Bladder cancer: a simple model becomes complex.
    Curr Genomics. 2012;13:395-415.
    Abstract     Related articles   

  138. REZAIANZADEH A , Mohammadbeigi A, Mobaleghi J, Mohammadsalehi N, et al
    Survival analysis of patients with bladder cancer, life table approach.
    J Midlife Health. 2012;3:88-92.
    Abstract     Related articles   

  139. DU H , Li J, McGuigan CF, Moe B, et al
    Cytotoxicity and Oxidative Damage Induced by Halobenzoquinones to T24 Bladder Cancer Cells.
    Environ Sci Technol. 2013.
    Abstract     Related articles   

  140. SABATER MARCO V , Navalon Verdejo P, Morera Faet A
    Morphological keys in the differential diagnosis of bladder inverted papilloma. Study of two types, trabecular and glandular.
    Arch Esp Urol. 2012;65:709-13.
    Abstract     Related articles   

  141. FRAGOSO MF , Prado MG, Barbosa L, Rocha NS, et al
    Inhibition of mouse urinary bladder carcinogenesis by acai fruit (Euterpe oleraceae Martius) intake.
    Plant Foods Hum Nutr. 2012;67:235-41.
    Abstract     Related articles   

  142. AMIN A , Epstein JI
    Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
    Hum Pathol. 2012;43:2124-8.
    Abstract     Related articles   

  143. BRIMO F , Wu C, Zeizafoun N, Tanguay S, et al
    Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion.
    Hum Pathol. 2013;44:95-102.
    Abstract     Related articles   

  144. HORIKAWA M , Saito H, Hokotate H, Mori T, et al
    Treatment of ureteroarterial fistula with an endoureteral stent graft.
    J Vasc Interv Radiol. 2012;23:1241-3.
    Abstract     Related articles   

  145. YUAN C , Xu N, Liao J
    Switch of FANCL, a key FA-BRCA component, between tumor suppressor and promoter by alternative splicing.
    Cell Cycle. 2012;11:3356.
    Abstract     Related articles   

  146. CHENG L , MacLennan GT, Lopez-Beltran A
    Histologic grading of urothelial carcinoma: a reappraisal.
    Hum Pathol. 2012;43:2097-108.
    Abstract     Related articles   

  147. WANG S , Li Q, Wang K, Dai Y, et al
    Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.
    Clin Transl Oncol. 2013.
    Abstract     Related articles   

  148. BOLT HM
    Human bladder cancer risk calculation based on genome-wide analysis of genetic variants.
    Arch Toxicol. 2013.
    Abstract     Related articles   

  149. JAISWAL PK , Singh V, Srivastava P, Mittal RD, et al
    Association of IL-12, IL-18 Variants and Serum IL 18 with Bladder Cancer Susceptibility in North Indian population.
    Gene. 2013 Feb 8. pii: S0378-1119(13)00066-8. doi: 10.1016/j.gene.2013.
    Abstract     Related articles   

  150. PIGNOT G , Colin P, Zerbib M, Audenet F, et al
    Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelialcarcinoma.
    Urol Oncol. 2013 Feb 8. pii: S1078-1439(12)00290.
    Abstract     Related articles   

  151. GUO Y , Chekaluk Y, Zhang J, Du J, et al
    TSC1 involvement in bladder cancer: diverse effects and therapeutic implications.
    J Pathol. 2013 Feb 7. doi: 10.1002/path.4176.
    Abstract     Related articles   

  152. PAYTON S
    Bladder cancer: Bovine milk protein complex has antitumour effect in vivo.
    Nat Rev Urol. 2013 Feb 12. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  153. LUO M , Li Z, Wang W, Zeng Y, et al
    Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.
    FEBS J. 2013 Feb 9. doi: 10.1111/febs.12185.
    Abstract     Related articles   

  154. GAKIS G , Stenzl A
    Gender-specific differences in muscle-invasive bladder cancer: the concept of sex steroid sensitivity.
    World J Urol. 2013.
    Abstract     Related articles   

  155. BRUINS HM , Skinner EC, Dorin RP, Ahmadi H, et al
    Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non-muscle invasive bladder cancer: Results from a prospective lymph node mapping study.
    Urol Oncol. 2013 Feb 6. pii: S1078-1439(12)00297.
    Abstract     Related articles   

  156. SONG YH , Shiota M, Yokomizo A, Uchiumi T, et al
    Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer().
    Urol Oncol. 2013 Feb 6. pii: S1078-1439(12)00396.
    Abstract     Related articles   

  157. CIMINO GD , Pan CX, Henderson PT
    Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer.
    Bioanalysis. 2013;5:369-91.
    Abstract     Related articles   

  158. KARKOULIS PK , Stravopodis DJ, Konstantakou EG, Voutsinas GE, et al
    Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines.
    Cancer Cell Int. 2013;13:11.
    Abstract     Related articles   

  159. SAVIC-RADOJEVIC A , Djukic T, Simic T, Pljesa-Ercegovac M, et al
    GSTM1-null and GSTA1-low activity genotypes are associated with enhanced oxidative damage in bladder cancer.
    Redox Rep. 2013.
    Abstract     Related articles   

  160. HOLMANG S
    High-grade non-muscle-invasive bladder cancer: Is re-resection necessary in all patients before intravesical bacillus Calmette-Guerin treatment?
    Scand J Urol. 2013.
    Abstract     Related articles   

  161. LAWRENTSCHUK N , Lee ST, Scott AM
    Current Role of PET, CT, MR for Invasive Bladder Cancer.
    Curr Urol Rep. 2013.
    Abstract     Related articles   

  162. QI Y , Chang L, Li H, Yu G, et al
    Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells.
    J Huazhong Univ Sci Technolog Med Sci. 2013;33:111-6.
    Abstract     Related articles   

  163. NOGUCHI S , Yamada N, Kumazaki M, Yasui Y, et al
    socs7, a target gene of microRNA-145, regulates interferon-beta induction through STAT3 nuclear translocation in bladder cancer cells.
    Cell Death Dis. 2013;4:e482.
    Abstract     Related articles   

  164. CHENG D , Liang B, Li Y
    Clinical value of vascular endothelial growth factor and endostatin in urine for diagnosis of bladder cancer.
    Tumori. 2012;98:762-7.
    Abstract     Related articles   

  165. ZHOU D , Zhang G, Gan Z
    c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer.
    J Control Release. 2013 Feb 3. pii: S0168-3659(13)00062.
    Abstract     Related articles   

  166. WOGNUM S , Bondar L, Zolnay AG, Chai X, et al
    Control over structure-specific flexibility improves anatomical accuracy for point-based deformable registration in bladder cancer radiotherapy.
    Med Phys. 2013;40:021702.
    Abstract     Related articles   

  167. ARNOLD CA , Limketkai BN, Illei PB, Montgomery E, et al
    Syphilitic and lymphogranuloma venereum (LGV) proctocolitis: clues to a frequently missed diagnosis.
    Am J Surg Pathol. 2013;37:38-46.
    Abstract     Related articles   

  168. KUL'CHAVENIA EV , Kholtobin DP
    [BCG-therapy in cancer of the bladder: benefits and drawbacks].
    Urologiia. 2012;:62-5.
    Abstract     Related articles   

  169. MARTOV AG , Andronov AS, Ergakov DV, Maksimov VA, et al
    [Optic diagnosis of muscular-noninvasive cancer of the urinary bladder].
    Urologiia. 2012;:52-7.
    Abstract     Related articles   

  170. POPOV SV , Novikov AI, Burlaka OO, Viazovtsev PV, et al
    [Results of monopolar versus quasibipolar transurethral resection of the prostate and urinary bladder].
    Urologiia. 2012;:38.
    Abstract     Related articles   

  171. HEGELE A , Heinzer H, Ruttinger D, Siebels M, et al
    [DGFIT: Immune and targeted therapy in urologic oncology - what can be expected?].
    Aktuelle Urol. 2012;43:219-26.
    Abstract     Related articles   

  172. SHE HL , Chan PH, Cheung SC
    Urinary bladder paraganglioma in a post-heart transplant patient.
    Ann Acad Med Singapore. 2012;41:362-3.
    Abstract     Related articles   

  173. SARMA J
    Sinus arrest during insertion of a Laryngeal Mask Airway.
    J Clin Anesth. 2012;24:507-8.
    Abstract     Related articles   

  174. SOMERS K , Iorizzo L, Scott G, Mercurio MG, et al
    Extramammary Paget disease of the penis as a manifestation of recurrent transitional cell carcinoma.
    Dermatol Online J. 2012;18:3.
    Abstract     Related articles   

  175. WANG ZH , Li YY, Hu ZQ, Zhu H, et al
    Does urothelial cancer of bladder behave differently in young patients?
    Chin Med J (Engl). 2012;125:2643-8.
    Abstract     Related articles   

  176. PETER J , May M, Ahmed AM, Ahmed A, et al
    [Simultaneous robot-assisted laparoscopic cystectomy and laparoscopic nephrectomy: first experience on 3 patients with short-term follow-up].
    Aktuelle Urol. 2012;43:255-61.
    Abstract     Related articles   

  177. HORSTMANN M , Kurz M, Padevit C, Horton K, et al
    [The urethral anastomosis in orthotopic neobladder following robot-assisted radical cystectomy (RARC) at German-speaking centres].
    Aktuelle Urol. 2012;43:250-4.
    Abstract     Related articles   

  178. KOIE T , Ohyama C, Yamamoto H, Hatakeyama S, et al
    Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.
    Eur J Surg Oncol. 2012;38:1101-5.
    Abstract     Related articles   

  179. MIYAKE H , Furukawa J, Muramaki M, Inoue T, et al
    Health related quality of life after radical cystectomy: comparative study between orthotopic sigmoid versus ileal neobladders.
    Eur J Surg Oncol. 2012;38:1089-94.
    Abstract     Related articles   

  180. FERNANDEZ-NAVARRO P , Garcia-Perez J, Ramis R, Boldo E, et al
    Proximity to mining industry and cancer mortality.
    Sci Total Environ. 2012;435-436:66-73.
    Abstract     Related articles   

  181. MCCREA PH , Chang M, Bailley G, Molinari M, et al
    Sarcomatoid carcinoma of the bladder after simultaneous kidney-pancreas transplant: a case report and review of the literature.
    BMJ Case Rep. 2012;2012.
    Abstract     Related articles   

  182. DI CAPUA M , Ierano P, Marrone E, Cerbone AM, et al
    Upper tract urothelial cell carcinoma presenting as fever of unknown origin and acid-sterile pyuria.
    Intern Emerg Med. 2012;7 Suppl 2:S117-8.
    Abstract     Related articles   

  183. WANG C , Wang W, Wang J, Zhan H, et al
    Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles.
    Tumour Biol. 2013.
    Abstract     Related articles   

  184. JAISWAL PK , Tripathi N, Shukla A, Mittal RD, et al
    Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk.
    Med Oncol. 2013;30:509.
    Abstract     Related articles   

  185. SANKHWAR M , Sankhwar SN
    Variations in CYP isoforms and bladder cancer: A superfamily paradigm.
    Urol Oncol. 2013 Feb 18. pii: S1078-1439(12)00351.
    Abstract     Related articles   

  186. MONTANARI E , de la Rosette J, Longo F, Del Nero A, et al
    Narrow-band imaging (NBI) and white light (WLI) transurethral resection of the bladder in the treatment of non-muscle-invasive bladder cancer.
    Arch Ital Urol Androl. 2012;84:179-83.
    Abstract     Related articles   

  187. JOHNSON JL , West DA, Travers JB
    Worsening of bullous pemphigoid following bacillus calmette-guerin treatment for bladder cancer.
    JAMA Dermatol. 2013;149:248-9.
    Abstract     Related articles   

  188. WU D , Ding J, Wang L, Pan H, et al
    microRNA-125b inhibits cell migration and invasion by targeting matrix metallopeptidase 13 in bladder cancer.
    Oncol Lett. 2013;5:829-834.
    Abstract     Related articles   

  189. ALI-EL-DEIN B , Mosbah A, Osman Y, El-Tabey N, et al
    Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: A report on 15 cases with long term follow-up.
    Eur J Surg Oncol. 2013 Feb 16. pii: S0748-7983(13)00248.
    Abstract     Related articles   

  190. GLADKOVA N , Kiseleva E, Streltsova O, Prodanets N, et al
    Combined use of fluorescence cystoscopy and cross-polarization OCT for diagnosis of bladder cancer and correlation with immunohistochemical markers.
    J Biophotonics. 2013 Feb 18. doi: 10.1002/jbio.201200105.
    Abstract     Related articles   

  191. CHEN MC , Lee CF, Huang WH, Chou TC, et al
    Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1alpha/VEGF signaling pathway in human bladder cancer cells.
    Biochem Pharmacol. 2013 Feb 14. pii: S0006-2952(13)00113.
    Abstract     Related articles   

  192. HASSAN HE , Mohamed AA, Bakhiet AO, Ahmed HG, et al
    Immunohistochemical expression of COX2 and iNOS in bladder cancer and its association with urinary schistosomiasis among Sudanese patients.
    Infect Agent Cancer. 2013;8:9.
    Abstract     Related articles   

  193. DOROUDCHI M , Saidi M, Malekzadeh M, Golmoghaddam H, et al
    Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status.
    Future Oncol. 2013;9:295-304.
    Abstract     Related articles   

  194. VAN AALDEREN MC , Yapici U, van der Pol JA, de Reijke TM, et al
    Polyomavirus BK in the pathogenesis of bladder cancer.
    Neth J Med. 2013;71:26-8.
    Abstract     Related articles   

  195. ISA F , Xie LP, Hu Z, Zhong Z, et al
    Dietary consumption and diet diversity and risk of developing bladder cancer: results from the South and East China case-control study.
    Cancer Causes Control. 2013.
    Abstract     Related articles   

  196. YAFI FA , Brimo F, Auger M, Aprikian A, et al
    Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer.
    Urol Oncol. 2013 Feb 11. pii: S1078-1439(12)00343.
    Abstract     Related articles   

  197. BRINCKS EL , Risk MC, Griffith TS
    PMN and anti-tumor immunity-The case of bladder cancer immunotherapy.
    Semin Cancer Biol. 2013 Feb 11. pii: S1044-579X(13)00014.
    Abstract     Related articles   

  198. STEWART JD , Marchan R
    Polymorphisms hit the headlines.
    Arch Toxicol. 2012;86:1799-801.
    Abstract     Related articles   

  199. VINALL RL , Kent MS, deVere White RW
    Expression of microRNAs in urinary bladder samples obtained from dogs with grossly normal bladders, inflammatory bladder disease, or transitional cell carcinoma.
    Am J Vet Res. 2012;73:1626-33.
    Abstract     Related articles   

  200. SHINJI S , Akimaru K, Tsuchiya Y, Shimizu T, et al
    Enterovesical fistula caused by non-Hodgkin's lymphoma of the ileum: report of a case.
    Surg Today. 2012;42:1005-9.
    Abstract     Related articles   

  201. BAUMANN BC , Guzzo TJ, He J, Keefe SM, et al
    A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
    Int J Radiat Oncol Biol Phys. 2013;85:81-8.
    Abstract     Related articles   

  202. BESARATINIA A , Tommasi S
    Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions.
    FASEB J. 2013.
    Abstract     Related articles   

  203. ELDEFRAWY A , Soloway MS, Katkoori D, Singal R, et al
    Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion.
    Indian J Urol. 2012;28:424-6.
    Abstract     Related articles   

  204. LI Y , Zheng Y, Izumi K, Ishiguro H, et al
    Androgen activates beta-catenin signaling in bladder cancer cells.
    Endocr Relat Cancer. 2013.
    Abstract     Related articles   

  205. TAKAOKA EI , Matsui Y, Inoue T, Miyazaki J, et al
    Risk Factors for Intravesical Recurrence in Patients with High-grade T1 Bladder Cancer in the Second TUR Era.
    Jpn J Clin Oncol. 2013.
    Abstract     Related articles   

  206. URBANOWICZ RJ , Andrew AS, Karagas MR, Moore JH, et al
    Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach.
    J Am Med Inform Assoc. 2013.
    Abstract     Related articles   


  207. Bladder cancer: Performance of urine cytology might be lower than expected.
    Nat Rev Urol. 2013 Feb 26. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  208. ZHAO Y , Li Y, Wang L, Yang H, et al
    microRNA response elements-regulated TRAIL expression shows specific survival-suppressing activity on bladder cancer.
    J Exp Clin Cancer Res. 2013;32:10.
    Abstract     Related articles   

  209. KABAT GC , Kim MY, Luo J, Hou L, et al
    Menstrual and reproductive factors and exogenous hormone use and risk of transitional cell bladder cancer in postmenopausal women.
    Eur J Cancer Prev. 2013.
    Abstract     Related articles   

  210. KIM KJ , Song SO, Lee BW
    Response: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).
    Diabetes Metab J. 2013;37:83-4.
    Abstract     Related articles   

  211. LI S , Tian H
    Letter: the risk of bladder cancer in korean diabetic subjects treated with pioglitazone (diabetes metab j 2012;36:371-8).
    Diabetes Metab J. 2013;37:81-2.
    Abstract     Related articles   

  212. FUJITA T , Satoh T, Timme TL, Hirayama T, et al
    Combined therapeutic effects of adenoviral vector-mediated GLIPR1 gene therapy and radiotherapy in prostate and bladder cancer models.
    Urol Oncol. 2013 Feb 20. pii: S1078-1439(12)00353.
    Abstract     Related articles   

  213. PINTO-LEITE R , Arantes-Rodrigues R, Palmeira C, Colaco B, et al
    Everolimus combined with cisplatin has a potential role in treatment of urothelial bladder cancer.
    Biomed Pharmacother. 2012 Dec 26. pii: S0753-3322(12)00121.
    Abstract     Related articles   

  214. ROYCHOWDHURY A , Dey RK, Bandyapadhyay A, Bhattacharya P, et al
    Study of mutated p53 protein by immunohistochemistry in urothelial neoplasm of urinary bladder.
    J Indian Med Assoc. 2012;110:393-6.
    Abstract     Related articles   

  215. DRAGUTESCU M , Geavlete B, Multescu R, Mihai B, et al
    The influence of toxic working environment on the urothelial bladder tumors characteristics, the experience of "Sf. Ioan" Clinical Emergency Hospital on selected series.
    J Med Life. 2012;5:304-7.
    Abstract     Related articles   

  216. MICHEL R , Peschetola V, Bedessem B, Etienne J, et al
    Inverse problems for the determination of traction forces by cells on a substrate: a comparison of two methods.
    Comput Methods Biomech Biomed Engin. 2012;15 Suppl 1:27-9.
    Abstract     Related articles   

  217. WANG DL , Lan JH, Chen L, Huang B, et al
    Integrin-linked kinase functions as a tumor promoter in bladder transitional cell carcinoma.
    Asian Pac J Cancer Prev. 2012;13:2799-806.
    Abstract     Related articles   

  218. NG KL , Htun TH, Dublin N, Ong TA, et al
    Assessment and clinical significance of haematuria in Malaysian patients - relevance to early cancer diagnosis.
    Asian Pac J Cancer Prev. 2012;13:2515-8.
    Abstract     Related articles   

  219. LAISHRAM RS , Kipgen P, Laishram S, Khuraijam S, et al
    Urothelial tumors of the urinary bladder in Manipur: a histopathological perspective.
    Asian Pac J Cancer Prev. 2012;13:2477-9.
    Abstract     Related articles   

  220. LUCHEY A , Zaslau S, Talug C
    Robotic assisted partial cystectomy with pelvic lymph node dissection for metastatic paraganglioma of the urinary bladder.
    Can J Urol. 2012;19:6389-91.
    Abstract     Related articles   

  221. SCHLAKE A , Crispen PL, Cap AP, Atkinson T, et al
    NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study.
    Can J Urol. 2012;19:6345-50.
    Abstract     Related articles   

  222. LIN L , Huang Z, Gao Y, Chen Y, et al
    LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery.
    Proteomics. 2012;12:2238-46.
    Abstract     Related articles   

  223. MACIA VILLA C , Sifuentes Giraldo W, Boteanu A, Gonzalez Lanza M, et al
    Reactive arthritis after the intravesical instillation of BCG.
    Reumatol Clin. 2012;8:284-6.
    Abstract     Related articles   

  224. MIYAZAKI J , Nishiyama H
    [Treatment for muscular layer invasiveness bladder cancer].
    Gan To Kagaku Ryoho. 2013;40:41-6.
    Abstract     Related articles   

  225. AFONSO J , Longatto-Filho A, Martinho O, Lobo F, et al
    Low RKIP expression associates with poor prognosis in bladder cancer patients.
    Virchows Arch. 2013.
    Abstract     Related articles   

  226. PANDA D , Sharma A, Shukla NK, Jaiswal R, et al
    Gall bladder cancer and the role of dietary and lifestyle factors: a case-control study in a north Indian population.
    Eur J Cancer Prev. 2013.
    Abstract     Related articles   

  227. FENNER A
    Bladder cancer: Aurora kinase inhibitors light up the therapeutic horizon in bladder cancer.
    Nat Rev Urol. 2013 Mar 5. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  228. COGOI S , Shchekotikhin AE, Membrino A, Sinkevich YB, et al
    Guanidino anthrathiophenediones as G-quadruplex binders: uptake, intracellular localization and anti Harvey-ras gene activity in bladder cancer cells.
    J Med Chem. 2013.
    Abstract     Related articles   

  229. NEUZILLET Y , Roupret M, Larre S, Irani J, et al
    [Diagnosis and management of severe adverse events occurring during BCG therapy for non-muscle invasive bladder cancer (NMIBC).]
    Presse Med. 2013 Feb 27. pii: S0755-4982(13)00019.
    Abstract     Related articles   

  230. KHURANA KK , Garcia JA, Tendulkar RD, Stephenson AJ, et al
    Multidisciplinary management of patients with localized bladder cancer.
    Surg Oncol Clin N Am. 2013;22:357-73.
    Abstract     Related articles   

  231. MARES J , Szakacsova M, Soukup V, Duskova J, et al
    Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.
    Neoplasma. 2013;60:295-301.
    Abstract     Related articles   

  232. TAKAHASHI A , Ichihara T
    [A case of a patient in welfare facilities in whom relief from sharp pain was difficult to achieve].
    Gan To Kagaku Ryoho. 2012;39 Suppl 1:101-2.
    Abstract     Related articles   

  233. ROSENTHAL DL , Vandenbussche CJ, Burroughs FH, Sathiyamoorthy S, et al
    The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template.
    Cancer Cytopathol. 2013;121:15-20.
    Abstract     Related articles   

  234. VANDENBUSSCHE CJ , Sathiyamoorthy S, Owens CL, Burroughs FH, et al
    The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    Cancer Cytopathol. 2013;121:21-8.
    Abstract     Related articles   

  235. OWENS CL , Vandenbussche CJ, Burroughs FH, Rosenthal DL, et al
    A review of reporting systems and terminology for urine cytology.
    Cancer Cytopathol. 2013;121:9-14.
    Abstract     Related articles   

  236. KAWAMORI R
    [Biguanide, pioglitazone and alpha-glucosidase inhibitors].
    Nihon Rinsho. 2012;70 Suppl 6:206-10.
    Abstract     Related articles   

  237. ROY S , Smith MA, Cieply KM, Acquafondata MB, et al
    Primary bladder adenocarcinoma versus metastatic colorectal adenocarcinoma: a persisting diagnostic challenge.
    Diagn Pathol. 2012;7:151.
    Abstract     Related articles   

  238. BALAR AV , Milowsky MI
    Novel agents in invasive urothelial cancer.
    Clin Adv Hematol Oncol. 2012;10:504-16.
    Abstract     Related articles   

  239. DUNBERGER G , Thulin H, Waldenstrom AC, Lind H, et al
    Cancer survivors' perception of participation in a long-term follow-up study.
    J Med Ethics. 2013;39:41-5.
    Abstract     Related articles   

  240. GUNLUSOY B , Arslan M, Vardar E, Degirmenci T, et al
    [The efficacy and toxicity of gemcitabine and cisplatin chemotherapy in advanced/metastatic bladder urothelial carcinoma].
    Actas Urol Esp. 2012;36:515-20.
    Abstract     Related articles   

  241. HAN Y , Liu Y, Gui Y, Cai Z, et al
    Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    J Surg Oncol. 2013;107:201-5.
    Abstract     Related articles   

  242. KOESTLER DC , Marsit CJ, Christensen BC, Accomando W, et al
    Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers.
    Cancer Epidemiol Biomarkers Prev. 2012;21:1293-302.
    Abstract     Related articles   

  243. GAYA JM , Palou J, Cosentino M, Patino D, et al
    [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
    Actas Urol Esp. 2012;36:539-44.
    Abstract     Related articles   

  244. ASTERMARK J , Makris M, Mauser-Bunschoten E, Nemes L, et al
    Malignant disease in the haemophilic population: moving towards a management consensus?
    Haemophilia. 2012;18:664-71.
    Abstract     Related articles   

  245. FAN R , Grignon DJ, Rhee A, Meldrum KK, et al
    Exstrophy polyp is a unique pathology entity.
    Pediatr Dev Pathol. 2012;15:471-7.
    Abstract     Related articles   

  246. ROMANUCCI M , Malatesta D, Ciccarelli A, Bongiovanni L, et al
    Expression of heat shock proteins in premalignant and malignant urothelial lesions of bovine urinary bladder.
    Cell Stress Chaperones. 2012;17:683-92.
    Abstract     Related articles   

  247. GOMEZ-VEIGA F , Alcaraz-Asensio A, Burgos-Revilla J, Cozar-Olmo J, et al
    [Advances in uro-oncology <<Oncoforum>>: the best of 2011].
    Actas Urol Esp. 2012;36:507-14.
    Abstract     Related articles   

  248. YOON WJ , Brown MA, Reinhall PG, Park S, et al
    Design and preliminary study of custom laser scanning cystoscope for automated bladder surveillance.
    Minim Invasive Ther Allied Technol. 2012;21:320-8.
    Abstract     Related articles   

  249. BAILEY KA , Wallace K, Smeester L, Thai SF, et al
    Transcriptional Modulation of the ERK1/2 MAPK and NF-kappaB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer.
    J Can Res Updates. 2012;1:57-68.
    Abstract     Related articles   

  250. ABDOLLAH F , Gandaglia G, Thuret R, Schmitges J, et al
    Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis.
    Cancer Epidemiol. 2013 Feb 25. pii: S1877-7821(13)00023.
    Abstract     Related articles   

  251. ZHANG Y , Yan L, Zhao Y, Ou L, et al
    Knockdown of Phospholipase C-Epsilon by Short-Hairpin RNA-Mediated Gene Silencing Induces Apoptosis in Human Bladder Cancer Cell Lines.
    Cancer Biother Radiopharm. 2013.
    Abstract     Related articles   

  252. WANG Z , Xue L, Chong T, Li H, et al
    Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
    Tumour Biol. 2013.
    Abstract     Related articles   

  253. MAURER T , Horn T, Beer AJ, Eiber M, et al
    [Functional imaging in bladder cancer.]
    Urologe A. 2013.
    Abstract     Related articles   

  254. GAI L , Cai N, Wang L, Xu X, et al
    Ursolic acid induces apoptosis via Akt/NF-kappaB signaling suppression in T24 human bladder cancer cells.
    Mol Med Rep. 2013 Mar 11. doi: 10.3892/mmr.2013.1364.
    Abstract     Related articles   

  255. ZHUO W , Zhang L, Cai L, Zhu B, et al
    XRCC1 Arg399Gln polymorphism and bladder cancer risk: updated meta-analyses based on 5767 cases and 6919 controls.
    Exp Biol Med (Maywood). 2013;238:66-76.
    Abstract     Related articles   

  256. GOODISON S , Rosser CJ, Urquidi V
    Bladder Cancer Detection and Monitoring: Assessment of Urine- and Blood-Based Marker Tests.
    Mol Diagn Ther. 2013.
    Abstract     Related articles   

  257. WOO KIM K , Shin Y, Promoda Perera A, Liu Q, et al
    Label-free, PCR-free chip-based detection of telomerase activity in bladder cancer cells.
    Biosens Bioelectron. 2013;45C:152-157.
    Abstract     Related articles   

  258. COEN JJ , Paly JJ, Niemierko A, Kaufman DS, et al
    Nomograms Predicting Response to Therapy and Outcomes After Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer.
    Int J Radiat Oncol Biol Phys. 2013 Mar 5. pii: S0360-3016(13)00084.
    Abstract     Related articles   

  259. BOUCHELOUCHE K , Turkbey B, Choyke PL
    PET/CT and MRI in Bladder Cancer.
    J Cancer Sci Ther. 2012;S14.
    Abstract     Related articles   

  260. OMRAN OM
    CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    J Environ Pathol Toxicol Oncol. 2012;31:203-12.
    Abstract     Related articles   

  261. OKUMURA K , Tani S, Shiogai Y, Kodama M, et al
    [A case of advanced rectal cancer with bladder carcinoma salvaged from myocardial infarction during operation, showing tumor regression by XELOX treatment, good quality of life].
    Gan To Kagaku Ryoho. 2013;40:111-3.
    Abstract     Related articles   

  262. ROPERTO S , Russo V, Ozkul A, Sepici-Dincel A, et al
    Bovine papillomavirus type 2 infects the urinary bladder of water buffalo (Bubalus bubalis) and plays a crucial role in bubaline urothelial carcinogenesis.
    J Gen Virol. 2013;94.
    Abstract     Related articles   

  263. MATSUMINE H , Takeuchi M
    Reconstruction for planned ventral hernia after surgery for generalised peritonitis: de-epithelialisation of split-thickness skin graft and transplantation of pedicled anterolateral thigh flap.
    J Plast Reconstr Aesthet Surg. 2013;66:290-1.
    Abstract     Related articles   

  264. MEN K , Liu W, Li L, Duan X, et al
    Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system.
    Nanoscale. 2012;4:6425-33.
    Abstract     Related articles   

  265. WANG GW , Wang Y, Chen YX, Li Q, et al
    [Perivascular epithelioid cell tumor of urinary system: a clinicopathologic analysis of 21 cases].
    Zhonghua Bing Li Xue Za Zhi. 2012;41:443-7.
    Abstract     Related articles   

  266. BERTZ S , Schmitz-Drager BJ, Protzel C, Hartmann A, et al
    [Intraoperative frozen section diagnosis of the genitourinary tract].
    Pathologe. 2012;33:441-9.
    Abstract     Related articles   

  267. TIU A , Jenkins LC, Soloway MS
    Active surveillance for low-risk bladder cancer.
    Urol Oncol. 2013 Mar 18. pii: S1078-1439(12)00466.
    Abstract     Related articles   

  268. LIN Y , Lu YY, Wang HY, Tsai SC, et al
    Accidental Finding of Bladder Cancer in 99mTc Methylene Diphosphonate Whole-Body Bone Scan.
    Clin Nucl Med. 2013.
    Abstract     Related articles   

  269. LIGHTFOOT AJ , Breyer BN, Rosevear HM, Erickson BA, et al
    Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer.
    Urol Oncol. 2013 Mar 16. pii: S1078-1439(13)00045.
    Abstract     Related articles   

  270. XU R , Zhong Z, Jiang H, Zhang L, et al
    A rare paraneoplastic dermatomyositis in bladder cancer with fatal outcome.
    Urol J. 2013;10:815-7.
    Abstract     Related articles   

  271. OSAWA T , Shinohara N, Maruyama S, Oba K, et al
    Long-term renal function outcomes in bladder cancer after radical cystectomy.
    Urol J. 2013;10:784-9.
    Abstract     Related articles   

  272. HSU JW , Hsu IW, Xu D, Miyamoto H, et al
    Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor.
    Am J Pathol. 2013 Mar 8. pii: S0002-9440(13)00102.
    Abstract     Related articles   

  273. GACCI M , Saleh O, Cai T, Gore JL, et al
    Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors.
    Health Qual Life Outcomes. 2013;11:43.
    Abstract     Related articles   

  274. MAO Y , Xu X, Lin Y, Chen H, et al
    Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.
    World J Surg Oncol. 2013;11:58.
    Abstract     Related articles   

  275. TANG K , Lin Y, Li LM
    The Role of Phenethyl Isothiocyanate on Bladder Cancer ADM Resistance Reversal and Its Molecular Mechanism.
    Anat Rec (Hoboken). 2013 Mar 13. doi: 10.1002/ar.22677.
    Abstract     Related articles   

  276. REEK C , Rink M, Bloch M, Hansen J, et al
    [Quality of care in patients with newly diagnosed bladder cancer : A prospective assessment in northern Germany.]
    Urologe A. 2013.
    Abstract     Related articles   

  277. DIP N , Reis ST, Srougi M, Dall'oglio MF, et al
    Expression profile of microrna-145 in urothelial bladder cancer.
    Int Braz J Urol. 2013;39:95-102.
    Abstract     Related articles   

  278. KOULOULIAS V , Tolia M, Kolliarakis N, Siatelis A, et al
    Evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.
    Int Braz J Urol. 2013;39:77-82.
    Abstract     Related articles   

  279. WILLSON TD , Revesz E, Podbielski FJ, Connolly MM, et al
    Unusual findings in a benign urachal tumor.
    Am Surg. 2013;79:E76-7.
    Abstract     Related articles   

  280. CHUNG MS , Lee SH, Lee DH, Chung BH, et al
    Evaluation of the 7th American Joint Committee on cancer TNM staging system for prostate cancer in point of classification of bladder neck invasion.
    Jpn J Clin Oncol. 2013;43:184-8.
    Abstract     Related articles   

  281. ZHANG Z , Zhang C, Liu R, Qiao B, et al
    New retractor facilitates exposure of the vascular pedicles in Chinese men with complex pelvis during radical cystectomy.
    Jpn J Clin Oncol. 2013;43:189-92.
    Abstract     Related articles   

  282. PARK MG , Oh MM, Yoon JH, Park JY, et al
    The value of plasma osteopontin levels as a predictive factor of disease stage and recurrence in patients with bladder urothelial carcinoma: a prospective study.
    Kaohsiung J Med Sci. 2012;28:526-30.
    Abstract     Related articles   

  283. RECHNER LA , Howell RM, Zhang R, Etzel C, et al
    Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer.
    Phys Med Biol. 2012;57:7117-32.
    Abstract     Related articles   

  284. KRAWCZYK M , Zimmermann S, Vidacek D, Lammert F, et al
    Intraperitoneal catumaxomab therapy in a cirrhotic patient with malignant ascites due to urethelial carcinoma: a case report.
    Onkologie. 2012;35:592-4.
    Abstract     Related articles   

  285. KAYA AO , Coskun U, Ozkan M, Sevinc A, et al
    Paclitaxel plus doxorubicin chemotherapy as second-line therapy in patients with advanced urothelial carcinoma pretreated with platinum plus gemcitabine chemotherapy.
    Onkologie. 2012;35:576-80.
    Abstract     Related articles   

  286. GHOZLANI I , Biyi A, Doudouh A, Maghraoui AE, et al
    Osteomalacia as a complication of ileal neobladder.
    Intern Med. 2012;51:2845.
    Abstract     Related articles   

  287. SCHNEIDER NI , Zigeuner R, Langner C
    Small cell carcinoma of the urinary bladder: a rare tumor with propensity for hepatic involvement.
    Am J Med Sci. 2013;345:155-7.
    Abstract     Related articles   

  288. WEI L , Liu JJ, Cao J, Du NC, et al
    [Role of autophagy in quercetin-induced apoptosis in human bladder carcinoma BIU-87 cells].
    Zhonghua Zhong Liu Za Zhi. 2012;34:414-8.
    Abstract     Related articles   

  289. CHEN X , Wang Y, Luo H, Luo Z, et al
    beta-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1.
    Mol Med Rep. 2012;6:989-95.
    Abstract     Related articles   

  290. SIMA J , Zhu MY, Ai Q, Zhang C, et al
    [Expression analysis of NOTCH1/HES1/PTEN signaling pathway in invasive bladder transitional cell carcinoma].
    Zhonghua Yi Xue Za Zhi. 2012;92:964-7.
    Abstract     Related articles   

  291. TAKEUCHI M , Kawai T, Ito M, Ogawa M, et al
    Split-bolus CT-urography using dual-energy CT: Feasibility, image quality and dose reduction.
    Eur J Radiol. 2012.
    Abstract     Related articles   

  292. LI QY , Tang J, He EH, Li YM, et al
    Clinical utility of three-dimensional contrast-enhanced ultrasound in the differentiation between noninvasive and invasive neoplasms of urinary bladder.
    Eur J Radiol. 2012.
    Abstract     Related articles   

  293. SWIETEK N , Waldert M, Susani M, Schatzl G, et al
    Intravesical bacillus Calmette-Guerin instillation therapy for non-muscle-invasive bladder cancer following solid organ transplantation.
    Wien Klin Wochenschr. 2013.
    Abstract     Related articles   

  294. SRIVASTAVA AK , Singh PK, Srivastava K, Singh D, et al
    Diagnostic Role of Survivin in Urinary Bladder Cancer.
    Asian Pac J Cancer Prev. 2013;14:81-85.
    Abstract     Related articles   

  295. OTTO T
    Correspondence (letter to the editor): Surgical Resection Should Be Viewed With Skepticism in Patients With Bladder Cancer.
    Dtsch Arztebl Int. 2013;110:176.
    Abstract     Related articles   

  296. KHADJAVI A , Notarpietro A, Mannu F, Pantaleo A, et al
    A high-throughput assay for the detection of Tyr-phosphorylated proteins in urine of bladder cancer patients.
    Biochim Biophys Acta. 2013 Mar 22. pii: S0304-4165(13)00094.
    Abstract     Related articles   

  297. SOHN W , Lee HJ, Ahlering TE
    Robotic surgery: review of prostate and bladder cancer.
    Cancer J. 2013;19:133-9.
    Abstract     Related articles   


  298. Bladder cancer: Urinary proteins identified as cancer-associated.
    Nat Rev Urol. 2013 Mar 26. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  299. SHEN HB , Gu ZQ, Jian K, Qi J, et al
    CXCR4-mediated Stat3 activation is essential for CXCL12-induced cell invasion in bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  300. FELIPE KB , Benites J, Glorieux C, Sid B, et al
    Antiproliferative effects of phenylaminonaphthoquinones are increased by ascorbate and associated with the appearance of a senescent phenotype in human bladder cancer cells.
    Biochem Biophys Res Commun. 2013 Mar 21. pii: S0006-291X(13)00443.
    Abstract     Related articles   

  301. RESNICK MJ , Chang SS
    Optimizing outcomes for octogenarians with invasive bladder cancer: One size does not fit all.
    Urol Oncol. 2013;31:1-4.
    Abstract     Related articles   

  302. WAN FC , Cui YP, Wu JT, Wang JM, et al
    The PPI network and cluster ONE analysis to explain the mechanism of bladder cancer.
    Eur Rev Med Pharmacol Sci. 2013;17:618-23.
    Abstract     Related articles   

  303. CHANG SS
    Non-muscle invasive bladder cancer.
    Urol Clin North Am. 2013;40:xiii.
    Abstract     Related articles   

  304. RITCH CR , Clark PE, Morgan TM
    Restaging transurethral resection for non-muscle invasive bladder cancer: who, why, when, and how?
    Urol Clin North Am. 2013;40:295-304.
    Abstract     Related articles   

  305. GILLESPIE JA , O'Donnell MA
    New imaging techniques for non-muscle invasive bladder cancer: ready for primetime.
    Urol Clin North Am. 2013;40:271-9.
    Abstract     Related articles   

  306. JAMES AC , Gore JL
    The costs of non-muscle invasive bladder cancer.
    Urol Clin North Am. 2013;40:261-9.
    Abstract     Related articles   

  307. AHN JJ , McKiernan JM
    New agents for bacillus calmette-guerin-refractory bladder cancer.
    Urol Clin North Am. 2013;40:219-32.
    Abstract     Related articles   

  308. TAO L , Day BW, Hu B, Xiang YB, et al
    Elevated 4-Aminobiphenyl and 2, 6-Dimethylaniline Hemoglobin Adducts and Increased Risk of Bladder Cancer among Lifelong Nonsmokers - The Shanghai Bladder Cancer Study.
    Cancer Epidemiol Biomarkers Prev. 2013.
    Abstract     Related articles   

  309. ROBAT C , Burton J, Thamm D, Vail D, et al
    Retrospective evaluation of doxorubicin-piroxicam combination for the treatment of transitional cell carcinoma in dogs.
    J Small Anim Pract. 2013;54:67-74.
    Abstract     Related articles   

  310. YAGER JW , Gentry PR, Thomas RS, Pluta L, et al
    Evaluation of gene expression changes in human primary uroepithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites.
    Environ Mol Mutagen. 2013;54:82-98.
    Abstract     Related articles   

  311. ZHAO L , Wang Y, Qu N, Huang C, et al
    Significance of plasma osteopontin levels in patients with bladder urothelial carcinomas.
    Mol Diagn Ther. 2012;16:311-6.
    Abstract     Related articles   

  312. JENTZMIK F , Schrader M, de Petriconi R, Hefty R, et al
    [Radical cystectomy and ileal neobladder reconstruction in elderly female patients over 70 years old: morbidity, functional and oncological long-term results].
    Urologe A. 2012;51:1419-23.
    Abstract     Related articles   

  313. ROGHMANN F , Noldus J, von Bodman C, Holz A, et al
    [Cystectomy in elderly patients: analysis of complications using the Clavien-Dindo classification].
    Urologe A. 2012;51:1386-92.
    Abstract     Related articles   

  314. JOHNSON JA , Colmers IN
    Balancing the risks and benefits for pioglitazone in type 2 diabetes.
    Diabetes Res Clin Pract. 2012;98:1-2.
    Abstract     Related articles   

  315. RABINOVICH J , Klotz T
    [Multiple synchronous urinary tract tumors in a hemodialysis patient].
    Urologe A. 2012;51:1447-9.
    Abstract     Related articles   

  316. SERONT E , Rottey S, Sautois B, Kerger J, et al
    Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.
    Ann Oncol. 2012;23:2663-70.
    Abstract     Related articles   

  317. WANG H , Liu W, Jin J, Zhou L, et al
    M-ds-P21 induces cell apoptosis in bladder cancer T24 cells through P53 independent pathway.
    J Cancer Res Ther. 2013;9:54-9.
    Abstract     Related articles   

  318. HAFEEZ S , Huddart R
    Advances in bladder cancer imaging.
    BMC Med. 2013;11:104.
    Abstract     Related articles   

  319. AYARI C , Larue H, Hovington H, Caron A, et al
    High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
    Hum Pathol. 2013 Apr 8. pii: S0046-8177(13)00047.
    Abstract     Related articles   

  320. ZHANG H , Qi F, Cao Y, Zu X, et al
    5-Aza-2'-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line.
    Cancer Biother Radiopharm. 2013.
    Abstract     Related articles   

  321. LIN YL , Ma JH, Luo XL, Guan TY, et al
    Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.
    J Int Med Res. 2013;41:48-54.
    Abstract     Related articles   

  322. MA JG , He ZK, Ma JH, Li WP, et al
    Downregulation of protocadherin-10 expression correlates with malignant behaviour and poor prognosis in human bladder cancer.
    J Int Med Res. 2013;41:38-47.
    Abstract     Related articles   

  323. WU K , Wang X, Xie Z, Liu Z, et al
    N-acetyltransferase 1 polymorphism and bladder cancer susceptibility: a meta-analysis of epidemiological studies.
    J Int Med Res. 2013;41:31-7.
    Abstract     Related articles   

  324. BOMAN K , Segersten U, Ahlgren G, Eberhard J, et al
    Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.
    BMC Urol. 2013;13:17.
    Abstract     Related articles   

  325. DELTO JC , Kobayashi T, Benson M, McKiernan J, et al
    Preclinical analyses of intravesical chemotherapy for prevention of bladder cancer progression.
    Oncotarget. 2013;4:269-76.
    Abstract     Related articles   

  326. SERRETTA V , Colombo R
    [Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer.]
    Urologia. 2013;0:0.
    Abstract     Related articles   

  327. COLOMBO R , Maccagnano C, Rocchini L, Pellucchi F, et al
    [When the conservative treatment in high-risk non-muscle invasive bladder cancer patients should be abandoned.]
    Urologia. 2013;0:0.
    Abstract     Related articles   

  328. CICIONE A , Cantiello F, Damiano R
    [Cystoscopy in non-muscle-invasive bladder cancer: when and how (rigid or flexible).]
    Urologia. 2013;0:0.
    Abstract     Related articles   

  329. HO CC , Huang AC, Yu CS, Lien JC, et al
    Ellagic acid induces apoptosis in tsgh8301 human bladder cancer cells through the endoplasmic reticulum stress- and mitochondria-dependent signaling pathways.
    Environ Toxicol. 2013 Mar 30. doi: 10.1002/tox.21857.
    Abstract     Related articles   

  330. YONEDA S , Kinjo T, Nonomura D, Yamamoto Y, et al
    [A case of bladder cancer with metastasis to the bone of the hand].
    Hinyokika Kiyo. 2013;59:129-31.
    Abstract     Related articles   

  331. PAN CC
    Does muscularis mucosae invasion in extensively lamina propria-invasive high-grade papillary urothelial carcinoma provide additional prognostic information?
    Am J Surg Pathol. 2013;37:459-60.
    Abstract     Related articles   

  332. YASUDA K , Nakamura M, Takamoto D, Sanjo H, et al
    [A case of long-term survivor after combined modality therapy for brain metastasis of bladder carcinoma].
    Hinyokika Kiyo. 2012;58:553-6.
    Abstract     Related articles   

  333. NAKAMURA T
    Bladder carcinoma with shadow cell differentiation: a case report with immunohistochemical analyses.
    Int J Clin Exp Pathol. 2012;5:840-4.
    Abstract     Related articles   

  334. WOLIN KY , Stoll C
    Physical activity and urologic cancers.
    Urol Oncol. 2012;30:729-34.
    Abstract     Related articles   

  335. VAN DER HORST G , Bos L, van der Pluijm G
    Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma.
    Mol Cancer Res. 2012;10:995-1009.
    Abstract     Related articles   

  336. HELISSEY C , Chargari C, Lahutte M, Ricard D, et al
    First case of posterior reversible encephalopathy syndrome associated with vinflunine.
    Invest New Drugs. 2012;30:2032-4.
    Abstract     Related articles   

  337. LIN CT , Tung CL, Tsai YS, Shen CH, et al
    Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma.
    Urol Oncol. 2012;30:680-7.
    Abstract     Related articles   

  338. HENRIQUEZ-HERNANDEZ LA , Navarro P, Luzardo OP, Alvarez-Leon EE, et al
    Polymorphisms of glutathione S-transferase mu and theta, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study.
    Urol Oncol. 2012;30:660-5.
    Abstract     Related articles   

  339. OLIVO M , Lucky SS, Kent Mancer JF, Lau WK, et al
    Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
    Urol Oncol. 2012;30:624-34.
    Abstract     Related articles   

  340. ZHANG H , Aina OH, Lam KS, de Vere White R, et al
    Identification of a bladder cancer-specific ligand using a combinatorial chemistry approach.
    Urol Oncol. 2012;30:635-45.
    Abstract     Related articles   

  341. BI J , Chen X, Zhang Y, Li B, et al
    Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
    Urol Oncol. 2012;30:688-94.
    Abstract     Related articles   

  342. XU WP , Cao DX, Lin ZM, Wu GH, et al
    Analysis of energy utilization and body composition in kidney, bladder, and adrenal cancer patients.
    Urol Oncol. 2012;30:711-8.
    Abstract     Related articles   

  343. PING SY , Wu CL, Yu DS
    Sunitinib can enhance BCG mediated cytotoxicity to transitional cell carcinoma through apoptosis pathway.
    Urol Oncol. 2012;30:652-9.
    Abstract     Related articles   

  344. KIM EJ , Yan C, Ha YS, Jeong P, et al
    Analysis of hOGG1 genotype as a prognostic marker for muscle invasive bladder cancer: a novel approach using peptide nucleic acid-mediated, real-time PCR clamping.
    Urol Oncol. 2012;30:673-9.
    Abstract     Related articles   

  345. ZHANG NZ , Chen J, Ma L, Xu ZS, et al
    Clinical characteristics of bladder urothelial tumors in male patients--the influences of benign prostatic hyperplasia/benign prostatic enlargement.
    Urol Oncol. 2012;30:646-51.
    Abstract     Related articles   

  346. LI Y , Xu X, Song L, Hou Y, et al
    Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer.
    Gigascience. 2012;1:12.
    Abstract     Related articles   

  347. YANG X , Yuan DD, Jiang XJ, Xi ZJ, et al
    [Cisplatin enhances apoptosis in bladder cancer cells via autophagy.]
    Beijing Da Xue Xue Bao. 2013;45:221-226.
    Abstract     Related articles   

  348. SABIR EF , Holmang S, Liedberg F, Ljungberg B, et al
    Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden.
    Scand J Urol. 2013.
    Abstract     Related articles   

  349. KOBAYASHI S , Koga F, Kajino K, Yoshita S, et al
    Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer.
    J Magn Reson Imaging. 2013 Apr 15. doi: 10.1002/jmri.24148.
    Abstract     Related articles   

  350. HSU I , Vitkus S, Da J, Yeh S, et al
    Role of oestrogen receptors in bladder cancer development.
    Nat Rev Urol. 2013 Apr 16. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  351. LIN J , Whalen M, Holder D, Hruby G, et al
    Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology.
    Can J Urol. 2013;20:6690-5.
    Abstract     Related articles   

  352. GARFIELD SS , Gavaghan MB, Armstrong SO, Jones JS, et al
    The cost-effectiveness of blue light cystoscopy in bladder cancer detection: United States projections based on clinical data showing 4.5 years of follow up after a single hexaminolevulinate hydrochloride instillation.
    Can J Urol. 2013;20:6682-9.
    Abstract     Related articles   

  353. MONTGOMERY JS , Miller DC, Weizer AZ
    Quality indicators in the management of bladder cancer.
    J Natl Compr Canc Netw. 2013;11:492-500.
    Abstract     Related articles   

  354. ABERN MR , Owusu RA, Anderson MR, Rampersaud EN, et al
    Perioperative intravesical chemotherapy in non-muscle-invasive bladder cancer: a systematic review and meta-analysis.
    J Natl Compr Canc Netw. 2013;11:477-84.
    Abstract     Related articles   

  355. CLARK PE , Agarwal N, Biagioli MC, Eisenberger MA, et al
    Bladder cancer.
    J Natl Compr Canc Netw. 2013;11:446-75.
    Abstract     Related articles   

  356. ARANTES-RODRIGUES R , Pinto-Leite R, Ferreira R, Neuparth MJ, et al
    Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer.
    Biomed Pharmacother. 2013 Feb 18. pii: S0753-3322(13)00013.
    Abstract     Related articles   

  357. LAZICA DA , Bottcher S, Degener S, von Rundstedt FC, et al
    [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
    Aktuelle Urol. 2013;44:124-8.
    Abstract     Related articles   

  358. D'ELISEO D , Manzi L, Velotti F
    Capsaicin as an inducer of damage-associated molecular patterns (DAMPs) of immunogenic cell death (ICD) in human bladder cancer cells.
    Cell Stress Chaperones. 2013.
    Abstract     Related articles   

  359. LI X , Su Y, Pan J, Zhou Z, et al
    Connexin 26 is Down-Regulated by KDM5B in the Progression of Bladder Cancer.
    Int J Mol Sci. 2013;14:7866-79.
    Abstract     Related articles   

  360. YOU W , Li Z, Jing C, Qian-Wei X, et al
    MTHFR C677T and A1298C Polymorphisms Were Associated with Bladder Cancer Risk and Disease Progression: A Meta-Analysis.
    DNA Cell Biol. 2013.
    Abstract     Related articles   

  361. ZHONG M , Gersbach E, Rohan SM, Yang XJ, et al
    Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance.
    Arch Pathol Lab Med. 2013;137:371-81.
    Abstract     Related articles   

  362. COMPERAT E , Jacquet SF, Varinot J, Conort P, et al
    Different subtypes of carcinoma in situ of the bladder do not have a different prognosis.
    Virchows Arch. 2013;462:343-8.
    Abstract     Related articles   

  363. ENACHE M , Simionescu C, Lascu LC
    Ki67 and Bcl-2 immunoexpression in primitive urothelial bladder carcinoma.
    Rom J Morphol Embryol. 2012;53:521-5.
    Abstract     Related articles   

  364. IZUMI K , Zheng Y, Hsu JW, Chang C, et al
    Androgen receptor signals regulate UDP-glucuronosyltransferases in the urinary bladder: a potential mechanism of androgen-induced bladder carcinogenesis.
    Mol Carcinog. 2013;52:94-102.
    Abstract     Related articles   

  365. ATASOY BM , Dane F, Alsan Cetin I, Ozgen Z, et al
    Concurrent chemoradiotherapy with low dose weekly gemcitabine in medically inoperable muscle-invasive bladder cancer patients.
    Clin Transl Oncol. 2013.
    Abstract     Related articles   

  366. SANO T , Hamada S, Haitani T, Nakashima M, et al
    Lung metastasis of ta bladder cancer: a case report and literature review.
    Korean J Urol. 2013;54:271-3.
    Abstract     Related articles   

  367. BARIONE DF , Lizarte FS, Novais PC, de Carvalho CA, et al
    Gene expression study related with the intrinsic pathway of apoptosis in bladder cancer by real-time PCR technique.
    Genet Mol Res. 2013;12:878-86.
    Abstract     Related articles   

  368. PAYTON S
    Bladder cancer: Biomarker panel predicts recurrence after radical cystectomy.
    Nat Rev Urol. 2013 Apr 23. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  369. WELK B , McIntyre A, Teasell R, Potter P, et al
    Bladder cancer in individuals with spinal cord injuries.
    Spinal Cord. 2013 Apr 23. doi: 10.1038/sc.2013.
    Abstract     Related articles   

  370. PADRAO AI , Oliveira P, Vitorino R, Colaco B, et al
    Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity.
    Int J Biochem Cell Biol. 2013 Apr 19. pii: S1357-2725(13)00119.
    Abstract     Related articles   

  371. DE MIGUEL-MARTINEZ I , Carrillo-Quintero D, Cano-Lira JF, Ojeda-Vargas M, et al
    [Kodamaea ohmeri: fungemia in a patient with invasive bladder cancer.]
    Enferm Infecc Microbiol Clin. 2013 Apr 19. pii: S0213-005X(13)00081.
    Abstract     Related articles   

  372. LIU X , Wu G, Hartmann C, Xing M, et al
    Highly prevalent TERT promoter mutations in bladder cancer and brain gliobastoma.
    Cell Cycle. 2013;12.
    Abstract     Related articles   

  373. ZHU YP , Bian XJ, Ye DW, Yao XD, et al
    -mannose-sensitive hemagglutinin inhibits proliferation and induces apoptosis in a caspase-dependent manner in human bladder cancer cell lines.
    Oncol Lett. 2013;5:1357-1362.
    Abstract     Related articles   

  374. CHEN X , Wang T, Yang D, Wang J, et al
    Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients.
    Oncol Lett. 2013;5:1278-1284.
    Abstract     Related articles   

  375. ARAS M , Ones T, Dane F, Nosheri O, et al
    False Positive FDG PET/CT Resulting from Fibrous Dysplasia of the Bone in the Work-Up of a Patient with Bladder Cancer: Case Report and Review of the Literature.
    Iran J Radiol. 2012;10:41-4.
    Abstract     Related articles   

  376. KIM JH , Shim JS, Noh TI, Ahn HJ, et al
    Concurrent bladder lymphoma and bladder cancer presenting as metastatic bladder cancer.
    World J Mens Health. 2012;30:141-5.
    Abstract     Related articles   

  377. BUCHNER A , May M, Burger M, Bolenz C, et al
    Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.
    Eur J Surg Oncol. 2013;39:372-9.
    Abstract     Related articles   

  378. BLOOM C , Chang B
    Case of the month. Foreign body.
    JAAPA. 2013;26:70.
    Abstract     Related articles   

  379. SENDUR MA , Aksoy S, Yazici O, Akinci MB, et al
    New treatment trends in small cell carcinoma of the urinary bladder.
    J BUON. 2012;17:799-800.
    Abstract     Related articles   

  380. JOHNSON DT , Luong R, Lee SH, Peng Y, et al
    Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.
    J Biol Chem. 2013;288:3727-38.
    Abstract     Related articles   

  381. CHHABRA S , Hegde P, Singhal P
    Primary small cell carcinoma of the urinary bladder--mini-review of the literature.
    Asian Pac J Cancer Prev. 2012;13:3549-53.
    Abstract     Related articles   

  382. ROUPRET M , Yates DR, Varinot J, Phe V, et al
    The presence of detrusor muscle in the pathological specimen after transurethral resection of primary pT1 bladder tumors and its relationship to operator experience.
    Can J Urol. 2012;19:6459-64.
    Abstract     Related articles   

  383. SADEGHI N , Badalato GM, Hruby G, Kates M, et al
    The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
    Can J Urol. 2012;19:6443-9.
    Abstract     Related articles   

  384. GOTOH A , Nagaya H, Kanno T, Nishizaki T, et al
    Antitumor action of alpha(1)-adrenoceptor blockers on human bladder, prostate and renal cancer cells.
    Pharmacology. 2012;90.
    Abstract     Related articles   

  385. LANG F , Linlin M, Ye T, Yuhai Z, et al
    Alterations of dendritic cell subsets and TH1/TH2 cytokines in the peripheral circulation of patients with superficial transitional cell carcinoma of the bladder.
    J Clin Lab Anal. 2012;26:365-71.
    Abstract     Related articles   

  386. HORSTMANN M , Kugler M, Anastasiadis AG, Walcher U, et al
    Laparoscopic radical cystectomy: initial experience using the single-incision triangulated umbilical surgery (SITUS) technique.
    World J Urol. 2012;30:619-24.
    Abstract     Related articles   

  387. BLOCHIN EB , Park KJ, Tickoo SK, Reuter VE, et al
    Urothelial carcinoma with prominent squamous differentiation in the setting of neurogenic bladder: role of human papillomavirus infection.
    Mod Pathol. 2012;25:1534-42.
    Abstract     Related articles   

  388. ALEXANDER RE , Hu Y, Kum JB, Montironi R, et al
    p16 expression is not associated with human papillomavirus in urinary bladder squamous cell carcinoma.
    Mod Pathol. 2012;25:1526-33.
    Abstract     Related articles   

  389. MAY M , Stief C, Brookman-May S, Otto W, et al
    Gender-dependent cancer-specific survival following radical cystectomy.
    World J Urol. 2012;30:707-13.
    Abstract     Related articles   

  390. NEUHAUS J , Schulte-Baukloh H, Stolzenburg JU, Speroni di Fenizio P, et al
    Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC).
    World J Urol. 2012;30:693-700.
    Abstract     Related articles   

  391. ZHANG F , Wu JH, Zhao W, Liu HT, et al
    XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  392. AJILI F , Kourda N, Karay S, Darouiche A, et al
    Impact of Smoking intensity on Outcomes of Patients with Non Muscle Invasive Bladder Cancer Treated by BCG Immunotherapy.
    Ultrastruct Pathol. 2013.
    Abstract     Related articles   

  393. AJILI F , Darouiche A, Chebil M, Boubaker S, et al
    The Impact of Age and Clinical Factors in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette Guerin Therapy.
    Ultrastruct Pathol. 2013.
    Abstract     Related articles   

  394. IKEDA M , Motoshima T, Kurosawa K, Fujii Y, et al
    [Efficacy and safety of maintenance intravesical instillation therapy with bacillus calmette-guerin and epirubicin for non-muscle invasive bladder cancer].
    Hinyokika Kiyo. 2013;59:153-7.
    Abstract     Related articles   

  395. CHEN CL , Lin TS, Tsai CH, Wu CC, et al
    Identification of Potential Bladder Cancer Markers in Urine by Abundant-Protein Depletion Coupled with Quantitative Proteomics.
    J Proteomics. 2013 Apr 27. pii: S1874-3919(13)00213.
    Abstract     Related articles   

  396. KANDIMALLA R , van Tilborg AA, Zwarthoff EC
    DNA methylation-based biomarkers in bladder cancer.
    Nat Rev Urol. 2013 Apr 30. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  397. BASSETT JC , Chang SS
    Treating octogenarians with muscle-invasive bladder cancer: Preoperative opportunities for increasing the benefits of surgical intervention.
    Urol Oncol. 2013 Apr 26. pii: S1078-1439(13)00132.
    Abstract     Related articles   

  398. GAI JW , Wahafu W, Hsieh YC, Liu M, et al
    Inhibition of presenilins attenuates proliferation and invasion in bladder cancer cells through multiple pathways.
    Urol Oncol. 2013 Apr 26. pii: S1078-1439(13)00090.
    Abstract     Related articles   

  399. LAMM D , Brausi M, O'Donnell MA, Witjes JA, et al
    Interferon alfa in the treatment paradigm for non-muscle-invasive bladder cancer.
    Urol Oncol. 2013 Apr 26. pii: S1078-1439(13)00073.
    Abstract     Related articles   

  400. LAMBROU GI , Adamaki M, Delakas D, Spandidos DA, et al
    Gene expression is highly correlated on the chromosome level in urinary bladder cancer.
    Cell Cycle. 2013;12.
    Abstract     Related articles   

  401. FAHMY M , Mansure JJ, Brimo F, Yafi FA, et al
    Relevance of the mammalian target of rapamycin pathway in the prognosis of patients with high-risk non-muscle invasive bladder cancer.
    Hum Pathol. 2013 Apr 23. pii: S0046-8177(13)00078.
    Abstract     Related articles   

  402. KONG CZ , Zhang Z
    Bcl-2 Overexpression Inhibits Generation of Intracellular Reactive Oxygen Species and Blocks Adriamycin-induced Apoptosis in Bladder Cancer Cells.
    Asian Pac J Cancer Prev. 2013;14:895-901.
    Abstract     Related articles   

  403. VERIM L , Toptas B, Ozkan NE, Cacina C, et al
    Possible Relation between the NOS3 Gene GLU298ASP Polymorphism and Bladder Cancer in Turkey.
    Asian Pac J Cancer Prev. 2013;14:665-8.
    Abstract     Related articles   

  404. HUANG YJ , Qi WX, He AN, Sun YJ, et al
    Prognostic Value of Tissue Vascular Endothelial Growth Factor Expression in Bladder Cancer: a Meta-analysis.
    Asian Pac J Cancer Prev. 2013;14:645-9.
    Abstract     Related articles   

  405. TSENG CH
    Rosiglitazone is not associated with an increased risk of bladder cancer.
    Cancer Epidemiol. 2013 Apr 22. pii: S1877-7821(13)00046.
    Abstract     Related articles   

  406. HU Z , Lin Y, Chen H, Mao Y, et al
    MicroRNA-101 suppresses motility of bladder cancer cells by targeting c-Met.
    Biochem Biophys Res Commun. 2013 Apr 22. pii: S0006-291X(13)00668.
    Abstract     Related articles   

  407. FERRIS J , Berbel O, Alonso-Lopez J, Garcia J, et al
    Environmental non-occupational risk factors associated with bladder cancer.
    Actas Urol Esp. 2013 Apr 22. pii: S0210-4806(13)00060.
    Abstract     Related articles   

  408. DE VRIES F , Zeegers M, Goossens ME
    Pioglitazone and bladder cancer: two studies, same database, two answers.
    Br J Clin Pharmacol. 2013 Apr 25. doi: 10.1111/bcp.12145.
    Abstract     Related articles   

  409. LOWTHER C , Miedler JD, Cockerell CJ
    Id-like reaction to BCG therapy for bladder cancer.
    Cutis. 2013;91:145-6.
    Abstract     Related articles   

  410. KAISER J
    Biomedicine. Rare cancer successes spawn 'exceptional' research efforts.
    Science. 2013;340:263.
    Abstract     Related articles   

  411. MAITI PK , Jana U, Ray A, Karmakar R, et al
    Patterns of cancer occurrence in different regions of West Bengal--a hospital based study.
    J Indian Med Assoc. 2012;110:445-8.
    Abstract     Related articles   

  412. OKANE K , Kizu N, Kanda S, Chiba S, et al
    [An adult case of rhabdmyosarcoma of the urinary bladder].
    Hinyokika Kiyo. 2012;58:691-4.
    Abstract     Related articles   

  413. CANNIZZARO LA
    Fluorescent in situ hybridization of DNA probes in the interphase and metaphase stages of the cell cycle.
    Methods Mol Biol. 2013;946:61-83.
    Abstract     Related articles   

  414. NAUGHTON JF , Widmer WR, Constable PD, Knapp DW, et al
    Accuracy of three-dimensional and two-dimensional ultrasonography for measurement of tumor volume in dogs with transitional cell carcinoma of the urinary bladder.
    Am J Vet Res. 2012;73:1919-24.
    Abstract     Related articles   

  415. LEE YR , Chen YW, Tsai MC, Chou HC, et al
    Redox- and expression-proteomic analysis of plasma biomarkers in bladder transitional cell carcinoma.
    Mol Biosyst. 2012;8:3314-24.
    Abstract     Related articles   

  416. STEWART JD , Marchan R
    Polymorphisms hit the headlines.
    Arch Toxicol. 2012;86:1637-9.
    Abstract     Related articles   

  417. DREWA T , Adamowicz J, Sharma A
    Tissue engineering for the oncologic urinary bladder.
    Nat Rev Urol. 2012;9:561-72.
    Abstract     Related articles   

  418. HO PL , Kurtova A, Chan KS
    Normal and neoplastic urothelial stem cells: getting to the root of the problem.
    Nat Rev Urol. 2012;9:583-94.
    Abstract     Related articles   

  419. XIE XL , Wei M, Yunoki T, Kakehashi A, et al
    Long-term treatment with L-isoleucine or L-leucine in AIN-93G diet has promoting effects on rat bladder carcinogenesis.
    Food Chem Toxicol. 2012;50:3934-40.
    Abstract     Related articles   

  420. KONING CC , Blank LE, Koedooder C, van Os RM, et al
    Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors.
    Ann Oncol. 2012;23:2948-53.
    Abstract     Related articles   

  421. HILLAIRE-BUYS D , Faillie JL, Montastruc JL, Petit P, et al
    Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!
    Eur J Clin Pharmacol. 2012;68:1681-3.
    Abstract     Related articles   

  422. TRINDADE AJ , Khaitov S, Potack JZ, Hall SJ, et al
    Successful EUS-guided FNA through a colonic stent array for diagnosis of an extraluminal pelvic malignancy causing colonic obstruction.
    Gastrointest Endosc. 2012;76:1070-2.
    Abstract     Related articles   

  423. GUST KM , McConkey DJ, Awrey S, Hegarty PK, et al
    Fibroblast Growth Factor Receptor 3 is a Rational Therapeutic Target in Bladder Cancer.
    Mol Cancer Ther. 2013.
    Abstract     Related articles   

  424. HULSHOF MC , Pieters BR, Koning CC
    [Bladder-conserving treatment for bladder cancer: potential of and developments in radiotherapy].
    Ned Tijdschr Geneeskd. 2013;157:A5556.
    Abstract     Related articles   

  425. HIDAS G , Pode D, Shapiro A, Katz R, et al
    The natural history of secondary muscle-invasive bladder cancer.
    BMC Urol. 2013;13:23.
    Abstract     Related articles   

  426. HATEFI N , Nouraee N, Parvin M, Ziaee SA, et al
    Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer.
    Iran J Basic Med Sci. 2012;15:1154-61.
    Abstract     Related articles   

  427. LI K , Hu YP, Yang Z, Sun T, et al
    Association between MTHFR Ala222Val (rs1801133) polymorphism and bladder cancer susceptibility: a systematic review and meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  428. PIANTINO CB , Reis ST, Viana NI, Silva IA, et al
    Prima-1 induces apoptosis in bladder cancer cell lines by activating p53.
    Clinics (Sao Paulo). 2013;68:297-303.
    Abstract     Related articles   

  429. ALDEBASI YH , Rahmani AH, Khan AA, Aly SM, et al
    The effect of vascular endothelial growth factor in the progression of bladder cancer and diabetic retinopathy.
    Int J Clin Exp Med. 2013;6:239-51.
    Abstract     Related articles   

  430. MAO S , Huang S
    Zinc and Copper Levels in Bladder Cancer: A Systematic Review and Meta-Analysis.
    Biol Trace Elem Res. 2013.
    Abstract     Related articles   

  431. OUERHANI S , Bougatef K, Soltani I, Elgaaied AB, et al
    The prevalence and prognostic significance of KRAS mutation in bladder cancer, chronic myeloid leukemia and colorectal cancer.
    Mol Biol Rep. 2013;40:4109-14.
    Abstract     Related articles   

  432. LIU D , Zhang Z, Kong CZ
    High FOXM1 expression was associated with bladder carcinogenesis.
    Tumour Biol. 2013;34:1131-8.
    Abstract     Related articles   

  433. GONZALEZ-ROIBON ND , Chaux A, Al-Hussain T, Osunkoya AO, et al
    Dysregulation of mammalian target of rapamycin pathway in plasmacytoid variant of urothelial carcinoma of the urinary bladder.
    Hum Pathol. 2013;44:612-22.
    Abstract     Related articles   

  434. QIU YT , Yang C, Chen MJ, Qiu WL, et al
    Metastatic spread to the mandibular condyle as initial clinical presentation: radiographic diagnosis and surgical experience.
    J Oral Maxillofac Surg. 2013;71:809-20.
    Abstract     Related articles   

  435. AARNIO M , Saily M, Juhola M, Gylling A, et al
    Uroepithelial and kidney carcinoma in Lynch syndrome.
    Fam Cancer. 2012;11:395-401.
    Abstract     Related articles   

  436. LIU L , Zhao X, Zhu X, Zhong Z, et al
    Decreased expression of miR-430 promotes the development of bladder cancer via the upregulation of CXCR7.
    Mol Med Rep. 2013 May 16. doi: 10.3892/mmr.2013.1477.
    Abstract     Related articles   

  437. FEKI-TOUNSI M , Olmedo P, Gil F, Khlifi R, et al
    Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking.
    Environ Sci Pollut Res Int. 2013.
    Abstract     Related articles   

  438. MOHAMMED MA , Seleim MF, Abdalla MS, Sharada HM, et al
    Urinary high molecular weight matrix metalloproteinases as non-invasive biomarker for detection of bladder cancer.
    BMC Urol. 2013;13:25.
    Abstract     Related articles   

  439. ZLOTTA AR
    Bladder cancer: Validating what we've got.
    Can Urol Assoc J. 2013;7.
    Abstract     Related articles   

  440. ISCHIA J , So AI
    The role of heat shock proteins in bladder cancer.
    Nat Rev Urol. 2013 May 14. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  441. AZUMA T , Nagase Y, Oshi M
    Pyuria Predicts Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2013 May 8. pii: S1558-7673(13)00048.
    Abstract     Related articles   

  442. FERRIS J , Garcia J, Berbel O, Ortega JA, et al
    Constitutional and occupational risk factors associated with bladder cancer.
    Actas Urol Esp. 2013 May 8. pii: S0210-4806(13)00003.
    Abstract     Related articles   

  443. INAMOTO T , Ubai T, Nishida T, Fujisue Y, et al
    Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guerin prophylaxis in nonmuscle invasive bladder cancer: Results of a randomized prospective compari
    Urol Ann. 2013;5:7-12.
    Abstract     Related articles   

  444. LI F , Zhou Y, Hu RT, Hou LN, et al
    Egg consumption and risk of bladder cancer: a meta-analysis.
    Nutr Cancer. 2013;65:538-46.
    Abstract     Related articles   

  445. FOMIN DK , Tararukhina OB, Nazarov AA, Borisova OA, et al
    [Systemic radiotherapy options in the treatment of metastatic skeletal involvement].
    Vestn Rentgenol Radiol. 2012;:30-4.
    Abstract     Related articles   

  446. FERNANDES JC , Sereno J, Garrido P, Parada B, et al
    Inhibition of bladder tumor growth by chitooligosaccharides in an experimental carcinogenesis model.
    Mar Drugs. 2012;10:2661-75.
    Abstract     Related articles   

  447. YIN L , Bu H, Chen M, Yu J, et al
    Perivascular epithelioid cell neoplasm of the urinary bladder in an adolescent: a case report and review of the literature.
    Diagn Pathol. 2012;7:183.
    Abstract     Related articles   

  448. NEOH CA , Wang RY, Din ZH, Su JH, et al
    Induction of apoptosis by sinulariolide from soft coral through mitochondrial-related and p38MAPK pathways on human bladder carcinoma cells.
    Mar Drugs. 2012;10:2893-911.
    Abstract     Related articles   

  449. TADIN T , Krpina K, Stifter S, Babarovic E, et al
    Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
    Diagn Pathol. 2012;7:152.
    Abstract     Related articles   

  450. CHENG SH , Wang SS, Lee CH, Ou YC, et al
    Malignant solitary fibrous tumor of the urinary bladder.
    J Chin Med Assoc. 2012;75:479-82.
    Abstract     Related articles   

  451. CONDE D , Fernandez MA, Rueda C, Salvador B, et al
    Classification of samples into two or more ordered populations with application to a cancer trial.
    Stat Med. 2012;31:3773-86.
    Abstract     Related articles   

  452. FAY MP , Shih JH
    Weighted logrank tests for interval censored data when assessment times depend on treatment.
    Stat Med. 2012;31:3760-72.
    Abstract     Related articles   

  453. ZHU Z , Shen Z, Xu C
    Targeted therapy for advanced urothelial cancer of the bladder: where do we stand?
    Anticancer Agents Med Chem. 2012;12:1081-7.
    Abstract     Related articles   

  454. VALERO-AGUILERA B , Bermudez-Tamayo C, Garcia-Gutierrez JF, Jimenez-Pernett J, et al
    Factors related to use of the Internet as a source of health information by urological cancer patients.
    Support Care Cancer. 2012;20:3087-94.
    Abstract     Related articles   

  455. SCHREIBER D , Rineer J, Weiss J, Leaf A, et al
    Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database.
    Am J Clin Oncol. 2013;36:126-31.
    Abstract     Related articles   

  456. DANCKERS DEGREGORI M , Zhou F, Nimeh D, Steiger D, et al
    Metastatic Bladder Cancer in a Patient With Active Wegener's Vasculitis.
    Chest. 2012;142.
    Abstract     Related articles   

  457. JOSEPH R , Aslam S, Wehbeh W, Fleming R, et al
    BCG Sepsis Following Intravesical BCG Administration for the Treatment of Bladder Cancer.
    Chest. 2012;142.
    Abstract     Related articles   

  458. MARCHBANK T , Mahmood A, Playford RJ
    Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration & invasion in bladder cancer & phosphorylates the EGF receptor, Akt 2 & 3, ERK1 & 2.
    Am J Physiol Renal Physiol. 2013.
    Abstract     Related articles   

  459. HAN B , Luan L, Xu Z, Wu B, et al
    Expression and biological roles of SATB1 in human bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  460. TAO W , Yang D, Shan Y, Xue B, et al
    Safety and efficacy of 120w high performance system greenlight laser vaporization for non-muscle-invasive bladder cancer.
    J Xray Sci Technol. 2013;21:309-16.
    Abstract     Related articles   

  461. CHHATRE S , Metzger DS, Woody G, Malkowicz SB, et al
    Substance abuse and quality of care in non-muscle invasive bladder cancer patients.
    Value Health. 2013;16:A200.
    Abstract     Related articles   

  462. DAVIS SR , Tao X, Bernacki EJ, Alfriend AS, et al
    Evaluation of a bladder cancer cluster in a population of criminal investigators with the bureau of alcohol, tobacco, firearms and explosives-part 2: the association of cancer risk and fire scene investigation.
    J Environ Public Health. 2013;2013:986023.
    Abstract     Related articles   

  463. KHOUBI J , Pourabdian S, Mohebbi I, Tajvidi M, et al
    Association between the high risk occupations and bladder cancer in Iran: A case-control study.
    Int J Occup Med Environ Health. 2013.
    Abstract     Related articles   

  464. FURBERG H , Bochner BH
    Bladder cancer: Towards risk stratification in bladder cancer.
    Nat Rev Urol. 2013 May 21. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  465. LAN KJ , Zhang ZH, Liang ZK, Wang JJ, et al
    [Construction of full-length human bladder cancer-specific antibody libraries based on mammalian display technology].
    Nan Fang Yi Ke Da Xue Xue Bao. 2013;33:684-91.
    Abstract     Related articles   

  466. HE W , Cai Q, Sun F, Zhong G, et al
    linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
    Biochim Biophys Acta. 2013 May 17. pii: S0925-4439(13)00164.
    Abstract     Related articles   

  467. ABOUMARZOUK OM , Hughes O, Narahari K, Drewa T, et al
    Safety and feasibility of Laparoscopic Radical Cystectomy for the treatment of bladder cancer.
    J Endourol. 2013.
    Abstract     Related articles   

  468. WADHWA N , Jatawa SK, Tiwari A
    Republished: Non-invasive urine based tests for the detection of bladder cancer.
    Postgrad Med J. 2013;89:352-7.
    Abstract     Related articles   

  469. YEGIN Z , Gunes S, Buyukalpelli R
    Hypermethylation of TWIST1 and NID2 in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients.
    DNA Cell Biol. 2013.
    Abstract     Related articles   

  470. TANEJA SS
    Urologic Clinics of North America. Diagnosis, evaluation, and treatment of non-muscle invasive bladder cancer. Foreword.
    Urol Clin North Am. 2013;40:xi.
    Abstract     Related articles   

  471. LARGE MC , Cohn JA, Steinberg GD
    Optimal risk-adapted surveillance strategies for NMIBC, including upper tract imaging.
    Urol Clin North Am. 2013;40:305-15.
    Abstract     Related articles   

  472. SANFRANCESCO J , Jones JS, Hansel DE
    Diagnostically challenging cases: what are atypia and dysplasia?
    Urol Clin North Am. 2013;40:281-93.
    Abstract     Related articles   

  473. INGIMARSSON JP , Seigne JD
    The conundrum of prostatic urethral involvement.
    Urol Clin North Am. 2013;40:249-59.
    Abstract     Related articles   

  474. DANESHMAND S
    Determining the role of cystectomy for high-grade T1 urothelial carcinoma.
    Urol Clin North Am. 2013;40:233-47.
    Abstract     Related articles   

  475. SHAH JB , Kamat AM
    Strategies for optimizing bacillus Calmette-Guerin.
    Urol Clin North Am. 2013;40:211-8.
    Abstract     Related articles   

  476. GRIFFIN JG , Holzbeierlein J
    Side effects of perioperative intravesical treatment and treatment strategies for these side effects.
    Urol Clin North Am. 2013;40:197-210.
    Abstract     Related articles   

  477. JOHNSON DC , Pruthi RS, Woods ME
    Perioperative chemotherapy: when to use it, what to use, and why.
    Urol Clin North Am. 2013;40:183-95.
    Abstract     Related articles   

  478. O'NEIL BB , Lowrance WT
    Office-based Bladder Tumor Fulguration and Surveillance: Indications and Techniques.
    Urol Clin North Am. 2013;40:175-82.
    Abstract     Related articles   

  479. TOMASINI JM , Konety BR
    Urinary markers/cytology: what and when should a urologist use.
    Urol Clin North Am. 2013;40:165-73.
    Abstract     Related articles   

  480. LAMMERS RJ , Sylvester RJ, Lee CT, Witjes JA, et al
    NMIBC risk calculators: how useful are they for the practicing urologist and how can their clinical utility be improved?
    Urol Clin North Am. 2013;40:155-64.
    Abstract     Related articles   

  481. KITAMURA Y , Yamada G, Narita Y, Kameda M, et al
    Bronchoscopic observation of endobronchial tumor cells.
    J Bronchology Interv Pulmonol. 2012;19:311-2.
    Abstract     Related articles   

  482. LODDE M , Mayr R, Martini T, Comploj E, et al
    Positive urine cytology and carcinoma in situ prior to second transurethral resection of the bladder correlate with positive second resection histology and the need for subsequent cystectomy.
    World J Urol. 2012;30:841-6.
    Abstract     Related articles   

  483. PORENA M , Mearini L, Zucchi A, Zingaro MD, et al
    Perugia ileal neobladder: functional results and complications.
    World J Urol. 2012;30:747-52.
    Abstract     Related articles   

  484. OTTO W , Denzinger S, Wieland WF, Hartmann A, et al
    First analysis of immune cell infiltration in stage pT1 urothelial bladder carcinoma: CD3 positivity as a prognostic marker for cancer-specific survival.
    World J Urol. 2012;30:875-7.
    Abstract     Related articles   

  485. RINK M , Shariat SF, Xylinas E, Fitzgerald JP, et al
    Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
    World J Urol. 2012;30:807-14.
    Abstract     Related articles   

  486. ALEXANDER RE , Lopez-Beltran A, Montironi R, MacLennan GT, et al
    KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas.
    Histopathology. 2012;61:1036-42.
    Abstract     Related articles   

  487. YANG ZJ , Liu FX, Yang YS, Yang X, et al
    Expression of bone-morphogenetic protein 2 and tumor necrosis factor alpha correlates with bone metastases in bladder urothelial carcinoma.
    Ann Diagn Pathol. 2013;17:51-3.
    Abstract     Related articles   

  488. QUINONES W , Ziober A, Yao Y, Bing Z, et al
    Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas.
    Ann Diagn Pathol. 2013;17:41-4.
    Abstract     Related articles   

  489. HUANG EY , Skinner EC, Boyd SD, Cai J, et al
    Radical cystectomy with orthotopic neobladder reconstruction following prior radical prostatectomy.
    World J Urol. 2012;30:741-5.
    Abstract     Related articles   

  490. TOLLEFSON MK , Boorjian SA, Farmer SA, Frank I, et al
    Downstaging to non-invasive urothelial carcinoma is associated with improved outcome following radical cystectomy for patients with cT2 disease.
    World J Urol. 2012;30:795-9.
    Abstract     Related articles   

  491. JEONG IG , You D, Kim J, Kim SC, et al
    Factors associated with non-orthotopic urinary diversion after radical cystectomy.
    World J Urol. 2012;30:815-20.
    Abstract     Related articles   

  492. RAMAN SP , Horton KM, Fishman EK
    Transitional cell carcinoma of the upper urinary tract: optimizing image interpretation with 3D reconstructions.
    Abdom Imaging. 2012;37:1129-40.
    Abstract     Related articles   

  493. NOVOTNY V , Zastrow S, Koch R, Wirth MP, et al
    Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality.
    World J Urol. 2012;30:769-76.
    Abstract     Related articles   

  494. CHROMECKI TF , Mauermann J, Cha EK, Svatek RS, et al
    Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy.
    World J Urol. 2012;30:753-9.
    Abstract     Related articles   

  495. PATSCHAN O , Shariat SF, Chade DC, Karakiewicz PI, et al
    Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder.
    World J Urol. 2012;30:785-94.
    Abstract     Related articles   

  496. NAGELE U , Anastasiadis AG, Stenzl A, Kuczyk M, et al
    Radical cystectomy with orthotopic neobladder for invasive bladder cancer: a critical analysis of long-term oncological, functional, and quality of life results.
    World J Urol. 2012;30:725-32.
    Abstract     Related articles   

  497. FANG Y , Cao Z, Hou Q, Ma C, et al
    Cyclin D1 Downregulation Contributes to Anti-Cancer Effect of Isorhapontigenin (ISO) on Human Bladder Cancer Cells.
    Mol Cancer Ther. 2013.
    Abstract     Related articles   

  498. MA B , Li H, Zhang C, Yang K, et al
    Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Eur J Surg Oncol. 2013 May 27. pii: S0748-7983(13)00367.
    Abstract     Related articles   

  499. WANG W , Li T, Han G, Li Y, et al
    Expression and role of miR-34a in bladder cancer.
    Indian J Biochem Biophys. 2013;50:87-92.
    Abstract     Related articles   

  500. CHU H , Wang M, Zhang Z
    Bladder cancer epidemiology and genetic susceptibility.
    J Biomed Res. 2013;27:170-8.
    Abstract     Related articles   

  501. KAWAMURA N , Matsushita M, Okada T, Ujike T, et al
    [Relative efficacy of neoadjuvant gemcitabine and Cisplatin versus methotrexate, vinblastine, adriamycin, and Cisplatin in the management for muscle-invasive bladder cancer].
    Hinyokika Kiyo. 2013;59:277-81.
    Abstract     Related articles   

  502. LAZICA DA , Degener S, Bottcher S, Brandt AS, et al
    [Impact of Operator Experience on TURB of High-Grade Non-Muscle-Invasive Bladder Cancer - Analysis of 254 Second Resections at a University Teaching Hospital].
    Aktuelle Urol. 2013;44:196-200.
    Abstract     Related articles   

  503. YOSHINO H , Seki N, Itesako T, Chiyomaru T, et al
    Aberrant expression of microRNAs in bladder cancer.
    Nat Rev Urol. 2013 May 28. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  504. FENNER A
    Bladder cancer: Outpatient laser ablation is an option for localized bladder cancer treatment.
    Nat Rev Urol. 2013 May 28. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  505. PAGLIARULO V , Ancona P, Niso M, Colabufo NA, et al
    The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.
    Mol Cancer. 2013;12:47.
    Abstract     Related articles   

  506. RAMBAU PF , Chalya PL, Jackson K
    Schistosomiasis and urinary bladder cancer in North Western Tanzania: a retrospective review of 185 patients.
    Infect Agent Cancer. 2013;8:19.
    Abstract     Related articles   

  507. YAO X , Li D, Xiong DM, Li L, et al
    A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
    Cell Tissue Res. 2013.
    Abstract     Related articles   

  508. WU S
    Imaging findings of atypical leiomyoma of the urinary bladder simulating bladder cancer: a case report and literature review.
    Med Ultrason. 2013;15:161-3.
    Abstract     Related articles   

  509. KOBAYASHI S , Fujii Y, Koga F, Yokoyama M, et al
    Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: A prospective validation study.
    Urol Oncol. 2013 May 20. pii: S1078-1439(13)00182.
    Abstract     Related articles   

  510. LIU Z , Antalek M, Nguyen L, Li X, et al
    The Effect of Gartanin, a Naturally Occurring Xanthone in Mangosteen Juice, on the mTOR Pathway, Autophagy, Apoptosis, and the Growth of Human Urinary Bladder Cancer Cell Lines.
    Nutr Cancer. 2013;65 Suppl 1:68-77.
    Abstract     Related articles   

  511. REETZ C , Crochik S, McKeirnan K, Rochat M, et al
    What is your diagnosis? Metastatic prostatic neoplasia.
    J Am Vet Med Assoc. 2013;242:35-7.
    Abstract     Related articles   

  512. SAMADIAN S , Phillips FM, Deeab D
    Mycobacterium bovis vertebral osteomyelitis and discitis with adjacent mycotic abdominal aortic aneurysm caused by intravesical BCG therapy: a case report in an elderly gentleman.
    Age Ageing. 2013;42:129-31.
    Abstract     Related articles   

  513. BORTOLINI M , Wright MB, Bopst M, Balas B, et al
    Examining the safety of PPAR agonists - current trends and future prospects.
    Expert Opin Drug Saf. 2013;12:65-79.
    Abstract     Related articles   

  514. ROBERTS WS , Davis F, Holmes JL, Collyer SD, et al
    Detection and imaging the expression of the trans-membrane protein CD44 in RT112 cells by use of enzyme-labeled antibodies and SECM.
    Biosens Bioelectron. 2013;41:282-8.
    Abstract     Related articles   

  515. KANG D , Cho HS, Toyokawa G, Kogure M, et al
    The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
    Genes Chromosomes Cancer. 2013;52:126-39.
    Abstract     Related articles   

  516. HAN Y , Liu Y, Gui Y, Cai Z, et al
    Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
    J Surg Oncol. 2013;107:555-9.
    Abstract     Related articles   

  517. PARK SY , Ollberding NJ, Woolcott CG, Wilkens LR, et al
    Fruit and Vegetable Intakes Are Associated with Lower Risk of Bladder Cancer among Women in the Multiethnic Cohort Study.
    J Nutr. 2013.
    Abstract     Related articles   

  518. TRIPATHI P , Somashekar BS, Ponnusamy M, Gursky A, et al
    HR-MAS NMR Tissue Metabolomic Signatures Cross-Validated by Mass Spectrometry Distinguish Bladder Cancer from Benign Disease.
    J Proteome Res. 2013.
    Abstract     Related articles   

  519. LAUTENSCHLAEGER T , George A, Klimowicz AC, Efstathiou JA, et al
    Bladder Preservation Therapy for Muscle-Invading Bladder Cancers on Radiation Therapy Oncology Group Trials 8802, 8903, 9506, and 9706: Vascular Endothelial Growth Factor B Overexpression Predicts for Increased Distant Metastasis and Shorter Survival.
    Oncologist. 2013.
    Abstract     Related articles   

  520. MOSES KA , Bochner BH, Prabharasuth D, Sfakianos JP, et al
    Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique.
    Transplant Proc. 2013;45:1661-6.
    Abstract     Related articles   

  521. YANG XQ , Xu C, Sun Y, Han RF, et al
    Diabetes Mellitus Increases the Risk of Bladder Cancer: An Updated Meta-analysis.
    Asian Pac J Cancer Prev. 2013;14:2583-9.
    Abstract     Related articles   

  522. ZHU Y , Mao Y, Chen H, Lin Y, et al
    Apigenin promotes apoptosis, inhibits invasion and induces cell cycle arrest of T24 human bladder cancer cells.
    Cancer Cell Int. 2013;13:54.
    Abstract     Related articles   

  523. EL-GAMAL EM , Gouida MS
    Quantitative changes in p53, Bcl-2 and apoptosis in blood and urine of bladder cancer patients.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  524. EISSA S , Motawi T, Badr S, Zaghlool A, et al
    Evaluation of urinary human telomerase reverse transcriptase mRNA and scatter factor protein as urine markers for diagnosis of bladder cancer.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  525. RESNICK MJ , Bassett JC, Clark PE
    Management of superficial and muscle-invasive urothelial cancers of the bladder.
    Curr Opin Oncol. 2013;25:281-8.
    Abstract     Related articles   

  526. CHUTTIANGTUM A , Udomthavornsuk B, Chumworathayi B
    Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
    Asian Pac J Cancer Prev. 2012;13:4931-3.
    Abstract     Related articles   

  527. CLIFTON MM , Tollefson MK
    Anatomic basis of radical cystectomy and orthotopic urinary diversion in female patients.
    Clin Anat. 2013;26:105-9.
    Abstract     Related articles   

  528. LAMM SH , Robbins SA, Zhou C, Lu J, et al
    Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 mug/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Regul Toxicol Pharmacol. 2013;65:147-56.
    Abstract     Related articles   

  529. PATEL P , Rabin HR, Vickers MM, Parkins MD, et al
    Metastatic bladder cancer presenting with persistent hematuria in young man with cystic fibrosis.
    Case Rep Pulmonol. 2013;2013:831871.
    Abstract     Related articles   

  530. LIU H , Wu J, Xue S, Zhang Q, et al
    Comparison of the safety and efficacy of conventional monopolar and 2-micron laser transurethral resection in the management of multiple nonmuscle-invasive bladder cancer.
    J Int Med Res. 2013.
    Abstract     Related articles   

  531. LAZICA DA , Bottcher S, Degener S, von Rundstedt FC, et al
    [T1 bladder cancer : Role of documentation for bladder tumor findings and targeted second resection.]
    Urologe A. 2013.
    Abstract     Related articles   

  532. PAYTON S
    Bladder cancer: Second-line nab-paclitaxel for advanced urothelial carcinoma.
    Nat Rev Urol. 2013 Jun 11. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  533. DUDEK AM , Grotenhuis AJ, Vermeulen SH, Kiemeney LA, et al
    Urinary Bladder Cancer Susceptibility Markers. What Do We Know about Functional Mechanisms?
    Int J Mol Sci. 2013;14:12346-66.
    Abstract     Related articles   

  534. CHEN ZG , Zhou W, Dai MJ, Wu ZG, et al
    [Association between the interaction polymorphisms of interleukin-10 and smoking on patients with bladder cancer risk from a case-control study].
    Zhonghua Liu Xing Bing Xue Za Zhi. 2013;34:183-6.
    Abstract     Related articles   

  535. GONG M , Yi Q, Wang W
    Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  536. KUNZE D , Erdmann K, Froehner M, Wirth MP, et al
    Enhanced Inhibition of Bladder Cancer Cell Growth by Simultaneous Knockdown of Antiapoptotic Bcl-xL and Survivin in Combination with Chemotherapy.
    Int J Mol Sci. 2013;14:12297-312.
    Abstract     Related articles   

  537. RODRIGUEZ FABA O , Gaya JM, Lopez JM, Capell M, et al
    Current management of non-muscle-invasive bladder cancer.
    Minerva Med. 2013;104:273-86.
    Abstract     Related articles   

  538. WU LM , Chen XX, Xu JR, Zhang XF, et al
    Clinical Value of T2-Weighted Imaging Combined with Diffusion-Weighted Imaging in Preoperative T Staging of Urinary Bladder Cancer: A Large-Scale, Multiobserver Prospective Study on 3.0-T MRI.
    Acad Radiol. 2013 Jun 5. pii: S1076-6332(13)00208.
    Abstract     Related articles   

  539. CARAMORI G , Artioli D, Ferrara G, Cazzuffi R, et al
    Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review.
    Monaldi Arch Chest Dis. 2013;79:44-8.
    Abstract     Related articles   

  540. MIASOIEDOV SD
    [Outcomes of the combined left-sided hemicolectomy, performed for colonic cancer].
    Klin Khir. 2013;:9-10.
    Abstract     Related articles   

  541. NOGUCHI K , Fujimoto N, Asano M, Fuchimoto Y, et al
    Extrapulmonary small cell carcinoma mimicking malignant pleural mesothelioma.
    J Clin Pathol. 2013;66:450-1.
    Abstract     Related articles   

  542. PARK JH , Lee SW, Kim HS, Kang SG, et al
    Combination of gemcitabine and carboplatin as first line treatment in elderly patients or those unfit for cisplatin-based chemotherapy with advanced transitional cell carcinoma of the urinary tract.
    Cancer Chemother Pharmacol. 2013;71:1033-9.
    Abstract     Related articles   

  543. FOROUDI F , Pham D, Bressel M, Gill S, et al
    Intrafraction bladder motion in radiation therapy estimated from pretreatment and posttreatment volumetric imaging.
    Int J Radiat Oncol Biol Phys. 2013;86:77-82.
    Abstract     Related articles   

  544. NAITO S , van Rees Vellinga S, de la Rosette J
    Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients.
    J Endourol. 2013;27:1-3.
    Abstract     Related articles   

  545. KNOX ML , El-Galley R, Busby JE
    Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach.
    J Endourol. 2013;27:40-4.
    Abstract     Related articles   

  546. DODURGA Y , Avci CB, Yilmaz S, Nazli O, et al
    UroVysion fluorescence hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.
    Contemp Oncol (Pozn). 2013;17:156-160.
    Abstract     Related articles   

  547. ERDURAK K , Dundar PE, Ozyurt BC, Negri E, et al
    Smoking, occupation, history of selected diseases and bladder cancer risk in Manisa, Turkey.
    Eur J Cancer Prev. 2013.
    Abstract     Related articles   

  548. PHAM D , Roxby P, Kron T, Rolfo A, et al
    Introduction of online adaptive radiotherapy for bladder cancer through a multicentre clinical trial (Trans-Tasman Radiation Oncology Group 10.01): Lessons learned.
    J Med Phys. 2013;38:59-66.
    Abstract     Related articles   

  549. DI MARTINO E , Taylor CF, Roulson JA, Knowles MA, et al
    An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer.
    Genes Chromosomes Cancer. 2013 Jun 14. doi: 10.1002/gcc.22082.
    Abstract     Related articles   

  550. WITJES JA
    Bladder cancer: Elderly and female patients fare the worst and deserve better.
    Nat Rev Urol. 2013 Jun 18. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  551. EUSTACE A , Irlam JJ, Taylor J, Denley H, et al
    Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
    Radiother Oncol. 2013 Jun 14. pii: S0167-8140(13)00232.
    Abstract     Related articles   

  552. XU W , Zhang H, Wang F, Wang H, et al
    Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.
    Diagn Pathol. 2013;8:95.
    Abstract     Related articles   

  553. GORE JL , Gilbert SM
    Improving bladder cancer patient care: a pharmacoeconomic perspective.
    Expert Rev Anticancer Ther. 2013;13:661-8.
    Abstract     Related articles   

  554. AARSAETHER E , Patel HR
    Contemplating bladder cancer care: can we cut costs and improve quality of care?
    Expert Rev Anticancer Ther. 2013;13:639-40.
    Abstract     Related articles   

  555. LEE EJ , Lee SJ, Kim S, Cho SC, et al
    Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-kappaB/AP-1 pathway: Involvement of the p21WAF1 expression.
    Cell Signal. 2013 Jun 11. pii: S0898-6568(13)00171.
    Abstract     Related articles   

  556. KASSAM SN , Aziz Z, Hung LS, Sridhar SS, et al
    A case of isolated rectal recurrence of muscle invasive bladder cancer.
    Can Urol Assoc J. 2013;7.
    Abstract     Related articles   

  557. FANG ZQ , Zang WD, Chen R, Ye BW, et al
    Gene expression profile and enrichment pathways in different stages of bladder cancer.
    Genet Mol Res. 2013;12:1479-89.
    Abstract     Related articles   

  558. MARTIN DT , Hoimes CJ, Kaimakliotis HZ, Cheng CJ, et al
    Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer.
    Nanomedicine. 2013 Jun 10. pii: S1549-9634(13)00268.
    Abstract     Related articles   

  559. MIRYAGHOUBZADEH J , Darabi M, Madaen K, Shaaker M, et al
    Tissue fatty acid composition in human urothelial carcinoma.
    Br J Biomed Sci. 2013;70:1-5.
    Abstract     Related articles   

  560. LU CC , Lin MY, Chen SY, Shen CH, et al
    The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder.
    BMC Complement Altern Med. 2013;13:44.
    Abstract     Related articles   

  561. ALEXIEV BA , Randhawa P, Vazquez Martul E, Zeng G, et al
    BK virus-associated urinary bladder carcinoma in transplant recipients: report of 2 cases, review of the literature, and proposed pathogenetic model.
    Hum Pathol. 2013;44:908-17.
    Abstract     Related articles   

  562. KNAPP DW , Henry CJ, Widmer WR, Tan KM, et al
    Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder.
    J Vet Intern Med. 2013;27:126-33.
    Abstract     Related articles   

  563. OLIVA E , Pinheiro NF, Heney NM, Kaufman DS, et al
    Immunohistochemistry as an adjunct in the differential diagnosis of radiation-induced atypia versus urothelial carcinoma in situ of the bladder: a study of 45 cases.
    Hum Pathol. 2013;44:860-6.
    Abstract     Related articles   

  564. MMEJE CO , Martin AD, Nunez-Nateras R, Parker AS, et al
    Cost analysis of open radical cystectomy versus robot-assisted radical cystectomy.
    Curr Urol Rep. 2013;14:26-31.
    Abstract     Related articles   

  565. ARORA VC , Price AP, Fleming S, Sohn MJ, et al
    Characteristic imaging features of desmoplastic small round cell tumour.
    Pediatr Radiol. 2012.
    Abstract     Related articles   

  566. DAVIS JW , Kamat AM
    Lymphadenectomy with robotic cystectomy.
    Curr Urol Rep. 2013;14:59-63.
    Abstract     Related articles   

  567. GELBER K , Bohrer J, Kim CO, Minaglia S, et al
    Vaginal repair of neobladder-vaginal fistula: a case report and review of the literature.
    Int Urogynecol J. 2013;24:175-8.
    Abstract     Related articles   

  568. TIAN F , Xu F, Zhang ZY, Ge JP, et al
    Expression of CHD1L in bladder cancer and its influence on prognosis and survival.
    Tumour Biol. 2013.
    Abstract     Related articles   

  569. KECK B , Wach S, Goebell PJ, Kunath F, et al
    SNAI1 Protein Expression is an Independent Negative Prognosticator in Muscle-Invasive Bladder Cancer.
    Ann Surg Oncol. 2013.
    Abstract     Related articles   

  570. KOBEISSI LH , Yassine IA, Jabbour ME, Moussa MA, et al
    Urinary bladder cancer risk factors: a lebanese case- control study.
    Asian Pac J Cancer Prev. 2013;14:3205-11.
    Abstract     Related articles   

  571. QIN Q , Xu X, Wang X, Zheng XY, et al
    Obesity and Risk of Bladder Cancer: A Meta-analysis of Cohort Studies.
    Asian Pac J Cancer Prev. 2013;14:3117-21.
    Abstract     Related articles   

  572. ELLIDAG HY , Eren E, Aydin O, Akgol E, et al
    Ischemia modified albumin levels and oxidative stress in patients with bladder cancer.
    Asian Pac J Cancer Prev. 2013;14:2759-63.
    Abstract     Related articles   

  573. DIMASHKIEH H , Wolff DJ, Smith TM, Houser PM, et al
    Evaluation of urovysion and cytology for bladder cancer detection: A study of 1835 paired urine samples with clinical and histologic correlation.
    Cancer Cytopathol. 2013 Jun 25. doi: 10.1002/cncy.21327.
    Abstract     Related articles   

  574. GHAFOORI M , Shakiba M, Ghiasi A, Asvadi N, et al
    Value of MRI in local staging of bladder cancer.
    Urol J. 2013;10:866-72.
    Abstract     Related articles   

  575. MADBOULY K
    Intravesical bacillus Calmette-Guerin for bladder cancer: What is known? What is not? What is next?
    Urol Ann. 2013;5:108-9.
    Abstract     Related articles   

  576. ALI-EL-DEIN B , Barakat TS, Nabeeh A, Ibrahiem el-HI, et al
    Weekly intravesical bacillus Calmette-Guerin (BCG) alternating with epirubicin in Ta and T1 urothelial bladder cancer: An approach to decrease BCG toxicity.
    Urol Ann. 2013;5:103-8.
    Abstract     Related articles   

  577. MUBARAK M
    A step towards refining prognostication in individual patients with bladder cancer.
    Urol Ann. 2013;5:85-7.
    Abstract     Related articles   

  578. HSIAO FY , Hsieh PH, Huang WF, Tsai YW, et al
    Risk of Bladder Cancer in Diabetic Patients Treated with Rosiglitazone or Pioglitazone: A Nested Case-Control Study.
    Drug Saf. 2013.
    Abstract     Related articles   

  579. LIN Y , Chen H, Hu Z, Mao Y, et al
    miR-26a inhibits proliferation and motility in bladder cancer by targeting HMGA1.
    FEBS Lett. 2013 Jun 22. pii: S0014-5793(13)00468.
    Abstract     Related articles   

  580. KAMAT AM
    Commentary on "Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience." Yafi FA, Aprikian AG, Fradet Y, Chin JL, Izawa J, Rendon R, Estey E, Fairey A, Cagiannos
    Urol Oncol. 2013;31:717-8.
    Abstract     Related articles   

  581. KAMAT AM
    Commentary on "Carboplatin based induction chemotherapy for nonorgan confined bladder cancer-a reasonable alternative for cisplatin unfit patients?" Mertens LS, Meijer RP, Kerst JM, Bergman AM, van Tinteren H, van Rhijn BW, Horenblas S, Department of
    Urol Oncol. 2013;31:716-7.
    Abstract     Related articles   

  582. KAMAT AM
    Commentary on "The value of transurethral bladder biopsy after intravesical bacillus Calmette-Guerin instillation therapy for nonmuscle invasive bladder cancer: a retrospective, single center study and cumulative analysis of the literature." Swietek N
    Urol Oncol. 2013;31:715-6.
    Abstract     Related articles   

  583. MUSQUERA M , Mengual L, Ribal MJ
    [Non-invasive diagnosis bladder cancer: New molecular markers and future perspectives].
    Arch Esp Urol. 2013;66:487-94.
    Abstract     Related articles   

  584. LIU H , Tan Q, Geddie WR, Jewett MA, et al
    Biophysical Characterization of Bladder Cancer Cells with Different Metastatic Potential.
    Cell Biochem Biophys. 2013.
    Abstract     Related articles   

  585. MERTENS LS , Neuzillet Y, Horenblas S, van Rhijn BW, et al
    Biomarkers for assesing therapeutic response in bladder cancer.
    Arch Esp Urol. 2013;66:495-504.
    Abstract     Related articles   

  586. TSENG CH
    Insulin Use and Smoking Jointly Increase the Risk of Bladder Cancer Mortality in Patients With Type 2 Diabetes.
    Clin Genitourin Cancer. 2013 Jun 19. pii: S1558-7673(13)00080.
    Abstract     Related articles   

  587. LENDINEZ-CANO G , Rico-Lopez J, Moreno S, Fernandez Parra E, et al
    Elective Bladder-Sparing Treatment for Muscle Invasive Bladder Cancer.
    Actas Urol Esp. 2013 Jun 19. pii: S0210-4806(13)00158.
    Abstract     Related articles   

  588. FOUTADAKIS S , Avgeris M, Tokas T, Stravodimos K, et al
    Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
    Urol Oncol. 2013 Jun 18. pii: S1078-1439(13)00191.
    Abstract     Related articles   

  589. AJILI F , Darouiche A, Chebil M, Boubaker S, et al
    The Efficacy of Intravesical Bacillus Calmette-Guerin in the Treatment of Patients with pT1 Stage Non-muscle-invasive Bladder Cancer.
    Ultrastruct Pathol. 2013.
    Abstract     Related articles   

  590. MILOWSKY MI
    Advanced urothelial carcinoma: moving the field forward.
    Oncology (Williston Park). 2013;27:233-4.
    Abstract     Related articles   

  591. DREICER R
    "Missing the target" in urothelial cancer.
    Oncology (Williston Park). 2013;27:227.
    Abstract     Related articles   

  592. VERDOORN BP , Kessler ER, Flaig TW
    Targeted therapy in advanced urothelial carcinoma.
    Oncology (Williston Park). 2013;27:219-26.
    Abstract     Related articles   

  593. GKIRLEMIS K , Miliadou A, Koukourakis G, Sotiropoulou-Lontou A, et al
    Small cell carcinoma of the bladder: a search of the current literature.
    J BUON. 2013;18:220-6.
    Abstract     Related articles   

  594. TANG X , Xing J, Li W, Wu Z, et al
    Expression of transcription factor Twist1 in bladder urothelial carcinoma and its clinical significance.
    J BUON. 2013;18:211-9.
    Abstract     Related articles   

  595. COLAROSSI C , Pino P, Giuffrida D, Aiello E, et al
    Large cell neuroendocrine carcinoma (LCNEC) of the urinary bladder: a case report.
    Diagn Pathol. 2013;8:19.
    Abstract     Related articles   

  596. HUGHES C , Iqbal-Wahid J, Brown M, Shanks JH, et al
    FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder.
    J Biophotonics. 2013;6:73-87.
    Abstract     Related articles   

  597. CHUNG SD , Tsai YC, Wang SM, Hung SF, et al
    Laparo-endoscopic single-site (LESS) bilateral nephroureterectomy for patients with end-stage renal disease.
    Minim Invasive Ther Allied Technol. 2013;22:61-4.
    Abstract     Related articles   

  598. SUTHERLAND M , Gill JH, Loadman PM, Laye JP, et al
    Antitumor activity of a duocarmycin analogue rationalized to be metabolically activated by cytochrome P450 1A1 in human transitional cell carcinoma of the bladder.
    Mol Cancer Ther. 2013;12:27-37.
    Abstract     Related articles   

  599. CHUGH S , Anand V, Swaroop L, Seth A, et al
    Involvement of Th17 cells in patients of urothelial carcinoma of bladder Role of Th17 cells in urinary bladder cancer.
    Hum Immunol. 2013 Jul 1. pii: S0198-8859(13)00196.
    Abstract     Related articles   

  600. MORIKAWA T , Kawai T, Abe H, Kume H, et al
    UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.
    Int J Clin Exp Pathol. 2013;6:1367-74.
    Abstract     Related articles   

  601. MITIN T , Hunt D, Shipley WU, Kaufman DS, et al
    Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre ph
    Lancet Oncol. 2013 Jun 28. pii: S1470-2045(13)70255.
    Abstract     Related articles   

  602. XU X , Chen H, Lin Y, Hu Z, et al
    MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met.
    Mol Cells. 2013.
    Abstract     Related articles   

  603. LIANG W , Zhu D, Cui X, Su J, et al
    Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells.
    Mol Cell Biochem. 2013.
    Abstract     Related articles   

  604. BONGIOVANNI L , Arena V, Vecchio FM, Racioppi M, et al
    HER-2 immunohistochemical expression as prognostic marker in high-grade T1 bladder cancer (T1G3).
    Arch Ital Urol Androl. 2013;85:73-7.
    Abstract     Related articles   

  605. DOU K , Xu Q, Han X
    The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.
    Diagn Pathol. 2013;8:112.
    Abstract     Related articles   

  606. WANG L , Feng C, Ding G, Zhou Z, et al
    Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification.
    J BUON. 2013;18:420-4.
    Abstract     Related articles   

  607. TRULSON JJ , Sharma P, Haden T, Kheterpal E, et al
    Comparative survival following different treatment modalities for stage T2 bladder cancer in octogenarians.
    World J Urol. 2013.
    Abstract     Related articles   

  608. BERNINI L , Manzini CU, Giuggioli D, Sebastiani M, et al
    Reactive arthritis induced by intravesical BCG therapy for bladder cancer: our clinical experience and systematic review of the literature.
    Autoimmun Rev. 2013 Jun 28. pii: S1568-9972(13)00121.
    Abstract     Related articles   

  609. GUO Y , Ying L, Tian Y, Yang P, et al
    miR-144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling.
    FEBS J. 2013 Jul 1. doi: 10.1111/febs.12417.
    Abstract     Related articles   

  610. SPENCER BA , McBride RB, Hershman DL, Buono D, et al
    Adjuvant intravesical bacillus calmette-guerin therapy and survival among elderly patients with non-muscle-invasive bladder cancer.
    J Oncol Pract. 2013;9:92-8.
    Abstract     Related articles   

  611. SORIA F , Gurioli A, Peraldo F, Oderda M, et al
    Innovations in the endoscopic management of bladder cancer: is the era of white light cystoscopy over.
    Urologia. 2013;0:0.
    Abstract     Related articles   

  612. XU C , Xu W, Ren S, Wu C, et al
    Establishment of a Chinese bladder cancer cell line (T921) with high metastatic activity.
    In Vitro Cell Dev Biol Anim. 2013.
    Abstract     Related articles   

  613. GUPTA S , Mahipal A
    Role of systemic chemotherapy in urothelial urinary bladder cancer.
    Cancer Control. 2013;20:200-10.
    Abstract     Related articles   

  614. BIAGIOLI MC , Fernandez DC, Spiess PE, Wilder RB, et al
    Primary bladder preservation treatment for urothelial bladder cancer.
    Cancer Control. 2013;20:188-99.
    Abstract     Related articles   

  615. QIU Z , Zhou B, Jin L, Yu H, et al
    In vitro antioxidant and antiproliferative effects of ellagic acid and its colonic metabolite, urolithins, on human bladder cancer T24 cells.
    Food Chem Toxicol. 2013 Jun 26. pii: S0278-6915(13)00402.
    Abstract     Related articles   

  616. HEMMAID KZ , Awadalla A, Elsawy E, Hussein AA, et al
    Impact of Hepatitis C Virus (HCV) infection on biomolecular markers influencing the pathogenesis of bladder cancer.
    Infect Agent Cancer. 2013;8:24.
    Abstract     Related articles   

  617. MORRIONE A , Neill T, Iozzo RV
    Dichotomy of decorin activity on the insulin-like growth factor-I system.
    FEBS J. 2013;280:2138-49.
    Abstract     Related articles   

  618. BURNSTOCK G
    Purinergic signalling in the lower urinary tract.
    Acta Physiol (Oxf). 2013;207:40-52.
    Abstract     Related articles   

  619. TROJAN B , Tang A, Chandrapal J, Filleur S, et al
    The Clinical Usefulness of Nuclear Matrix Protein-22 in Patients with End-Stage Renal Disease and Microscopic Hematuria.
    Ren Fail. 2012.
    Abstract     Related articles   

  620. PAL SK , Milowsky MI, Plimack ER
    Optimizing Systemic Therapy for Bladder Cancer.
    J Natl Compr Canc Netw. 2013;11:793-804.
    Abstract     Related articles   

  621. LUKACS S , Tschobotko B, Szabo NA, Symes A, et al
    Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer.
    Case Rep Urol. 2013;2013:821526.
    Abstract     Related articles   

  622. KIM PH , Kent M, Zhao P, Sfakianos JP, et al
    The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer.
    World J Urol. 2013.
    Abstract     Related articles   

  623. JENSEN BT , Laustsen S, Petersen AK, Borre M, et al
    Preoperative risk factors related to bladder cancer rehabilitation: a registry study.
    Eur J Clin Nutr. 2013 Jul 10. doi: 10.1038/ejcn.2013.
    Abstract     Related articles   

  624. OLIVEIRA TR , Stauffer PR, Lee CT, Landon C, et al
    Preclinical Dosimetry of Magnetic Fluid Hyperthermia for Bladder Cancer.
    Proc SPIE. 2013;8584:1656985.
    Abstract     Related articles   

  625. KANEMARU K , Nishiyama Y, Yoshioka H, Satoh K, et al
    In-stent Thrombosis after Carotid Artery Stenting Despite Sufficient Antiplatelet Therapy in a Bladder Cancer Patient.
    J Stroke Cerebrovasc Dis. 2013 Jul 5. pii: S1052-3057(12)00442.
    Abstract     Related articles   

  626. RAINA K , Tyagi A, Kumar D, Agarwal R, et al
    Role of Oxidative Stress in Cytotoxicity of Grape Seed Extract in Human Bladder Cancer Cells.
    Food Chem Toxicol. 2013 Jul 3. pii: S0278-6915(13)00418.
    Abstract     Related articles   

  627. HE XF , Wei W, Li JL, Shen XL, et al
    Association between the XRCC3 T241M polymorphism and risk of cancer: evidence from 157 case-control studies.
    Gene. 2013;523:10-9.
    Abstract     Related articles   

  628. OLSSON H , Hultman P, Rosell J, Soderkvist P, et al
    MDM2 SNP309 promoter polymorphism and p53 mutations in urinary bladder carcinoma stage T1.
    BMC Urol. 2013;13:5.
    Abstract     Related articles   

  629. GAISA NT , Reinartz A, Schneider U, Klaus C, et al
    Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
    Histol Histopathol. 2013;28:353-64.
    Abstract     Related articles   

  630. LEVIDOU G , Thymara I, Saetta AA, Papanastasiou P, et al
    TRAIL and osteoprotegerin (OPG) expression in bladder urothelial carcinoma: correlation with clinicopathological parameters and prognosis.
    Pathology. 2013;45:138-44.
    Abstract     Related articles   

  631. TAVORA F , Kryvenko ON, Epstein JI
    Mesenchymal tumours of the bladder and prostate: an update.
    Pathology. 2013;45:104-15.
    Abstract     Related articles   

  632. GUO P , Zhao P, Liu J, Ma H, et al
    Preparation of a Novel Organoselenium Compound and Its Anticancer Effects on Cervical Cancer Cell Line HeLa.
    Biol Trace Elem Res. 2012.
    Abstract     Related articles   

  633. LA VERDE N , Piva S, Colombo F, Borgonovo K, et al
    Lung infiltrates in cancer patients: differentiating metastases from bronchiolitis obliterans organizing pneumonia.
    Immunopharmacol Immunotoxicol. 2013;35:195-7.
    Abstract     Related articles   

  634. HOFFMAN KL , Lerner SP, Smith CL
    Raloxifene inhibits growth of RT4 urothelial carcinoma cells via estrogen receptor-dependent induction of apoptosis and inhibition of proliferation.
    Horm Cancer. 2013;4:24-35.
    Abstract     Related articles   

  635. PARADA B , Reis F, Cerejo R, Garrido P, et al
    Omega-3 Fatty acids inhibit tumor growth in a rat model of bladder cancer.
    Biomed Res Int. 2013;2013:368178.
    Abstract     Related articles   

  636. SMITH ZL , Guzzo TJ
    Urinary markers for bladder cancer.
    F1000Prime Rep. 2013;5:21.
    Abstract     Related articles   

  637. MIYAZAKI J , Hinotsu S, Ishizuka N, Naito S, et al
    Adverse Reactions Related to Treatment Compliance During BCG Maintenance Therapy for Non-muscle-invasive Bladder Cancer.
    Jpn J Clin Oncol. 2013.
    Abstract     Related articles   


  638. Bladder cancer: New data on bladder-sparing chemoradiation regimens.
    Nat Rev Urol. 2013 Jul 16. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  639. BRAUSI M
    [Transurethral resection of bladder cancer: a simple and diffusely-performed technique but with controversial outcomes.]
    Urologia. 2013;80:127-129.
    Abstract     Related articles   

  640. RACIOPPI M , D'Agostino D, Pugliese D, Ragonese M, et al
    [Innovative tratments of non muscle invasive bladder cancer].
    Urologia. 2013;80:120-6.
    Abstract     Related articles   

  641. COLOMBO R , Moschini M
    [Role of the combined regimen with local chemotherapy and Mw-induced hyperthermia for non-muscle invasive bladder cancer management. A systematic review].
    Urologia. 2013;80:112-9.
    Abstract     Related articles   

  642. TEJIDO-SANCHEZ A , Garcia-Gonzalez L, Jimenez-Alcaide E, Arrebola-Pajares A, et al
    Quality of Life in Patients with Ileal Conduit Cystectomy Due to Bladder Cancer.
    Actas Urol Esp. 2013 Jul 10. pii: S0210-4806(13)00162.
    Abstract     Related articles   

  643. MAZARIS E , Nafie S, Boustead G
    Is TURBT able to cure high risk recurrent superficial or muscle invasive bladder cancer: Factors resulting in pT0 radical cystectomy specimens.
    Int Braz J Urol. 2013;39:364-70.
    Abstract     Related articles   

  644. SANGKUM P , Patcharatrakul S, Khongchareonsombat W
    Open-assisted laparoscopic radical cystectomy using an ileal neobladder with intracorporeal urethra-neobladder anastomosis: technique and early experiences.
    J Med Assoc Thai. 2013;96:564-8.
    Abstract     Related articles   

  645. THAIDUMRONG T
    Laparoscopic radical cystectomy with total intracorporeal ileal neobladder: first case report in Thailand.
    J Med Assoc Thai. 2013;96 Suppl 3:S109-13.
    Abstract     Related articles   

  646. WALLACE E , Twomey M, Victory R, O'Reilly M, et al
    Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm.
    J Palliat Care. 2013;29:49-51.
    Abstract     Related articles   

  647. HUANG Y , Chen H, Wang J, Bunjhoo H, et al
    Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
    Gene. 2013;524:54-8.
    Abstract     Related articles   

  648. LIANG PY , Li HY, Zhou ZY, Jin YX, et al
    Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
    Tumour Biol. 2013;34:1783-91.
    Abstract     Related articles   

  649. INOUE K , Fukuhara H, Kurabayashi A, Furihata M, et al
    Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
    Cancer Sci. 2013;104:765-72.
    Abstract     Related articles   

  650. NOMURA S , Suzuki Y, Saito Y, Tanabe K, et al
    [Plasmacytoid variant of urothelial carcinoma of urinary bladder: a case report].
    Nihon Hinyokika Gakkai Zasshi. 2013;104:26-9.
    Abstract     Related articles   

  651. SUZUKI T , Takeuchi M, Naiki T, Kawai N, et al
    MRI findings of granulomatous prostatitis developing after intravesical Bacillus Calmette-Guerin therapy.
    Clin Radiol. 2013;68:595-9.
    Abstract     Related articles   

  652. EMMERT-STREIB F , Abogunrin F, de Matos Simoes R, Duggan B, et al
    Collectives of diagnostic biomarkers identify high-risk subpopulations of hematuria patients: exploiting heterogeneity in large-scale biomarker data.
    BMC Med. 2013;11:12.
    Abstract     Related articles   

  653. TODENHOFER T , Hennenlotter J, Esser M, Mohrhardt S, et al
    Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma.
    Cancer Cytopathol. 2013;121:252-60.
    Abstract     Related articles   

  654. XYLINAS E , Colin P, Audenet F, Phe V, et al
    Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.
    World J Urol. 2013;31:61-8.
    Abstract     Related articles   

  655. YATES DR , Roupret M, Drouin SJ, Audouin M, et al
    Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
    World J Urol. 2013;31:53-9.
    Abstract     Related articles   

  656. PERLIS N , Turker P, Bostrom PJ, Kuk C, et al
    Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols.
    World J Urol. 2013;31:161-7.
    Abstract     Related articles   

  657. COSENTINO M , Palou J, Gaya JM, Breda A, et al
    Upper urinary tract urothelial cell carcinoma: location as a predictive factor for concomitant bladder carcinoma.
    World J Urol. 2013;31:141-5.
    Abstract     Related articles   

  658. YEATON-MASSEY A , Brookfield KF, Aziz N, Mrazek-Pugh B, et al
    Maternal bladder cancer diagnosed at routine first-trimester obstetric ultrasound examination.
    Obstet Gynecol. 2013;122.
    Abstract     Related articles   

  659. CHISM DD , Woods ME, Milowsky MI
    Neoadjuvant Paradigm for Accelerated Drug Development: An Ideal Model in Bladder Cancer.
    Oncologist. 2013.
    Abstract     Related articles   

  660. SHINAGARE AB , Sadow CA, Silverman SG
    Surveillance of patients with bladder cancer following cystectomy: yield of CT urography.
    Abdom Imaging. 2013.
    Abstract     Related articles   

  661. SUGIYAMA N , Yoneyama MS, Hatakeyama S, Yamamoto H, et al
    In vivo selection of high-metastatic subline of bladder cancer cell and its characterization.
    Oncol Res. 2013;20:289-95.
    Abstract     Related articles   

  662. PURANIK AD , Purandare N, Agrawal A, Shah S, et al
    Bone Marrow Metastases in an Otherwise Operable Gall Bladder Cancer: Rare Site of Distant Metastases Detected on FDG PET/CT.
    Clin Nucl Med. 2013.
    Abstract     Related articles   

  663. ZHANG H , Wen X, Lu X, Zhang H, et al
    Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  664. PALMER S , Sokolovski SG, Rafailov E, Nabi G, et al
    Technologic Developments in the Field of Photonics for the Detection of Urinary Bladder Cancer.
    Clin Genitourin Cancer. 2013 Jul 18. pii: S1558-7673(13)00077.
    Abstract     Related articles   

  665. KATO Y , Konari S, Obara W, Sugai T, et al
    Concurrence of villous adenoma and non-muscle invasive bladder cancer arising in the bladder: a case report and review of the literature.
    BMC Urol. 2013;13:36.
    Abstract     Related articles   

  666. FAILLIE JL , Petit P, Montastruc JL, Hillaire-Buys D, et al
    Scientific Evidence and Controversies About Pioglitazone and Bladder Cancer: Which Lessons Can Be Drawn?
    Drug Saf. 2013.
    Abstract     Related articles   

  667. KOHLER CU , Bryk O, Meier S, Lang K, et al
    Analyses in human urothelial cells identify methylation of miR-152, miR-200b and miR-10a genes as candidate bladder cancer biomarkers.
    Biochem Biophys Res Commun. 2013 Jul 16. pii: S0006-291X(13)01161.
    Abstract     Related articles   

  668. PARSONS JK , Pierce JP, Natarajan L, Newman VA, et al
    A Randomized Pilot Trial of Dietary Modification for Non-invasive Bladder Cancer: The Dietary Intervention in Bladder Cancer Study (DIBS).
    Cancer Prev Res (Phila). 2013.
    Abstract     Related articles   

  669. LOPEZ-ABENTE G
    Cancer surveillance in Spain: regional inequalities and peculiarities of temporal trends.
    Bull Cancer. 2013;100:E11-4.
    Abstract     Related articles   

  670. WANG W , Qiu J, Liu Z, Zeng Y, et al
    Overexpression of RING box protein-1 (RBX1) associated with poor prognosis of non-muscle-invasive bladder transitional cell carcinoma.
    J Surg Oncol. 2013;107:758-61.
    Abstract     Related articles   

  671. KAO CS , Kum JB, Fan R, Grignon DJ, et al
    Nephrogenic adenomas in pediatric patients: a morphologic and immunohistochemical study of 21 cases.
    Pediatr Dev Pathol. 2013;16:80-5.
    Abstract     Related articles   

  672. PEUGNIEZ C , Ghoneim T, Leroy X, Amela E, et al
    [Urachal cancers].
    Bull Cancer. 2013;100:509-17.
    Abstract     Related articles   

  673. ROZZI A , Santini D, Salerno M, Bordin F, et al
    Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study.
    Med Oncol. 2013;30:407.
    Abstract     Related articles   

  674. KAPOOR S
    Leukocyte telomere length and colorectal cancer risk.
    Cancer Epidemiol Biomarkers Prev. 2013;22:175.
    Abstract     Related articles   

  675. XUE Y , Wu G, Wang X, Zou X, et al
    CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.
    Med Oncol. 2013;30:406.
    Abstract     Related articles   

  676. ANDERSON B
    Detecting and treating bladder cancer.
    Br J Nurs. 2013;22:628-Unknown.
    Abstract     Related articles   

  677. AJILI F , Darouiche A, Chebil M, Boubaker S, et al
    The Efficiency of the EORTC Scoring System for the Prediction of Recurrence and Progression of Non-muscle-invasive Bladder Cancer Treated by Bacillus Calmette-Guerin Immunotherapy.
    Ultrastruct Pathol. 2013;37:249-53.
    Abstract     Related articles   

  678. KOKSAL AS , Bilge Z, Torun S, Sasmaz N, et al
    Perianal abscess as a complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer.
    Acta Gastroenterol Belg. 2013;76:260.
    Abstract     Related articles   

  679. PEZZEI C , Brunner A, Bonn GK, Huck CW, et al
    Fourier transform infrared imaging analysis in discrimination studies of bladder cancer.
    Analyst. 2013.
    Abstract     Related articles   

  680. CLYNE M
    Bladder cancer: Getting into the right (urine) headspace.
    Nat Rev Urol. 2013 Jul 30. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  681. OKEGAWA T , Ushio K, Imai M, Morimoto M, et al
    Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene.
    Oncogenesis. 2013;2:e58.
    Abstract     Related articles   

  682. WANG H , Jiang D, Liu J, Ye S, et al
    Compound K Induces Apoptosis of Bladder Cancer T24 Cells Via Reactive Oxygen Species-Mediated p38 MAPK Pathway.
    Cancer Biother Radiopharm. 2013.
    Abstract     Related articles   

  683. JIANG L , Ren J, Xiao X, Tang YY, et al
    Proteomic analysis of bladder cancer by iTRAQ after Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene treatment.
    Biol Chem. 2013.
    Abstract     Related articles   

  684. LI J , Luo F, Zhang H, Li L, et al
    The CCND1 G870A polymorphism and susceptibility to bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  685. LEOPARDO D , Cecere SC, Di Napoli M, Cavaliere C, et al
    Intravesical chemo-immunotherapy in non muscle invasive bladder cancer.
    Eur Rev Med Pharmacol Sci. 2013;17:2145-58.
    Abstract     Related articles   

  686. SEILER R , Thalmann GN, Rotzer D, Perren A, et al
    CCND1/CyclinD1 status in metastasizing bladder cancer: a prognosticator and predictor of chemotherapeutic response.
    Mod Pathol. 2013 Jul 26. doi: 10.1038/modpathol.2013.
    Abstract     Related articles   

  687. BERBER U , Yilmaz I, Yilmaz O, Haholu A, et al
    CYP1A1 (Ile462Val), CYP1B1 (Ala119Ser and Val432Leu), GSTM1 (null), and GSTT1 (null) Polymorphisms and Bladder Cancer Risk in a Turkish Population.
    Asian Pac J Cancer Prev. 2013;14:3925-9.
    Abstract     Related articles   

  688. ZHANG Y , Wang JH, Liu B, Qu PB, et al
    Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
    Asian Pac J Cancer Prev. 2013;14:3847-50.
    Abstract     Related articles   

  689. WONGPAIBOONWATTANA W , Tosukhowong P, Dissayabutra T, Mutirangura A, et al
    Oxidative Stress Induces Hypomethylation of LINE-1 and Hypermethylation of the RUNX3 Promoter in a Bladder Cancer Cell Line.
    Asian Pac J Cancer Prev. 2013;14:3773-8.
    Abstract     Related articles   

  690. PASIKANTI KK , Esuvaranathan K, Hong Y, Ho PC, et al
    Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
    J Proteome Res. 2013.
    Abstract     Related articles   

  691. RISTIC-PETROVIC A , Stojnev S, Jankovic-Velickovic L, Marjanovic G, et al
    Malakoplakia mimics urinary bladder cancer: a case report.
    Vojnosanit Pregl. 2013;70:606-8.
    Abstract     Related articles   

  692. ANDREI S , Andrei A, Rusu Muntean G, Ungureanu M, et al
    A rare case of metastatic squamous urachal carcinoma.
    Chirurgia (Bucur). 2013;108:280-4.
    Abstract     Related articles   

  693. ALBERTI C
    Tissue engineering as innovative chance for organ replacement in radical tumor surgery.
    Eur Rev Med Pharmacol Sci. 2013;17:624-31.
    Abstract     Related articles   

  694. FRANZ T , Hafner T, Horn LC, Kassahun W, et al
    [Huge retrovesical tumor as an incidental finding: desmoid-type fibromatosis: a case report].
    Urologe A. 2013;52:74-8.
    Abstract     Related articles   

  695. HALIM A , Abotouk N
    Methotrexate-paclitaxel-epirubicin-carboplatin as second-line chemotherapy in patients with metastatic transitional cell carcinoma of the bladder pretreated with cisplatin-gemcitabine: a phase II study.
    Asia Pac J Clin Oncol. 2013;9:60-5.
    Abstract     Related articles   

  696. VIGLIAR E , Marino G, Matano E, Imbimbo C, et al
    Signet-ring-cell carcinoma of stomach metastatic to the bladder: a case report with cytological and histological correlation and literature review.
    Int J Surg Pathol. 2013;21:72-5.
    Abstract     Related articles   

  697. MOATAMED NA , Apple SK, Bennett CJ, Aronson WJ, et al
    Exclusion of the uniform tetraploid cells significantly improves specificity of the urine FISH assay.
    Diagn Cytopathol. 2013;41:218-25.
    Abstract     Related articles   

  698. CHAN ES , Yip SK, Hou SM, Cheung HY, et al
    Age, tumour stage, and preoperative serum albumin level are independent predictors of mortality after radical cystectomy for treatment of bladder cancer in Hong Kong Chinese.
    Hong Kong Med J. 2013 Aug 8. doi: 10.12809/hkmj133964.
    Abstract     Related articles   

  699. REN MH , Yu JS, Song EL, Zhang C, et al
    Antitumor effects of mutant endostatin are enhanced by Bcl-2 antisense oligonucleotides in UM-UC-3 bladder cancer cell line.
    Chin Med J (Engl). 2013;126:2834-9.
    Abstract     Related articles   

  700. LI NC , Ye ZQ, Na YQ
    Efficacy of immediate instillation combined with regular instillations of pirarubicin for Ta and T1 transitional cell bladder cancer after transurethral resection: a prospective, randomized, multicenter study.
    Chin Med J (Engl). 2013;126:2805-9.
    Abstract     Related articles   

  701. FRANTZI M , Zoidakis J, Papadopoulos T, Zurbig P, et al
    IMAC fractionation in combination to LC/MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.
    J Proteome Res. 2013.
    Abstract     Related articles   

  702. DAI QS , Hua RX, Zeng RF, Long JT, et al
    XPC gene polymorphisms contribute to bladder cancer susceptibility: a meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  703. SAIDI S , Popov Z, Stavridis S, Janevska V, et al
    Digital quantitative immunofluorescent detection of p53 protein in urinary bladder cancer tissue samples.
    Prilozi. 2013;34:167-75.
    Abstract     Related articles   

  704. REMZI M , Shariat SF
    Bladder cancer: Is contrast-enhanced CT necessary for following up NMIBC?
    Nat Rev Urol. 2013 Aug 6. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  705. RAMON DE FATA F , Ferruelo A, Andres G, Gimbernat H, et al
    The role of matrix metalloproteinase MMP-9 and TIMP-2 tissue inhibitor of metalloproteinasas as serum markers of bladder cancer.
    Actas Urol Esp. 2013 Jul 31. pii: S0210-4806(13)00209.
    Abstract     Related articles   

  706. LOPEZ V , Gonzalez-Peramato P, Suela J, Serrano A, et al
    Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA.
    J Transl Med. 2013;11:182.
    Abstract     Related articles   

  707. GUANCIAL EA , Bellmunt J, Yeh S, Rosenberg JE, et al
    The evolving understanding of microRNA in bladder cancer.
    Urol Oncol. 2013 Aug 1. pii: S1078-1439(13)00200.
    Abstract     Related articles   

  708. KANG SG , Ha YR, Ko YH, Kang SH, et al
    Effect of laminin 332 on motility and invasion in bladder cancer.
    Kaohsiung J Med Sci. 2013;29:422-9.
    Abstract     Related articles   

  709. KASHDAN E , Bunimovich-Mendrazitsky S
    Hybrid discrete-continuous model of invasive bladder cancer.
    Math Biosci Eng. 2013;10:729-42.
    Abstract     Related articles   

  710. HAIE-MEDER C , Mazeron R, Martelli H, Oberlin O, et al
    [Brachytherapy role in pediatric rhabdomyosarcomas].
    Cancer Radiother. 2013;17:155-8.
    Abstract     Related articles   

  711. CHENG L , Huang WB, Rao Q
    [Diagnosis and differential diagnosis of malignant glandular and glandular-like lesions of the urinary bladder].
    Zhonghua Bing Li Xue Za Zhi. 2013;42:57-61.
    Abstract     Related articles   

  712. SONG T , Zhang X, Zhang L, Dong J, et al
    miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2.
    J Cancer Res Clin Oncol. 2013;139:1189-98.
    Abstract     Related articles   

  713. AKAIKE G , Nozaki T, Matsusako M, Matsui M, et al
    Magnetic resonance imaging for extramammary Paget's disease: radiological and pathological correlations.
    Skeletal Radiol. 2013;42:437-42.
    Abstract     Related articles   

  714. XYLINAS E , Rink M, Novara G, Green DA, et al
    Predictors of survival in patients with soft tissue surgical margin involvement at radical cystectomy.
    Ann Surg Oncol. 2013;20:1027-34.
    Abstract     Related articles   

  715. SEGAL RL , Readal N, Pieororazio PM, Kutlu O, et al
    Radical cystectomy in patients with preexisting three-piece inflatable penile prosthesis.
    J Sex Med. 2013;10:595-8.
    Abstract     Related articles   

  716. RAYNOR MC , Lavien G, Nielsen M, Wallen EM, et al
    Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion.
    Urol Oncol. 2013;31:32-5.
    Abstract     Related articles   

  717. CHO SY , Moon KC, Park JH, Kwak C, et al
    Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
    Urol Oncol. 2013;31:24-31.
    Abstract     Related articles   

  718. UCHIDA Y , Chiyomaru T, Enokida H, Kawakami K, et al
    MiR-133a induces apoptosis through direct regulation of GSTP1 in bladder cancer cell lines.
    Urol Oncol. 2013;31:115-23.
    Abstract     Related articles   

  719. VOLPE A , Racioppi M, D'Agostino D, D'Addessi A, et al
    Advanced bladder cancer: new agents and new approaches. A review.
    Urol Oncol. 2013;31:9-16.
    Abstract     Related articles   

  720. KAMAT AM
    To the editor: response to Barlow et al, Urol Oncol 2010.
    Urol Oncol. 2013;31:124.
    Abstract     Related articles   

  721. LIU C , Zheng S, Shen H, Xu K, et al
    Clinical significance of CD24 as a predictor of bladder cancer recurrence.
    Oncol Lett. 2013;6:96-100.
    Abstract     Related articles   

  722. CHEN RC , Shipley WU, Efstathiou JA, Zietman AL, et al
    Trimodality bladder preservation therapy for muscle-invasive bladder cancer.
    J Natl Compr Canc Netw. 2013;11:952-60.
    Abstract     Related articles   

  723. OHTAKE S , Kawaji K, Nakaigawa N, Inayama Y, et al
    [Vesical tuberculosis after bacillus calmette-guerin intravesical instillation therapy for bladder cancer].
    Hinyokika Kiyo. 2013;59:457-60.
    Abstract     Related articles   

  724. UEDA N , Nakayama M, Matsuzaki K, Yamamoto Y, et al
    [A Case of Portal Vein Thrombosis during Chemotheraphy for Bladder Cancer].
    Hinyokika Kiyo. 2013;59:449-52.
    Abstract     Related articles   

  725. MATSUZAKI K , Okumi M, Kishimoto N, Yazawa K, et al
    [A case of bladder cancer producing granulocyte colony-stimulating factor and interleukin-6 causing respiratory failure treated with neoadjuvant sytemic chemotherapy along with sivelestat].
    Hinyokika Kiyo. 2013;59:443-7.
    Abstract     Related articles   

  726. RATERT N , Meyer HA, Jung M, Lioudmer P, et al
    miRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome.
    J Mol Diagn. 2013 Jul 30. pii: S1525-1578(13)00108.
    Abstract     Related articles   

  727. CANTIELLO F , Cicione A, Autorino R, Salonia A, et al
    Visceral obesity predicts adverse pathological features in urothelial bladder cancer patients undergoing radical cystectomy: a retrospective cohort study.
    World J Urol. 2013.
    Abstract     Related articles   

  728. BEHRENS T , Bonberg N, Casjens S, Pesch B, et al
    A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example.
    Biochim Biophys Acta. 2013 Aug 9. pii: S1570-9639(13)00290.
    Abstract     Related articles   


  729. Bladder cancer: Preoperative factors predict outcomes after cystectomy.
    Nat Rev Urol. 2013 Aug 13. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  730. YUAN X , Li D, Zhao H, Jiang J, et al
    Licochalcone a-induced human bladder cancer t24 cells apoptosis triggered by mitochondria dysfunction and endoplasmic reticulum stress.
    Biomed Res Int. 2013;2013:474272.
    Abstract     Related articles   

  731. GROSELJ B , Kerr M, Kiltie AE
    Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
    Radiother Oncol. 2013 Aug 6. pii: S0167-8140(13)00300.
    Abstract     Related articles   

  732. AMR S , Dawson R, Saleh DA, Magder LS, et al
    Agricultural workers and urinary bladder cancer risk in egypt.
    Arch Environ Occup Health. 2014;69:3-10.
    Abstract     Related articles   

  733. KOGURE M , Takawa M, Cho HS, Toyokawa G, et al
    Deregulation of the histone demethylase JMJD2A is involved in human carcinogenesis through regulation of the G(1)/S transition.
    Cancer Lett. 2013;336:76-84.
    Abstract     Related articles   

  734. GUNES S , Sullu Y, Yegin Z, Buyukalpelli R, et al
    ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma.
    Pathol Res Pract. 2013;209:99-104.
    Abstract     Related articles   

  735. LI K , Lin T, Fan X, Xu K, et al
    Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy.
    Cancer Treat Rev. 2013;39:551-60.
    Abstract     Related articles   

  736. PINO L , Rijo E, Nohales G, Frances A, et al
    Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient.
    Transpl Infect Dis. 2013;15:E25-7.
    Abstract     Related articles   

  737. HADJIISKI L , Chan HP, Caoili EM, Cohan RH, et al
    Auto-initialized cascaded level set (AI-CALS) segmentation of bladder lesions on multidetector row CT urography.
    Acad Radiol. 2013;20:148-55.
    Abstract     Related articles   

  738. LATOSINSKA A , Frantzi M, Vlahou A, Mischak H, et al
    Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.
    Proteomics Clin Appl. 2013 Aug 23. doi: 10.1002/prca.201300038.
    Abstract     Related articles   

  739. YANG L , Wu XH, Wang D, Luo CL, et al
    Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro.
    Mol Med Rep. 2013 Aug 14. doi: 10.3892/mmr.2013.1634.
    Abstract     Related articles   

  740. REGNIER E , Nguyen TD, Beckendorf V, Lagrange JL, et al
    [Bladder cancer radiotherapy margins.]
    Cancer Radiother. 2013 Aug 19. pii: S1278-3218(13)00136.
    Abstract     Related articles   

  741. MISHRA K , Behari A, Kapoor VK, Khan S, et al
    Vascular Endothelial Growth Factor Single Nucleotide Polymorphism in Gall Bladder Cancer.
    J Gastroenterol Hepatol. 2013 Aug 21. doi: 10.1111/jgh.12343.
    Abstract     Related articles   

  742. PARADZIK M , Bucevic-Popovic V, Situm M, Jaing CJ, et al
    Association of Kaposi's sarcoma-associated herpesvirus (KSHV) with bladder cancer in Croatian patients.
    Tumour Biol. 2013.
    Abstract     Related articles   

  743. RAZZAK M
    Bladder cancer: Gaps in staging and care identified.
    Nat Rev Urol. 2013 Aug 20. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  744. HUDDART RA , Hall E, Hussain SA, Jenkins P, et al
    Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004).
    Int J Radiat Oncol Biol Phys. 2013;87:261-9.
    Abstract     Related articles   

  745. ZHANG ZL , Dong P, Li YH, Liu ZW, et al
    Radical cystectomy for treating bladder cancer: oncological outcome in 271 Chinese patients.
    Chin J Cancer. 2013 Aug 6. doi: 10.5732/cjc.012.10312.
    Abstract     Related articles   

  746. VAN LINGEN AV , Witjes JA
    Current intravesical therapy for non-muscle invasive bladder cancer.
    Expert Opin Biol Ther. 2013.
    Abstract     Related articles   

  747. RAO MV , Quek ML, Jayram G, Ellimoottil C, et al
    Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy.
    ISRN Urol. 2013;2013:405064.
    Abstract     Related articles   

  748. CHUNG SS , Koh CJ
    Bladder cancer cell in co-culture induces human stem cell differentiation to urothelial cells through paracrine FGF10 signaling.
    In Vitro Cell Dev Biol Anim. 2013.
    Abstract     Related articles   

  749. BERRADA N , Al-Bouzidi A, Ameur A, Abbar M, et al
    Human papillomavirus detection in Moroccan patients with bladder cancer.
    J Infect Dev Ctries. 2013;7:586-92.
    Abstract     Related articles   

  750. CHANG L , Xiao W, Yang Y, Li H, et al
    Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits epidermal growth factor receptor signaling pathway activation and induces apoptosis in bladder cancer cells in vitro and in vivo.
    Urol Oncol. 2013 Aug 12. pii: S1078-1439(13)00077.
    Abstract     Related articles   

  751. LIMA L , Ferreira JA, Tavares A, Oliveira D, et al
    FASL polymorphism is associated with response to bacillus Calmette-Guerin immunotherapy in bladder cancer.
    Urol Oncol. 2013 Aug 12. pii: S1078-1439(13)00209.
    Abstract     Related articles   

  752. COLOMBO R , Serretta V
    [Open questions - Non-muscle invasive carcinoma of the bladder - Introduction].
    Urologia. 2013;80 Suppl 21.
    Abstract     Related articles   

  753. DE NUNZIO C , Cindolo L, Leonardo C, Antonelli A, et al
    Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort.
    Eur J Surg Oncol. 2013;39:792-8.
    Abstract     Related articles   

  754. RACIOPPI M , D'Agostino D, Gianfrancesco LD, Bassi PF, et al
    [Second-line intravesical therapy. What is the present role of device-assisted therapy?].
    Urologia. 2013;80 Suppl 21:37-41.
    Abstract     Related articles   

  755. CAMPODONICO F
    [Urine cytology and new markers. Are there any advantages in terms of cost-effectiveness?].
    Urologia. 2013;80 Suppl 21:7-10.
    Abstract     Related articles   

  756. MONTANARO V , Di Girolamo A, Ferro M, Altieri V, et al
    [How to apply follow-up in relation to risk group].
    Urologia. 2013;80 Suppl 21:42-7.
    Abstract     Related articles   

  757. CUROTTO AG
    [Intravesical chemotherapy].
    Urologia. 2013;80 Suppl 21:20-3.
    Abstract     Related articles   

  758. POMARA G , Francesca F
    [Endoscopic resection. Aspects of technique and optimization of outcomes. Current indications to PDD-guided resection].
    Urologia. 2013;80 Suppl 21:16-9.
    Abstract     Related articles   

  759. FIORITO C , Gontero P
    [Adverse events after intravesical therapy: are we always ready to recognize and prevent them?].
    Urologia. 2013;80 Suppl 21:27-32.
    Abstract     Related articles   

  760. SERRETTA V , Colombo R
    [Epidemiology of disease conditions in Italy. Has anything changed? Environment, professional exposure, and lifestyle. Is time for screening?].
    Urologia. 2013;80 Suppl 21:3-6.
    Abstract     Related articles   

  761. WILLIAMSON SR , Zhang S, Lopez-Beltran A, Montironi R, et al
    Telomere shortening distinguishes inverted urothelial neoplasms.
    Histopathology. 2013;62:595-601.
    Abstract     Related articles   

  762. IDREES MT , Alexander RE, Kum JB, Cheng L, et al
    The spectrum of histopathologic findings in vesical diverticulum: implications for pathogenesis and staging.
    Hum Pathol. 2013;44:1223-32.
    Abstract     Related articles   

  763. LUSUARDI L , Janetschek G
    Update on use of enhanced imaging to optimize lymphadenectomy in patients undergoing minimally invasive surgery for urothelial cancer of the bladder.
    Curr Urol Rep. 2013;14:124-9.
    Abstract     Related articles   

  764. FREIFELD Y , Dekel Y, Stein A
    Adjuvant methods to improve results of local bladder irrigations by chemotherapy for NMIBC.
    Curr Urol Rep. 2013;14:71-7.
    Abstract     Related articles   

  765. NIEDERHAUSER BD , Kawashima A, King BF, Takahashi N, et al
    Utility of gadolinium-enhanced MR urography in detection of bladder carcinoma.
    Eur J Radiol. 2013;82:472-7.
    Abstract     Related articles   

  766. CATTI M
    Commentary to 'Granulocytic sarcoma of the urinary bladder in a pediatric patient'.
    J Pediatr Urol. 2013;9:e11.
    Abstract     Related articles   

  767. AMIN MF , Abd El Hamid AM
    The diagnostic accuracy of multidetector computed tomography with multiplanar reformatted imaging and virtual cystoscopy in the early detection and evaluation of bladder carcinoma: comparison with conventional cystoscopy.
    Abdom Imaging. 2012.
    Abstract     Related articles   

  768. KAPLAN J , Dardanelli E, Sierre S, Moguillansky S, et al
    Granulocytic sarcoma of the urinary bladder in a pediatric patient.
    J Pediatr Urol. 2013;9:e9-11.
    Abstract     Related articles   

  769. PING SY , Shen KH, Yu DS
    Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
    Mol Carcinog. 2013;52:568-79.
    Abstract     Related articles   

  770. NISHIYAMA N , Kitamura H, Maeda T, Takahashi S, et al
    Clinicopathological Analysis of Patients with Non-muscle-invasive Bladder Cancer: Prognostic Value and Clinical Reliability of the 2004 WHO Classification System.
    Jpn J Clin Oncol. 2013.
    Abstract     Related articles   

  771. CLYNE M
    Bladder cancer: Aristolochic acid-one of the most potent carcinogens known to man.
    Nat Rev Urol. 2013 Aug 27. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  772. KAPLAN AL , Litwin MS, Chamie K
    The future of bladder cancer care in the USA.
    Nat Rev Urol. 2013 Aug 27. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  773. KAISER S , Dietrich F, Resende PE, Verza SG, et al
    Cat's Claw Oxindole Alkaloid Isomerization Induced by Cell Incubation and Cytotoxic Activity against T24 and RT4 Human Bladder Cancer Cell Lines.
    Planta Med. 2013.
    Abstract     Related articles   

  774. BESARATINIA A , Cockburn M, Tommasi S
    Alterations of DNA methylome in human bladder cancer.
    Epigenetics. 2013;8.
    Abstract     Related articles   

  775. THISSEN AK , Pfister D, Heidenreich A
    [Muscle invasive bladder cancer after radical cystectomy : Prognostic factors of adjuvant chemotherapy.]
    Urologe A. 2013.
    Abstract     Related articles   

  776. KOHNO M , Kishida T, Fujikawa A, Muraoka K, et al
    [A case of aggressively growing bladder cancer in patient with long-term cystostomy due to spinal cord injury].
    Nihon Hinyokika Gakkai Zasshi. 2013;104:612-5.
    Abstract     Related articles   

  777. MATSUSHIMA M , Kuwabara T
    [The history and the present conditions of the occupational bladder cancer in our country].
    Nihon Hinyokika Gakkai Zasshi. 2013;104:569-78.
    Abstract     Related articles   

  778. SULLIVAN JF , Fanning DM, Cheema I, Creagh T, et al
    A rare case of recurrent urachal adenocarcinoma of the bladder.
    Ir Med J. 2013;106:147-8.
    Abstract     Related articles   

  779. JINDAL T , Mukherjee S, Mandal SN, Karmakar D, et al
    Transobturator taping for the treatment of incontinence after neobladder reconstruction.
    Female Pelvic Med Reconstr Surg. 2013;19:245-6.
    Abstract     Related articles   

  780. EROGLU Z , Fruehauf JP
    A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder.
    Cancer Chemother Pharmacol. 2013;72:263-7.
    Abstract     Related articles   

  781. ISHIKAWA T , Ito F, Goya N, Suzuki K, et al
    [Pseudosarcomatous myofibroblastic proliferation of the bladder-case report].
    Hinyokika Kiyo. 2013;59:125-7.
    Abstract     Related articles   

  782. KOIZUMI K , Shiga J, Yokota H, Motoori K, et al
    [A case of inverted papilloma of the renal pelvis, associated with metachronous urothelial carcinoma of the urinary bladder].
    Hinyokika Kiyo. 2013;59:121-4.
    Abstract     Related articles   

  783. NAKAZAWA S , Imamura R, Hayashi T, Yamamoto Y, et al
    [Urothelial carcinoma after renal transplantation : a case report].
    Hinyokika Kiyo. 2013;59:117-20.
    Abstract     Related articles   

  784. SAMARATUNGA H , Martignoni G, Egevad L, Delahunt B, et al
    Premalignant lesions of the urinary bladder.
    Pathology. 2013;45:243-50.
    Abstract     Related articles   

  785. MATSUO M , Azuma T
    [A case of fistula of small intestine and ileal conduit urinary diversion improved by conservative therapy].
    Hinyokika Kiyo. 2013;59:47-9.
    Abstract     Related articles   

  786. OKADA M , Takahashi S, Matsuki M, Ichihara K, et al
    [A case of squamous cell carcinoma of the bladder in a patient with interstitial cystitis].
    Hinyokika Kiyo. 2013;59:31-3.
    Abstract     Related articles   

  787. JIA AY , Castillo-Martin M, Domingo-Domenech J, Bonal DM, et al
    A common MicroRNA signature consisting of miR-133a, miR-139-3p, and miR-142-3p clusters bladder carcinoma in situ with normal umbrella cells.
    Am J Pathol. 2013;182:1171-9.
    Abstract     Related articles   

  788. MOORJANI N , Rubens M, Price S, DeSouza A, et al
    Mobile thrombus in the ascending aorta following cisplatin-based chemotherapy.
    J Card Surg. 2013;28:48-9.
    Abstract     Related articles   

  789. CHEN YH , Wang SQ, Wu XL, Shen M, et al
    Characterization of microRNAs expression profiling in one group of Chinese urothelial cell carcinoma identified by Solexa sequencing.
    Urol Oncol. 2013;31:219-27.
    Abstract     Related articles   

  790. LEVITT JM , Jian W, Lerner SP, Sonpavde G, et al
    A conventional preclinical schedule of cisplatin is more effective than a metronomic frequent bolus schedule for urothelial carcinoma.
    Urol Oncol. 2013;31:234-40.
    Abstract     Related articles   

  791. FENG CC , Wang PH, Ding Q, Guan M, et al
    Expression of pigment epithelium-derived factor and tumor necrosis factor-alpha is correlated in bladder tumor and is related to tumor angiogenesis.
    Urol Oncol. 2013;31:241-6.
    Abstract     Related articles   

  792. JUENGEL E , Santos SM, Schneider T, Makarevic J, et al
    HDAC inhibition suppresses bladder cancer cell adhesion to collagen under flow conditions.
    Exp Biol Med (Maywood). 2013.
    Abstract     Related articles   

  793. HOSSAIN D , Hull D, Kalantarpour F, Maitlen R, et al
    Does polyomavirus infection interfere with bladder cancer fluorescence in situ hybridization?
    Diagn Cytopathol. 2013 Sep 5. doi: 10.1002/dc.23027.
    Abstract     Related articles   

  794. XU Y , Luo S, Liu Y, Li J, et al
    Integrated gene network analysis and text mining revealing PIK3R1 regulated by miR-127 in human bladder cancer.
    Eur J Med Res. 2013;18:29.
    Abstract     Related articles   

  795. DOLIN P
    Pioglitazone, bladder cancer, and detection bias.
    J Diabetes. 2013 Sep 5. doi: 10.1111/1753-0407.12087.
    Abstract     Related articles   

  796. CORDES I , Kluth M, Zygis D, Rink M, et al
    PTEN deletions are related to disease progression and unfavourable prognosis in early bladder cancer.
    Histopathology. 2013 Jun 21. doi: 10.1111/his.12209.
    Abstract     Related articles   

  797. PLATANIOTIS GA , Dale RG
    Radio-chemotherapy for bladder cancer: Contribution of chemotherapy on local control.
    World J Radiol. 2013;5:267-74.
    Abstract     Related articles   

  798. SAID N , Frierson HF, Sanchez-Carbayo M, Brekken RA, et al
    Loss of SPARC in bladder cancer enhances carcinogenesis and progression.
    J Clin Invest. 2013;123:4089.
    Abstract     Related articles   

  799. CORDEIRO FEIJOO ER , Geijsen DE, Zum Vorde Sive Vording PJ, Schooneveldt G, et al
    Novel multi-sensor probe for monitoring bladder temperature during loco-regional chemo-hyperthermia for non-muscle invasive bladder cancer: technical feasibility study.
    J Endourol. 2013.
    Abstract     Related articles   

  800. LI X , Wang Y, Xu J, Zhang Q, et al
    Sandwich ELISA for detecting urinary Survivin in bladder cancer.
    Chin J Cancer Res. 2013;25:375-81.
    Abstract     Related articles   

  801. CHOI JW , Kim Y, Lee JH, Kim YS, et al
    High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer.
    Virchows Arch. 2013.
    Abstract     Related articles   

  802. HAGIYA Y , Fukuhara H, Matsumoto K, Endo Y, et al
    Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
    Photodiagnosis Photodyn Ther. 2013;10:288-95.
    Abstract     Related articles   

  803. JIANG QQ , Liu B, Yuan T
    MicroRNA-16 Inhibits Bladder Cancer Proliferation by Targeting Cyclin D1.
    Asian Pac J Cancer Prev. 2013;14:4127-30.
    Abstract     Related articles   

  804. COLMERS IN , Majumdar SR, Yasui Y, Bowker SL, et al
    Detection Bias and Overestimation of Bladder Cancer Risk in Type 2 Diabetes: A matched cohort study.
    Diabetes Care. 2013.
    Abstract     Related articles   

  805. RAGHAVAN D
    Invasive bladder cancer: ignoring the data.
    Oncologist. 2013;18:895-6.
    Abstract     Related articles   

  806. OLUMI AF , Kaufman DS, Zietman A, Harisinghani MG, et al
    Case records of the Massachusetts General Hospital. Case 25-2013. A 71-year-old man with hematuria and a mass in the bladder.
    N Engl J Med. 2013;369:660-7.
    Abstract     Related articles   

  807. BELTRAN AL , Ordonez JL, Otero AP, Blanca A, et al
    Fluorescence in situ hybridization analysis of CCND3 gene as marker of progression in bladder carcinoma.
    J Biol Regul Homeost Agents. 2013;27:559-67.
    Abstract     Related articles   

  808. TRIPODI SA , Rocca BJ, Mourmouras V, Barbanti G, et al
    Benign glomus tumor of the urinary bladder.
    Arch Pathol Lab Med. 2013;137:1005-8.
    Abstract     Related articles   

  809. ZHOU AG , Owens CL, Cosar EF, Jiang Z, et al
    Clinical implications of current developments in genitourinary pathology.
    Arch Pathol Lab Med. 2013;137:887-93.
    Abstract     Related articles   

  810. BEKELMAN JE , Handorf EA, Guzzo T, Evan Pollack C, et al
    Radical cystectomy versus bladder-preserving therapy for muscle-invasive urothelial carcinoma: examining confounding and misclassification biasin cancer observational comparative effectiveness research.
    Value Health. 2013;16:610-8.
    Abstract     Related articles   

  811. ONISHI A , Sugiyama D, Kumagai S, Morinobu A, et al
    Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.
    Arthritis Rheum. 2013;65:1913-21.
    Abstract     Related articles   

  812. LIANG PI , Wang YH, Wu TF, Wu WR, et al
    IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
    J Clin Pathol. 2013;66:573-82.
    Abstract     Related articles   

  813. MUOKA OE , Muoka O, Daruwalla P
    Leiomyoma of the bladder.
    BMJ Case Rep. 2013;2013.
    Abstract     Related articles   

  814. CHRISTODOULIDOU M , Lucky M, Mansour P, Gammal M, et al
    Incidental paraganglioma of the urinary bladder in a 66-year-old woman.
    BMJ Case Rep. 2013;2013.
    Abstract     Related articles   

  815. EN-NAFAA I , Latib R, Africha T, Chami I, et al
    [Adenocarcinoma of the urachus: a rare cause of hematuria].
    Pan Afr Med J. 2013;14:8.
    Abstract     Related articles   

  816. WU R , Liu G, Bharadwaj S, Zhang Y, et al
    Isolation and myogenic differentiation of mesenchymal stem cells for urologic tissue engineering.
    Methods Mol Biol. 2013;1001:65-80.
    Abstract     Related articles   

  817. HEMPEL N , Bartling TR, Mian B, Melendez JA, et al
    Acquisition of the metastatic phenotype is accompanied by H2O2-dependent activation of the p130Cas signaling complex.
    Mol Cancer Res. 2013;11:303-12.
    Abstract     Related articles   

  818. BAMIAS A , Dafni U, Karadimou A, Timotheadou E, et al
    Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).
    Ann Oncol. 2013;24:1011-7.
    Abstract     Related articles   

  819. NEUHAUS J , Schastak S, Berndt M, Walther J, et al
    [Photodynamic therapy of bladder cancer : A new option].
    Urologe A. 2013;52:1225-32.
    Abstract     Related articles   

  820. LI S , Wu J, Chen Y, Tang W, et al
    ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis.
    Anticancer Drugs. 2013.
    Abstract     Related articles   

  821. XU W , Wang F, Ying L, Wang HH, et al
    Association between glutathione S-transferase M1 null variant and risk of bladder cancer in Chinese Han population.
    Tumour Biol. 2013.
    Abstract     Related articles   

  822. MUNK M , Memon A, Poulsen SS, Borre M, et al
    The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor alpha is not expressed.
    Scand J Clin Lab Invest. 2013;73:503-13.
    Abstract     Related articles   

  823. WANG L , Su G, Zhao X, Cai Y, et al
    Association between the cytotoxic T-lymphocyte antigen 4 +49A/G polymorphism and bladder cancer risk.
    Tumour Biol. 2013.
    Abstract     Related articles   

  824. WU K , Ning Z, Zeng J, Fan J, et al
    Silibinin inhibits beta-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Cell Signal. 2013 Sep 4. pii: S0898-6568(13)00263.
    Abstract     Related articles   

  825. MIYAKE M , Ross S, Lawton A, Chang M, et al
    Investigation of CCL18 and A1AT as potential urinary biomarkers for bladder cancer detection.
    BMC Urol. 2013;13:42.
    Abstract     Related articles   

  826. MENG MV , Nelson H
    What is the appropriate extent of lymphadenectomy for bladder cancer?
    Bull Am Coll Surg. 2013;98:60-2.
    Abstract     Related articles   

  827. TAN MY , Mu XY, Liu B, Wang Y, et al
    SUMO-Specific Protease 2 Suppresses Cell Migration and Invasion through Inhibiting the Expression of MMP13 in Bladder Cancer Cells.
    Cell Physiol Biochem. 2013;32:542-548.
    Abstract     Related articles   

  828. CHRISTOFORIDOU EP , Riza E, Kales SN, Hadjistavrou K, et al
    Bladder cancer and arsenic through drinking water: A systematic review of epidemiologic evidence.
    J Environ Sci Health A Tox Hazard Subst Environ Eng. 2013;48:1764-75.
    Abstract     Related articles   

  829. ZHANG Q , Su M, Lu G, Wang J, et al
    The complexity of bladder cancer: long noncoding RNAs are on the stage.
    Mol Cancer. 2013;12:101.
    Abstract     Related articles   

  830. KO YJ , Canil CM, Mukherjee SD, Winquist E, et al
    Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study.
    Lancet Oncol. 2013;14:769-76.
    Abstract     Related articles   

  831. SONPAVDE G , Galsky MD, Bellmunt J
    A new approach to second-line therapy for urothelial cancer?
    Lancet Oncol. 2013;14:682-4.
    Abstract     Related articles   

  832. SUGITA Y , Ishikawa W, Hirai S, Maru N, et al
    [A case of inverted urothelial carcinoma of bladder].
    Hinyokika Kiyo. 2013;59:243-6.
    Abstract     Related articles   

  833. MIZUNO K , Nakanishi S, Sakatani T, Kimura R, et al
    [A case of primary mucosa-associated lymphoid tissue-type lymphoma of the urinary bladder that progressed after antibiotic therapy].
    Hinyokika Kiyo. 2013;59:239-42.
    Abstract     Related articles   

  834. NAGASHIMA M , Araki A, Yanagisawa M, Komiya A, et al
    [Effect of prophylactic intravesical instillation of pirarubicin to prevent recurrent bladder tumors following nephroureterectomy for upper urinary tract cancer].
    Hinyokika Kiyo. 2013;59:213-6.
    Abstract     Related articles   

  835. FAKHR I , Mohamed AM, Moustafa A, Al-Sherbiny M, et al
    Neobladder long term follow-up.
    J Egypt Natl Canc Inst. 2013;25:43-9.
    Abstract     Related articles   

  836. EL-MAHALLAWY HA , Hassan SS, Khalifa HI, El-Sayed Safa MM, et al
    Comparing a combination of penicillin G and gentamicin to a combination of clindamycin and amikacin as prophylactic antibiotic regimens in prevention of clean contaminated wound infections in cancer surgery.
    J Egypt Natl Canc Inst. 2013;25:31-5.
    Abstract     Related articles   

  837. AMMANNAGARI N , Polu V
    'Cannon ball' pulmonary metastases.
    BMJ Case Rep. 2013;2013.
    Abstract     Related articles   

  838. SELINSKI S , Blaszkewicz M, Agundez JA, Martinez C, et al
    Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.
    Front Biosci (Schol Ed). 2013;5:672-84.
    Abstract     Related articles   

  839. MUEZZINOGLU T , Inceboz U, Baytur Y, Nese N, et al
    Bladder carcinoma in pregnancy: unusual cause for frequent urinary tract infection-case report.
    Arch Gynecol Obstet. 2012.
    Abstract     Related articles   

  840. SATAGOPAN JM , Elston RC
    Evaluation of removable statistical interaction for binary traits.
    Stat Med. 2013;32:1164-90.
    Abstract     Related articles   

  841. SHIM UJ , Lee IS, Kang HW, Kim J, et al
    Decreased DBC1 Expression Is Associated With Poor Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer.
    Korean J Urol. 2013;54:631-7.
    Abstract     Related articles   

  842. AL-SAMAWI AS , Aulaqi SM
    Urinary bladder cancer in yemen.
    Oman Med J. 2013;28:337-40.
    Abstract     Related articles   

  843. ABDULLAH LS
    The value of urine cytology in the diagnosis of bladder cancer. Cytopathological correlation.
    Saudi Med J. 2013;34:937-41.
    Abstract     Related articles   

  844. RAZZAK M
    Bladder cancer: Urologists, time to take the helm as antimicrobial stewards.
    Nat Rev Urol. 2013 Sep 17. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  845. GAN C , Mostafid H, Khan MS, Lewis DJ, et al
    BCG immunotherapy for bladder cancer-the effects of substrain differences.
    Nat Rev Urol. 2013 Sep 17. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  846. XIE H , Gong Y, Dai J, Wu X, et al
    Genetic variations in base excision repair pathway and risk of bladder cancer: A case-control study in the United States.
    Mol Carcinog. 2013 Sep 4. doi: 10.1002/mc.22073.
    Abstract     Related articles   

  847. CAO M , Mu X, Jiang C, Yang G, et al
    Single-nucleotide polymorphisms of GPX1 and MnSOD and susceptibility to bladder cancer: a systematic review and meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  848. LI Y , Liu H, Lai C, Du X, et al
    The Lin28/let-7a/c-Myc pathway plays a role in non-muscle invasive bladder cancer.
    Cell Tissue Res. 2013.
    Abstract     Related articles   

  849. FERRECCIO C , Yuan Y, Calle J, Benitez H, et al
    Arsenic, Tobacco Smoke, and Occupation: Associations of Multiple Agents with Lung and Bladder Cancer.
    Epidemiology. 2013.
    Abstract     Related articles   

  850. GOERLITZ D , Amr S, Dash C, Saleh DA, et al
    Genetic polymorphisms in NQO1 and SOD2: Interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt?>
    Urol Oncol. 2013 Sep 10. pii: S1078-1439(13)00286.
    Abstract     Related articles   

  851. PINTO-LEITE R , Arantes-Rodrigues R, Ferreira R, Palmeira C, et al
    Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.
    Urol Oncol. 2013 Sep 10. pii: S1078-1439(13)00198.
    Abstract     Related articles   


  852. [Comparative evaluation of informative value of UroVysion and AURKA FISH tests of urine sediment cells for the diagnosis of bladder cancer].
    Vopr Onkol. 2013;59:483-6.
    Abstract     Related articles   

  853. CHENG L , Davison DD, Adams J, Lopez-Beltran A, et al
    Biomarkers in bladder cancer: Translational and clinical implications.
    Crit Rev Oncol Hematol. 2013 Aug 29. pii: S1040-8428(13)00185.
    Abstract     Related articles   

  854. MUKHTAR S , Ayres BE, Issa R, Swinn MJ, et al
    Challenging boundaries: an enhanced recovery programme for radical cystectomy.
    Ann R Coll Surg Engl. 2013;95:200-6.
    Abstract     Related articles   

  855. BISSONNETTE ML , Kocherginsky M, Tretiakova M, Jimenez RE, et al
    The different morphologies of urachal adenocarcinoma do not discriminate genomically by micro-RNA expression profiling.
    Hum Pathol. 2013;44:1605-11.
    Abstract     Related articles   

  856. YU HJ , Chang YH, Pan CC
    Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder.
    Histopathology. 2013;62:788-98.
    Abstract     Related articles   

  857. MAGER R , Hartmann S, Husch T, Reiter M, et al
    [Differential diagnosis of multilocular bladder tumors in young patients: nephrogenic adenoma of the bladder in a 25-year old male cystinuria patient].
    Urologe A. 2013;52:396-8.
    Abstract     Related articles   

  858. IYER G , Milowsky MI
    Fibroblast growth factor receptor-3 in urothelial tumorigenesis.
    Urol Oncol. 2013;31:303-11.
    Abstract     Related articles   

  859. SHAKER O , Hammam O, Wishahi M, Roshdi M, et al
    TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal.
    Urol Oncol. 2013;31:372-8.
    Abstract     Related articles   

  860. BOLENZ C , West AM, Ortiz N, Kabbani W, et al
    Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
    Urol Oncol. 2013;31:366-71.
    Abstract     Related articles   

  861. EL-MONIM HA , El-Baradie MM, Younis A, Ragab Y, et al
    A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer.
    Urol Oncol. 2013;31:359-65.
    Abstract     Related articles   

  862. PLIARCHOPOULOU K , Laschos K, Pectasides D
    Current chemotherapeutic options for the treatment of advanced bladder cancer: a review.
    Urol Oncol. 2013;31:294-302.
    Abstract     Related articles   

  863. LAN W , Zhang D, Jiang J
    The roles of LSD1-mediated epigenetic modifications in maintaining the pluripotency of bladder cancer stem cells.
    Med Hypotheses. 2013 Sep 8. pii: S0306-9877(13)00439.
    Abstract     Related articles   

  864. LIU C , Yin Q, Hu J, Weng J, et al
    Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk.
    Tumour Biol. 2013.
    Abstract     Related articles   

  865. SHARRON LIN X , Hu L, Sandy K, Correll M, et al
    Differentiating progressive from nonprogressive T1 bladder cancer by gene expression profiling: Applying RNA-sequencing analysis on archived specimens.
    Urol Oncol. 2013 Sep 18. pii: S1078-1439(13)00284.
    Abstract     Related articles   

  866. BECKER MN , Wu KJ, Marlow LA, Kreinest PA, et al
    The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro.
    Urol Oncol. 2013 Sep 17. pii: S1078-1439(13)00251.
    Abstract     Related articles   

  867. XYLINAS E , Kluth LA, Rieken M, Karakiewicz PI, et al
    Urine markers for detection and surveillance of bladder cancer.
    Urol Oncol. 2013 Sep 17. pii: S1078-1439(13)00250.
    Abstract     Related articles   

  868. OLIVEIRA TR , Stauffer PR, Lee CT, Landon CD, et al
    Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study.
    Int J Hyperthermia. 2013.
    Abstract     Related articles   

  869. ASGARI MA , Safarinejad MR, Shakhssalim N, Soleimani M, et al
    Quality of life after radical cystectomy for bladder cancer in men with an ileal conduit or continent urinary diversion: A comparative study.
    Urol Ann. 2013;5:190-6.
    Abstract     Related articles   

  870. RAHMANI AH , Alzohairy M, Babiker AY, Khan AA, et al
    Implication of androgen receptor in urinary bladder cancer: a critical mini review.
    Int J Mol Epidemiol Genet. 2013;4:150-5.
    Abstract     Related articles   

  871. ROSSER CJ , Urquidi V, Goodison S
    Urinary biomarkers of bladder cancer: an update and future perspectives.
    Biomark Med. 2013;7:779-90.
    Abstract     Related articles   

  872. CHOUDHARY S , Sood S, Wang HC
    Synergistic induction of cancer cell death and reduction of clonogenic resistance by cisplatin and FK228.
    Biochem Biophys Res Commun. 2013;436:325-30.
    Abstract     Related articles   

  873. MIZUSAWA H , Mimura Y, Saito T
    [A case of adenocarcinoma arising in an ileal conduit].
    Hinyokika Kiyo. 2013;59:297-9.
    Abstract     Related articles   

  874. ALEXANDER RE , Davidson DD, Lopez-Beltran A, Montironi R, et al
    Human papillomavirus is not an etiologic agent of urothelial inverted papillomas.
    Am J Surg Pathol. 2013;37:1223-8.
    Abstract     Related articles   

  875. SENDO H , Harada H, Hasegawa H, Yasuda T, et al
    [A case of gallbladder metastasis from a malignant perivascular epithelioid cell tumor of the bladder].
    Nihon Shokakibyo Gakkai Zasshi. 2013;110:861-8.
    Abstract     Related articles   

  876. DAL MORO F
    BCG shortage in Europe.
    Prev Med. 2013;57:146.
    Abstract     Related articles   

  877. BULUT Y , Ozdemir E, Ozercan HI, Etem EO, et al
    Potential relationship between BK virus and renal cell carcinoma.
    J Med Virol. 2013;85:1085-9.
    Abstract     Related articles   

  878. NETTO GJ
    Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Adv Anat Pathol. 2013;20:175-203.
    Abstract     Related articles   

  879. CAGLAR D , Gagnon RF, Kassouf W
    Tadpole cells in an unstained urine sediment.
    Kidney Int. 2013;83:763-4.
    Abstract     Related articles   

  880. KOJIMA Y , Takasawa A, Murata M, Akagashi K, et al
    A case of urothelial carcinoma, lipid cell variant.
    Pathol Int. 2013;63:183-7.
    Abstract     Related articles   

  881. PARISIAN KR , Lopez R, Shen B
    Chronic Pouch Inflammation and Risk for New-Onset Extraintestinal Cancers in Patients With Restorative Proctocolectomy for Ulcerative Colitis.
    Inflamm Bowel Dis. 2013.
    Abstract     Related articles   

  882. MAKIS W , Rakheja R, Nahal A, Hickeson M, et al
    Urinary Bladder Leiomyosarcoma: Staging With 18F-FDG PET/CT.
    Clin Nucl Med. 2013.
    Abstract     Related articles   

  883. OZTURK U , Goktug HN, Tuygun C, Sener NC, et al
    Pediatric bladder rhabdomyosarcoma: report of organ sparing treatment of two cases.
    J Pediatr Urol. 2013;9:e111-3.
    Abstract     Related articles   

  884. RASPOLLINI MR , Minervini A, Lapini A, Lanzi F, et al
    A proposed score for assessing progression in pT1 high-grade urothelial carcinoma of the bladder.
    Appl Immunohistochem Mol Morphol. 2013;21:218-27.
    Abstract     Related articles   

  885. SCHWARTZ L , Guais A, Israel M, Junod B, et al
    Tumor regression with a combination of drugs interfering with the tumor metabolism: efficacy of hydroxycitrate, lipoic acid and capsaicin.
    Invest New Drugs. 2013;31:256-64.
    Abstract     Related articles   

  886. PESCH B , Gawrych K, Rabstein S, Weiss T, et al
    NAT2 acetylator phenotype, occupation and bladder cancer risk: Results from the EPIC cohort.
    Cancer Epidemiol Biomarkers Prev. 2013.
    Abstract     Related articles   

  887. HE S , Tang YH, Zhao G, Yang X, et al
    Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  888. MENG XD , Zhou ZS, Qiu JH, Shen WH, et al
    Increased SPHK1 expression is associated with poor prognosis in bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  889. D'SOUZA AM , Phillips GS, Pohar KS, Zynger DL, et al
    Clinicopathologic characteristics and overall survival in patients with bladder cancer involving the gastrointestinal tract.
    Virchows Arch. 2013.
    Abstract     Related articles   

  890. JIANG J , Yuan X, Zhao H, Yan X, et al
    Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production.
    Biomed Mater Eng. 2013;23:S1071-S1077.
    Abstract     Related articles   

  891. MUELLER J , Schrader AJ, Schrader M, Schnoeller T, et al
    Management of muscle-invasive bladder cancer.
    Minerva Urol Nefrol. 2013;65:235-248.
    Abstract     Related articles   

  892. ZHONG MZ , Guo SJ, Jiang LJ, Yun JP, et al
    [Prognostic significance of the 2004 WHO classification compared with the 1973 WHO classification for organ-confined invasive bladder cancer.]
    Zhonghua Wai Ke Za Zhi. 2013;51:538-541.
    Abstract     Related articles   

  893. MIR MC , Stephenson AJ, Grubb RL 3rd, Black A, et al
    Predicting risk of bladder cancer using clinical and demographic information from prostate, lung, colorectal, and ovarian cancer (PLCO) screening trial participants.
    Cancer Epidemiol Biomarkers Prev. 2013.
    Abstract     Related articles   

  894. MA Q , Zhao Y, Wang S, Zhang X, et al
    Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.
    Tumour Biol. 2013.
    Abstract     Related articles   

  895. KARBAKHSH M , Dabbagh N, Shabani A, Tabibi A, et al
    Age at Diagnosis in Bladder Cancer: Does Opium Addiction Play a Role?
    Asian Pac J Cancer Prev. 2013;14:4723-4725.
    Abstract     Related articles   

  896. HUANG YD , Shan W, Zeng L, Wu Y, et al
    Screening of Differentially Expressed Genes Related to Bladder Cancer and Functional Analysis with DNA Microarray.
    Asian Pac J Cancer Prev. 2013;14:4553-4557.
    Abstract     Related articles   

  897. STERNBERG CN , Skoneczna IA, Castellano D, Theodore C, et al
    Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB).
    Oncology. 2013;85:208-215.
    Abstract     Related articles   

  898. PAYTON S
    Bladder cancer: Mutation found in >70% of tumours.
    Nat Rev Urol. 2013 Oct 1. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  899. MONFARED H , Ziaee SA, Hashemitabar M, Khayatzadeh H, et al
    Co-Regulated Expression of TGF-? Variants and miR-21 In Bladder Cancer.
    Urol J. 2013;10:981-7.
    Abstract     Related articles   

  900. MATIC M , Pekmezovic T, Djukic T, Mimic-Oka J, et al
    GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: A case-control study.
    Urol Oncol. 2013;31:1184-92.
    Abstract     Related articles   

  901. OWUSU RA , Abern MR, Inman BA
    Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer.
    Biomed Res Int. 2013;2013:262313.
    Abstract     Related articles   

  902. ZHANG D , Sun P, Li P, Xue A, et al
    A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guerin in the treatment of bladder cancer.
    Biomaterials. 2013 Sep 23. pii: S0142-9612(13)01110.
    Abstract     Related articles   

  903. POMMERGAARD HC , Burcharth J, Rosenberg J, Raskov H, et al
    Oral chemoprevention with acetyl salicylic Acid, vitamin D and calcium reduces the risk of tobacco carcinogen-induced bladder tumors in mice.
    Cancer Invest. 2013;31:490-3.
    Abstract     Related articles   

  904. MARTINEZ-FERNANDEZ A
    The long road to bladder sparing in muscle invasive cancer.
    Lancet Oncol. 2013;14:795-6.
    Abstract     Related articles   

  905. DEMIRTAS A , Sabur V, Akinsal EC, Demirci D, et al
    Can neutrophil-lymphocyte ratio and lymph node density be used as prognostic factors in patients undergoing radical cystectomy?
    ScientificWorldJournal. 2013;2013:703579.
    Abstract     Related articles   

  906. DAMMERT P , Boujaoude Z, Rafferty W, Kass J, et al
    Fever of unknown origin and pancytopenia caused by culture-proven delayed onset disseminated bacillus Calmette-Guerin (BCG) infection after intravesical instillation.
    BMJ Case Rep. 2013;2013.
    Abstract     Related articles   

  907. MUUS UBAGO J , Mehta V, Wojcik EM, Barkan GA, et al
    Evaluation of atypical urine cytology progression to malignancy.
    Cancer Cytopathol. 2013;121:387-91.
    Abstract     Related articles   

  908. COMPLOJ E , Mian C, Ambrosini-Spaltro A, Dechet C, et al
    uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses.
    Cancer Cytopathol. 2013;121:392-7.
    Abstract     Related articles   

  909. HSI RS , Welty CJ, Sorensen MD, Koreishi AF, et al
    Combined partial cystectomy and cesarean delivery in a pregnant female with bladder pheochromocytoma.
    Can J Urol. 2013;20:6646-8.
    Abstract     Related articles   

  910. CANTER DJ
    Is simpler better? Quality of life based on type of urinary diversion.
    Can J Urol. 2013;20:6632.
    Abstract     Related articles   

  911. METCALFE M , Estey E, Jacobsen NE, Voaklander D, et al
    Association between urinary diversion and quality of life after radical cystectomy.
    Can J Urol. 2013;20:6626-31.
    Abstract     Related articles   

  912. MCPARTLIN DS , Klausner AP, Nottingham CU, Wolters JP, et al
    Is cystoscopy indicated for incidentally identified bladder wall thickening?
    Can J Urol. 2013;20:6615-9.
    Abstract     Related articles   

  913. JACKSON J , Barkan GA, Kapur U, Wojcik EM, et al
    Cytologic and cystoscopic predictors of recurrence and progression in patients with low-grade urothelial carcinoma.
    Cancer Cytopathol. 2013;121:398-402.
    Abstract     Related articles   

  914. LU B , Gatsonis C
    Efficiency of study designs in diagnostic randomized clinical trials.
    Stat Med. 2013;32:1451-66.
    Abstract     Related articles   

  915. MUTO S , Sugiura SI, Nakajima A, Horiuchi A, et al
    Isomorphic red blood cells using automated urine flow cytometry is a reliable method in diagnosis of bladder cancer.
    Int J Clin Oncol. 2013.
    Abstract     Related articles   

  916. PENG Q , Mo C, Tang W, Chen Z, et al
    DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  917. COMPERAT E , Egevad L, Lopez-Beltran A, Camparo P, et al
    An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps.
    Histopathology. 2013 Jun 24. doi: 10.1111/his.12214.
    Abstract     Related articles   

  918. LIPPKA Y , Patschan O, Todenhofer T, Schwentner C, et al
    Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion board.
    Springerplus. 2013;2:445.
    Abstract     Related articles   

  919. LV S , Turlova E, Zhao S, Kang H, et al
    Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   


  920. Bladder cancer: Predicting response to BCG in patients with bladder CIS.
    Nat Rev Urol. 2013 Oct 8. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  921. VESTERGAARD A , Muren LP, Sondergaard J, Elstrom UV, et al
    Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: A dose accumulation comparison.
    Radiother Oncol. 2013 Oct 4. pii: S0167-8140(13)00455.
    Abstract     Related articles   

  922. ROGLER A , Hoja S, Socher E, Nolte E, et al
    Role of two single nucleotide polymorphisms in secreted frizzled related protein 1 and bladder cancer risk.
    Int J Clin Exp Pathol. 2013;6:1984-98.
    Abstract     Related articles   

  923. PESCH B , Taeger D, Johnen G, Gawrych K, et al
    Screening for bladder cancer with urinary tumor markers in chemical workers with exposure to aromatic amines.
    Int Arch Occup Environ Health. 2013.
    Abstract     Related articles   

  924. DAVIS NF , McLoughlin LC, Dowling C, Power R, et al
    Incidence and long-term outcomes of squamous cell bladder cancer after deceased donor renal transplantation.
    Clin Transplant. 2013 Oct 11. doi: 10.1111/ctr.12245.
    Abstract     Related articles   

  925. FAN B , Zhang L, Li XC, Song YS, et al
    [Effects of neoadjuvant chemotherapy on the prognostic mortality risk of invasive transitional bladder cancer: a meta-analysis.]
    Zhonghua Yi Xue Za Zhi. 2013;93:1705-1710.
    Abstract     Related articles   

  926. BARTON MK
    High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer.
    CA Cancer J Clin. 2013 Oct 7. doi: 10.3322/caac.21201.
    Abstract     Related articles   

  927. GUO G , Sun X, Chen C, Wu S, et al
    Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation.
    Nat Genet. 2013 Oct 13. doi: 10.1038/ng.2798.
    Abstract     Related articles   

  928. BALBAS-MARTINEZ C , Sagrera A, Carrillo-de-Santa-Pau E, Earl J, et al
    Recurrent inactivation of STAG2 in bladder cancer is not associated with aneuploidy.
    Nat Genet. 2013 Oct 13. doi: 10.1038/ng.2799.
    Abstract     Related articles   

  929. SOLOMON DA , Kim JS, Bondaruk J, Shariat SF, et al
    Frequent truncating mutations of STAG2 in bladder cancer.
    Nat Genet. 2013 Oct 13. doi: 10.1038/ng.2800.
    Abstract     Related articles   

  930. RETZ M , Schmid SC, Kramer MW, Merseburger AS, et al
    [Systemic therapy of metastatic bladder cancer.]
    Urologe A. 2013.
    Abstract     Related articles   

  931. WANG H , Liu Z, Wang ZP, Li FY, et al
    [Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2013;35:412-7.
    Abstract     Related articles   

  932. JIN BY , Fu GH, Jiang X, Pan H, et al
    CRABP2 and FABP5 identified by 2D DIGE profiling are upregulated in human bladder cancer.
    Chin Med J (Engl). 2013;126:3787-9.
    Abstract     Related articles   

  933. CORDEIRO ER , Geijsen DE, Zum Vorde Sive Vording PJ, Schooneveldt G, et al
    Novel Multisensor Probe for Monitoring Bladder Temperature During Locoregional Chemohyperthermia for Nonmuscle-Invasive Bladder Cancer: Technical Feasibility Study.
    J Endourol. 2013.
    Abstract     Related articles   

  934. SEIFERT G , Seifert M, Wittel UA
    Searching for the common denominator of systemic inflammation and tumor invasion in the cases of bikunin and the inter-alpha-trypsin inhibitor heavy chains.
    J Surg Res. 2013;183:983.
    Abstract     Related articles   

  935. DONG WX , Ping YX, Liang WC, Jian LZ, et al
    Small cell carcinoma of the urinary bladder diverticulum: a case report and review of the literature.
    J Cancer Res Ther. 2013;9:151-3.
    Abstract     Related articles   

  936. HERNANDEZ-TORRES A , Garcia-Vazquez E, Laso-Ortiz A, Herrero-Martinez JA, et al
    [Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
    Rev Esp Quimioter. 2013;26:51-5.
    Abstract     Related articles   

  937. INMAN BA , Etienne W, Rubin R, Owusu RA, et al
    The impact of temperature and urinary constituents on urine viscosity and its relevance to bladder hyperthermia treatment.
    Int J Hyperthermia. 2013;29:206-10.
    Abstract     Related articles   

  938. ALEXIEV BA , Papadimitriou JC, Chai TC, Ramos E, et al
    Polyomavirus (BK)-associated pleomorphic giant cell carcinoma of the urinary bladder: a case report.
    Pathol Res Pract. 2013;209:255-9.
    Abstract     Related articles   

  939. WEISS T , Bolt HM, Schluter G, Koslitz S, et al
    Metabolic dephenylation of the rubber antioxidant N-phenyl-2-naphthylamine to carcinogenic 2-naphthylamine in rats.
    Arch Toxicol. 2013;87:1265-72.
    Abstract     Related articles   

  940. KAPOOR S
    Bikunin and its emerging role in the modulation of tumor invasion and metastasis.
    J Surg Res. 2013;183:982.
    Abstract     Related articles   

  941. ZHANG J , Wu J
    Options for diagnosis and treatment of urachal carcinoma.
    Asia Pac J Clin Oncol. 2013;9:117-22.
    Abstract     Related articles   

  942. IDE H , Kikuchi E, Hasegawa M, Hattori S, et al
    Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
    Cancer Med. 2013;2:488-95.
    Abstract     Related articles   

  943. WANG P , Ye D, Guo J, Liu F, et al
    Genetic score of multiple risk-associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer.
    Genes Chromosomes Cancer. 2013 Oct 24. doi: 10.1002/gcc.22121.
    Abstract     Related articles   

  944. EL BEHI M , Krumeich S, Lodillinsky C, Kamoun A, et al
    An essential role for decorin in bladder cancer invasiveness.
    EMBO Mol Med. 2013 Oct 20. doi: 10.1002/emmm.201302655.
    Abstract     Related articles   

  945. LIN YH , Wang CC, Lei KF
    Bubble-driven mixer integrated with a microfluidic bead-based ELISA for rapid bladder cancer biomarker detection.
    Biomed Microdevices. 2013.
    Abstract     Related articles   

  946. OU Y , Zheng X, Gao Y, Shu M, et al
    Activation of cyclic AMP/PKA pathway inhibits bladder cancer cell invasion by targeting MAP4-dependent microtubule dynamics.
    Urol Oncol. 2013 Oct 17. pii: S1078-1439(13)00287.
    Abstract     Related articles   

  947. SAPRE N , Anderson PD, Costello AJ, Hovens CM, et al
    Gene-based urinary biomarkers for bladder cancer: An unfulfilled promise?
    Urol Oncol. 2013 Oct 17. pii: S1078-1439(13)00289.
    Abstract     Related articles   

  948. ALBERICE JV , Amaral AF, Armitage EG, Lorente JA, et al
    Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
    J Chromatogr A. 2013 Oct 4. pii: S0021-9673(13)01584.
    Abstract     Related articles   

  949. MO M , Peng F, Wang L, Peng L, et al
    Roles of mitochondrial transcription factor A and microRNA-590-3p in the development of bladder cancer.
    Oncol Lett. 2013;6:617-623.
    Abstract     Related articles   

  950. HANSEL DE , Zhang Z, Petillo D, Teh BT, et al
    Gene profiling suggests a common evolution of bladder cancer subtypes.
    BMC Med Genomics. 2013;6:42.
    Abstract     Related articles   

  951. PEDROSA JA , Koch MO, Cheng L
    Lymph node-positive bladder cancer: surgical, pathologic, molecular and prognostic aspects.
    Expert Rev Anticancer Ther. 2013.
    Abstract     Related articles   

  952. EISSA S , Badr S, Barakat M, Zaghloul AS, et al
    The diagnostic efficacy of urinary survivin and hyaluronidase mRNA as urine markers in patients with bladder cancer.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  953. BADR S , Salem A, Yuosif AH, Awadallah H, et al
    Hypoxia inducible factor-1alpha and microvessel density as angiogenic factors in bilharzial and non-bilharzial bladder cancer.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  954. JANTIP J , Tanthanuch M, Kanngurn S, Karnchanawanichkul W, et al
    Mutations of fibroblast growth factor receptor 3 gene (FGFR3) in transitional cell carcinoma of urinary bladder in Thai patients [Revision-2a].
    J Med Assoc Thai. 2013;96:976-83.
    Abstract     Related articles   

  955. ORDONEZ NG
    Value of GATA3 immunostaining in tumor diagnosis: a review.
    Adv Anat Pathol. 2013;20:352-60.
    Abstract     Related articles   

  956. KOYUNCUER A
    Immunohistochemical expression of p63, p53 in urinary bladder carcinoma.
    Indian J Pathol Microbiol. 2013;56:10-5.
    Abstract     Related articles   

  957. SUZUKI T , Furuse H, Kurita Y, Imanishi T, et al
    [Long-term survival of metastatic clear cell adenocarcinoma of the female urethra by multidisciplinary treatment: a case report].
    Nihon Hinyokika Gakkai Zasshi. 2013;104:549-53.
    Abstract     Related articles   

  958. ISHII T , Matsubara T, Taira H, Hiratsuka Y, et al
    [Metastatic micropapillary variant of urothelial carcinoma of the urinary bladder responding to gemcitabine and cisplatin chemotherapy].
    Nihon Hinyokika Gakkai Zasshi. 2013;104:540-4.
    Abstract     Related articles   

  959. ZHANG GJ , Zhang Z
    Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced by adriamycin in bladder carcinoma BIU87 cells.
    Asian Pac J Cancer Prev. 2013;14:2387-91.
    Abstract     Related articles   

  960. SUN YW , Xuan Q, Shu QA, Wu SS, et al
    Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
    Genet Mol Res. 2013;12:1045-53.
    Abstract     Related articles   

  961. GALSKY MD , Domingo-Domenech J
    Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approaches.
    Clin Adv Hematol Oncol. 2013;11:86-92.
    Abstract     Related articles   

  962. SINHA B , Ghosal S
    Pioglitazone--do we really need it to manage type 2 diabetes?
    Diabetes Metab Syndr. 2013;7:52-5.
    Abstract     Related articles   

  963. CARRERA S , Cuadrado-Castano S, Samuel J, Jones GD, et al
    Stra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage.
    Cell Death Differ. 2013;20:910-9.
    Abstract     Related articles   

  964. BRAIT M , Munari E, LeBron C, Noordhuis MG, et al
    Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma.
    Cell Cycle. 2013;12:1058-70.
    Abstract     Related articles   

  965. SHAW EC , Oxley JD, Varma M, Theaker J, et al
    High grade prostatic adenocarcinoma with a partly intraductal growth pattern producing a mimic of urothelial carcinoma in situ.
    J Clin Pathol. 2013;66:729-31.
    Abstract     Related articles   

  966. FERGUSON J , Wheeler W, Fu Y, Prokunina-Olsson L, et al
    Statistical tests for detecting associations with groups of genetic variants: generalization, evaluation, and implementation.
    Eur J Hum Genet. 2013;21:680-6.
    Abstract     Related articles   

  967. YUN SJ , Kim WJ
    Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target.
    Korean J Urol. 2013;54:645-650.
    Abstract     Related articles   

  968. SETON-ROGERS S
    Bladder cancer: No cohesion for cohesin's role.
    Nat Rev Cancer. 2013 Oct 31. doi: 10.1038/nrc3631.
    Abstract     Related articles   

  969. ZHANG Y
    Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens.
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2013;31:287-304.
    Abstract     Related articles   

  970. BEUKERS W , Hercegovac A, Zwarthoff EC
    HRAS mutations in bladder cancer at an early age and the possible association with the Costello Syndrome.
    Eur J Hum Genet. 2013 Oct 30. doi: 10.1038/ejhg.2013.
    Abstract     Related articles   

  971. KOGA F , Kobayashi S, Fujii Y, Ishioka J, et al
    Significance of Positive Urine Cytology on Progression and Cancer-Specific Mortality of Non-Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2013 Oct 26. pii: S1558-7673(13)00197.
    Abstract     Related articles   

  972. VAN LINGEN AV , Arends TJ, Witjes JA
    Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2013;13:1257-68.
    Abstract     Related articles   

  973. GRIVAS PD , Day KC, Karatsinides A, Paul A, et al
    Evaluation of the Anti-Tumor Activity of Dacomitinib in Models of Human Bladder Cancer.
    Mol Med. 2013 Oct 23. doi: 10.2119/molmed.2013.00108.
    Abstract     Related articles   


  974. Bladder cancer: Intracorporeal vs extracorporeal urinary diversion.
    Nat Rev Urol. 2013 Oct 29. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   


  975. Bladder cancer: TERT mutations as urine biomarkers of neoplasia.
    Nat Rev Urol. 2013 Oct 29. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   


  976. Bladder cancer: Localized radiotherapy for muscle-invasive bladder cancer.
    Nat Rev Urol. 2013 Oct 29. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  977. COMPLOJ E , Dechet CB, Mian M, Trenti E, et al
    Perforation during TUR of bladder tumours influences the natural history of superficial bladder cancer.
    World J Urol. 2013.
    Abstract     Related articles   

  978. KARAOGLU I , van der Heijden AG, Witjes JA
    The role of urine markers, white light cystoscopy and fluorescence cystoscopy in recurrence, progression and follow-up of non-muscle invasive bladder cancer.
    World J Urol. 2013.
    Abstract     Related articles   

  979. FIGUEROA JD , Ye Y, Siddiq A, Garcia-Closas M, et al
    Genome-wide association study identifies multiple loci associated with bladder cancer risk.
    Hum Mol Genet. 2013.
    Abstract     Related articles   

  980. KUNATH F , Krause SF, Wullich B, Goebell PJ, et al
    Bladder cancer -- the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register clinicaltrials.gov.
    BMC Urol. 2013;13:56.
    Abstract     Related articles   

  981. MIHARA T , Itoh H, Hashimoto K, Goto T, et al
    Trans-resectoscope stimulation predicts the need to block adductor response during bladder tumor resection.
    Anesth Analg. 2013;117:740-4.
    Abstract     Related articles   

  982. KAO CS , Epstein JI
    Tubular adenoma of the urinary tract: a newly described entity.
    Hum Pathol. 2013;44:1890-4.
    Abstract     Related articles   

  983. TERADA T
    Inverted variant of urothelial carcinoma of the urinary bladder: a report of three cases and a proposal for a new clinicopathologic entity.
    Int J Clin Exp Pathol. 2013;6:766-70.
    Abstract     Related articles   

  984. STEINMAUS CM , Ferreccio C, Romo JA, Yuan Y, et al
    Drinking water arsenic in northern chile: high cancer risks 40 years after exposure cessation.
    Cancer Epidemiol Biomarkers Prev. 2013;22:623-30.
    Abstract     Related articles   

  985. WEN H , Feng CC, Ding GX, Meng DL, et al
    Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2.
    Ann Diagn Pathol. 2013;17:259-64.
    Abstract     Related articles   

  986. RAJABI B , Khoury J, Brewer C, Goodman OB Jr, et al
    Urothelial bladder carcinoma with choriocarcinomatous differentiation presenting with a false-positive pregnancy test.
    Am J Med Sci. 2013;346:256-8.
    Abstract     Related articles   

  987. OHLMANN CH , De Santis M
    [Neoadjuvant, inductive or adjuvant chemotherapy of bladder cancer].
    Urologe A. 2013;52:1534-40.
    Abstract     Related articles   

  988. SHINDO T , Masumori N, Kitamura H, Tanaka T, et al
    Clinical significance of definite muscle layer in TUR specimen for evaluating progression rate in T1G3 bladder cancer: multicenter retrospective study by the Sapporo Medical University Urologic Oncology Consortium (SUOC).
    World J Urol. 2013.
    Abstract     Related articles   

  989. RAZZAK M
    Bladder cancer: STAG2 in the spotlight-have genomic studies identified a plausible biomarker?
    Nat Rev Urol. 2013 Nov 5. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  990. CERANTOLA Y , Valerio M, Persson B, Jichlinski P, et al
    Guidelines for perioperative care after radical cystectomy for bladder cancer: Enhanced Recovery After Surgery (ERAS) society recommendations.
    Clin Nutr. 2013 Oct 17. pii: S0261-5614(13)00254.
    Abstract     Related articles   

  991. ZHU YT , Lei CY, Luo Y, Liu N, et al
    A modified method for isolation of bladder cancer stem cells from a MB49 murine cell line.
    BMC Urol. 2013;13:57.
    Abstract     Related articles   

  992. EISSA S , Shawky SM, Matboli M, Mohamed S, et al
    Direct detection of unamplified hepatoma upregulated protein RNA in urine using gold nanoparticles for bladder cancer diagnosis.
    Clin Biochem. 2013 Oct 29. pii: S0009-9120(13)00496.
    Abstract     Related articles   

  993. MEEKS JJ , Herr HW
    Office-based Management of Nonmuscle Invasive Bladder Cancer.
    Urol Clin North Am. 2013;40:473-9.
    Abstract     Related articles   

  994. XU X , Li S, Lin Y, Chen H, et al
    MicroRNA-124-3p inhibits cell migration and invasion in bladder cancer cells by targeting ROCK1.
    J Transl Med. 2013;11:276.
    Abstract     Related articles   

  995. FANG H , Yao B, Yan Y, Xu H, et al
    Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies.
    Diabetes Technol Ther. 2013;15:914-22.
    Abstract     Related articles   

  996. WANG D , Jing Y, Ouyang S, Liu B, et al
    Inhibitory effect of valproic acid on bladder cancer in combination with chemotherapeutic agents and
    Oncol Lett. 2013;6:1492-1498.
    Abstract     Related articles   

  997. YANG D , Liu C, Shi J, Wang N, et al
    Association of XRCC1 Arg399Gln polymorphism with bladder cancer susceptibility: A meta-analysis.
    Gene. 2013 Oct 28. pii: S0378-1119(13)01447-9. doi: 10.1016/j.gene.2013.
    Abstract     Related articles   

  998. YAVUZCAN A , Caglar M, Kayikci MA, Basaran E, et al
    Can reproductive characteristics predict bladder cancer in women with haematuria?
    Asian Pac J Cancer Prev. 2013;14:5107-10.
    Abstract     Related articles   

  999. FUESSL HS , Stiefelhagen P
    [Mother, father and brother died of malignancies. How do I calm my patient's fear of cancer?].
    MMW Fortschr Med. 2013;155:26.
    Abstract     Related articles   

  1000. DAI QS , Hua RX, Zhang R, Huang YS, et al
    Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
    Gene. 2013;528:335-42.
    Abstract     Related articles   

  1001. MCNALLY L , Osmundson S, Barth R, Chueh J, et al
    Urachal duct carcinoma complicating pregnancy.
    Obstet Gynecol. 2013;122.
    Abstract     Related articles   

  1002. SHI Z , Yang Z, Zhang G, Cui G, et al
    Characterization of texture features of bladder carcinoma and the bladder wall on MRI: initial experience.
    Acad Radiol. 2013;20:930-8.
    Abstract     Related articles   

  1003. MASON EF , Sadow PM, Wagner AJ, Remillard SP, et al
    Identification of succinate dehydrogenase-deficient bladder paragangliomas.
    Am J Surg Pathol. 2013;37:1612-8.
    Abstract     Related articles   

  1004. WILLIAMSON SR , Bunde PJ, Montironi R, Lopez-Beltran A, et al
    Malignant perivascular epithelioid cell neoplasm (PEComa) of the urinary bladder with TFE3 gene rearrangement: clinicopathologic, immunohistochemical, and molecular features.
    Am J Surg Pathol. 2013;37:1619-26.
    Abstract     Related articles   

  1005. PAPARO F , Campodonico F, Piccazzo R, Rollandi GA, et al
    A case of spontaneous rupture of the renal pelvis initially misdiagnosed as a ruptured aneurysm of the abdominal aorta.
    J Emerg Med. 2013;44:e365-7.
    Abstract     Related articles   

  1006. HARTINGER J , Haussermann R, Olbert P, Hofmann R, et al
    [Predictors for presence of residual tumor in follow-up transurethral resection of bladder tumors: single center results].
    Urologe A. 2013;52:557-61.
    Abstract     Related articles   

  1007. LU X , Wang Y, Luo H, Qiu W, et al
    beta-elemene inhibits the proliferation of T24 bladder carcinoma cells through upregulation of the expression of Smad4.
    Mol Med Rep. 2013;7:513-8.
    Abstract     Related articles   

  1008. HUANG CC , Attele A, Michael CW
    Cytomorphologic features of metastatic urothelial carcinoma in serous effusions.
    Diagn Cytopathol. 2013;41:569-74.
    Abstract     Related articles   

  1009. MATSUI Y , Nishiyama H, Yoshimura K, Xing ND, et al
    The effect of gemcitabine/paclitaxel chemotherapy on the survival of patients with metastatic urothelial cancers.
    Int J Clin Oncol. 2013;18:321-8.
    Abstract     Related articles   

  1010. PUSZTASZERI M , Douaihy N, Pelte MF, Pache JC, et al
    Cervical lymph node metastasis of a micropapillary carcinoma of the bladder: a case report with fine-needle aspiration cytology and differential diagnosis.
    Diagn Cytopathol. 2013;41:617-9.
    Abstract     Related articles   

  1011. MOLINA ESCUDERO R , Herranz Amo F, Monzo Gardiner J, Paez Borda A, et al
    Usefulness of the Memorial Sloan Kettering Cancer Center Nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer.
    Arch Esp Urol. 2013;66:859-864.
    Abstract     Related articles   

  1012. TURKER P , Turkeri L
    Treatment of bacillus Calmette-Guerin refractory non-muscle invasive bladder cancer.
    Arch Esp Urol. 2013;66:833-840.
    Abstract     Related articles   

  1013. SHEN H , Morrison CD, Zhang J, Underwood W 3rd, et al
    6p22.3 amplification as a biomarker and potential therapeutic target of advanced stage bladder cancer.
    Oncotarget. 2013.
    Abstract     Related articles   

  1014. LIU Q , Wang X
    Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells.
    Exp Ther Med. 2013;6:1277-1282.
    Abstract     Related articles   

  1015. SURIANO F , Altobelli E, Sergi F, Buscarini M, et al
    Bladder Cancer After Radiotherapy for Prostate Cancer.
    Rev Urol. 2013;15:108-112.
    Abstract     Related articles   

  1016. MARTIN DT , Steinbach JM, Liu J, Shimizu S, et al
    Surface modified nanoparticles enhance transurothelial penetration and delivery of survivin siRNA in treating bladder cancer.
    Mol Cancer Ther. 2013.
    Abstract     Related articles   

  1017. SELINSKI S , Blaszkewicz M, Ickstadt K, Hengstler JG, et al
    Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Arch Toxicol. 2013.
    Abstract     Related articles   

  1018. LI S , Xu X, Xu X, Hu Z, et al
    MicroRNA-490-5p inhibits proliferation of bladder cancer by targeting c-Fos.
    Biochem Biophys Res Commun. 2013 Nov 9. pii: S0006-291X(13)01879.
    Abstract     Related articles   

  1019. AMR S , Dawson R, Saleh DA, Magder LS, et al
    Pesticide, Gene Polymorphisms and Bladder Cancer among Egyptian Agricultural Workers.
    Arch Environ Occup Health. 2013.
    Abstract     Related articles   

  1020. BANSAL N , Gupta A, Mitash N, Shakya PS, et al
    Low- and High-Grade Bladder Cancer Determination via Human Serum-Based Metabolomics Approach.
    J Proteome Res. 2013.
    Abstract     Related articles   

  1021. HITZENBICHLER F , Stoehr CG, Rogenhofer M, Wieland WF, et al
    Mdm2 SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer.
    Pathobiology. 2013;81:53-59.
    Abstract     Related articles   

  1022. BAZELIER MT , de Vries F, Vestergaard P, Leufkens HG, et al
    Use of Thiazolidinediones and Risk of Bladder Cancer: Disease or Drugs?
    Curr Drug Saf. 2013.
    Abstract     Related articles   

  1023. YAFI FA , Aprikian AG, Chin JL, Fradet Y, et al
    Impact of concomitant carcinoma in situ on upstaging and outcome following radical cystectomy for bladder cancer.
    World J Urol. 2013.
    Abstract     Related articles   

  1024. PAPADOGIANNI D , Soulitzis N, Delakas D, Spandidos DA, et al
    Expression of p53 family genes in urinary bladder cancer: correlation with disease aggressiveness and recurrence.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1025. JIANG J , Yuan X, Zhao H, Yan X, et al
    Licochalcone A inhibiting proliferation of bladder cancer T24 cells by inducing reactive oxygen species production.
    Biomed Mater Eng. 2014;24:1019-25.
    Abstract     Related articles   

  1026. CHEN YK , Yeh CH, Su CT, Tsui CC, et al
    A New Method for Detecting Urinary Bladder Cancer by Using FDG PET/CT.
    Technol Cancer Res Treat. 2013.
    Abstract     Related articles   

  1027. KAWANISHI K , Morita M, Nakahara K, Tetsuka S, et al
    [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
    Brain Nerve. 2013;65:1401-5.
    Abstract     Related articles   

  1028. ALQUATI S , Gira FA, Bartoli V, Contini S, et al
    Low-grade myofibroblastic proliferations of the urinary bladder.
    Arch Pathol Lab Med. 2013;137:1117-28.
    Abstract     Related articles   

  1029. CHAPMAN-FREDRICKS JR , Cioffi-Lavina M, Accola MA, Rehrauer WM, et al
    High-risk human papillomavirus DNA detected in primary squamous cell carcinoma of urinary bladder.
    Arch Pathol Lab Med. 2013;137:1088-93.
    Abstract     Related articles   

  1030. LI JR , Cheng CL, Yang CR, Ou YC, et al
    Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux.
    Toxicol Lett. 2013;220:267-76.
    Abstract     Related articles   

  1031. ABDOU AG , El-Wahed MM, Kandil MA, Samaka RM, et al
    Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
    APMIS. 2013;121:982-96.
    Abstract     Related articles   

  1032. COUGHLIN LM , Orr DP 2nd
    Laparoscopic management of a small bowel herniation from an ileal conduit: report of a case and review of the literature.
    Surg Laparosc Endosc Percutan Tech. 2013;23:e81-3.
    Abstract     Related articles   

  1033. HOGSTEDT C , Jansson C, Hugosson M, Tinnerberg H, et al
    Cancer incidence in a cohort of Swedish chimney sweeps, 1958-2006.
    Am J Public Health. 2013;103:1708-14.
    Abstract     Related articles   

  1034. IWA N , Ito S, Takegaki Y, Ikura Y, et al
    Cytologic features of sarcomatoid carcinoma of the urinary bladder: a case report.
    Diagn Cytopathol. 2013;41:536-41.
    Abstract     Related articles   

  1035. KIM SM , Kang HW, Kim WT, Kim YJ, et al
    Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer.
    Korean J Urol. 2013;54:791-796.
    Abstract     Related articles   

  1036. CASADIO V , Molinari C, Calistri D, Tebaldi M, et al
    DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach.
    J Exp Clin Cancer Res. 2013;32:94.
    Abstract     Related articles   

  1037. PORSERUD A , Sherif A, Tollback A
    The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial.
    Clin Rehabil. 2013.
    Abstract     Related articles   

  1038. YANG LP
    Hexaminolevulinate Blue Light Cystoscopy: A Review of Its Use in the Diagnosis of Bladder Cancer.
    Mol Diagn Ther. 2013.
    Abstract     Related articles   

  1039. WANG L , Feng C, Ding G, Ding Q, et al
    Ki67 and TP53 expressions predict recurrence of non-muscle-invasive bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1040. MIRKIN K , Casey JT, Mukherjee S, Kielb SJ, et al
    Risk of bladder cancer in patients with spina bifida: Case reports and review of the literature.
    J Pediatr Rehabil Med. 2013;6:155-62.
    Abstract     Related articles   

  1041. SHARMA T , Jain S, Verma A, Sharma N, et al
    Gene environment interaction in urinary bladder cancer with special reference to organochlorine pesticide: A case control study.
    Cancer Biomark. 2013;13:243-51.
    Abstract     Related articles   

  1042. NOSSIER AI , Eissa S, Ismail MF, Hamdy MA, et al
    Direct detection of hyaluronidase in urine using cationic gold nanoparticles: A potential diagnostic test for bladder cancer.
    Biosens Bioelectron. 2013;54C:7-14.
    Abstract     Related articles   

  1043. LAMB BW , Vasdev N, Jalil RT, McMenemin R, et al
    Second-line chemotherapy for advanced bladder cancer: A survey of current UK practice.
    Urol Oncol. 2013 Nov 13. pii: S1078-1439(13)00318.
    Abstract     Related articles   

  1044. KATES M , Gorin MA, Deibert CM, Pierorazio PM, et al
    In-hospital death and hospital-acquired complications among patients undergoing partial cystectomy for bladder cancer in the United States.
    Urol Oncol. 2013 Nov 13. pii: S1078-1439(13)00335.
    Abstract     Related articles   

  1045. KYOU KWON J , Kim SJ, Hoon Kim J, Mee Lee K, et al
    Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer,?>
    Urol Oncol. 2013 Nov 13. pii: S1078-1439(13)00315.
    Abstract     Related articles   

  1046. GERHARDT D , Bertola G, Dietrich F, Figueiro F, et al
    Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3beta
    Urol Oncol. 2013 Nov 13. pii: S1078-1439(13)00076.
    Abstract     Related articles   

  1047. LEE WY , Sun LM, Lin CL, Liang JA, et al
    Risk of prostate and bladder cancers in patients with spinal cord injury: A population-based cohort study.
    Urol Oncol. 2013 Nov 13. pii: S1078-1439(13)00310.
    Abstract     Related articles   

  1048. JINESH GG , Willis DL, Kamat AM
    Bladder Cancer Stem Cells: Biological and Therapeutic Perspectives.
    Curr Stem Cell Res Ther. 2013.
    Abstract     Related articles   

  1049. STANTON ML , Xiao L, Czerniak BA, Guo CC, et al
    Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
    Arch Pathol Lab Med. 2013;137:1337-41.
    Abstract     Related articles   

  1050. MAI KT , Flood TA, Williams P, Kos Z, et al
    Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance.
    Virchows Arch. 2013;463:575-81.
    Abstract     Related articles   

  1051. ZYGOGIANNI A , Kouloulias V, Armpilia C, Antypas C, et al
    A weekly hypofractionated radiotherapeutic schedule for bladder carcinoma in elderly patients: local response, acute and late toxicity, dosimetric parameters and pain relief.
    J BUON. 2013;18:407-12.
    Abstract     Related articles   

  1052. HUANG W , Williamson SR, Rao Q, Lopez-Beltran A, et al
    Novel markers of squamous differentiation in the urinary bladder.
    Hum Pathol. 2013;44:1989-97.
    Abstract     Related articles   

  1053. OLLESCH J , Drees SL, Heise HM, Behrens T, et al
    FTIR spectroscopy of biofluids revisited: an automated approach to spectral biomarker identification.
    Analyst. 2013;138:4092-102.
    Abstract     Related articles   

  1054. BERGNER N , Romeike BF, Reichart R, Kalff R, et al
    Tumor margin identification and prediction of the primary tumor from brain metastases using FTIR imaging and support vector machines.
    Analyst. 2013;138:3983-90.
    Abstract     Related articles   

  1055. TSAI CC , Huang CH, Huang CN, Wu WJ, et al
    Neoadjuvant chemotherapy improves survival rate in advanced urothelial carcinoma.
    Kaohsiung J Med Sci. 2013;29:200-5.
    Abstract     Related articles   

  1056. BELLMUNT J , Fougeray R, Rosenberg JE, von der Maase H, et al
    Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy.
    Ann Oncol. 2013;24:1466-72.
    Abstract     Related articles   

  1057. CHEN G , Wang B, Li H, Ma X, et al
    Applying narrow-band imaging in complement with white-light imaging cystoscopy in the detection of urothelial carcinoma of the bladder.
    Urol Oncol. 2013;31:475-9.
    Abstract     Related articles   

  1058. KASSOUF W , Svatek RS, Shariat SF, Novara G, et al
    Critical analysis and validation of lymph node density as prognostic variable in urothelial carcinoma of bladder.
    Urol Oncol. 2013;31:480-6.
    Abstract     Related articles   

  1059. WILLIAMSON SR , Lopez-Beltran A, MacLennan GT, Montironi R, et al
    Unique clinicopathologic and molecular characteristics of urinary bladder tumors in children and young adults.
    Urol Oncol. 2013;31:414-26.
    Abstract     Related articles   

  1060. PANDITH AA , Shah ZA, Siddiqi MA
    Oncogenic role of fibroblast growth factor receptor 3 in tumorigenesis of urinary bladder cancer.
    Urol Oncol. 2013;31:398-406.
    Abstract     Related articles   

  1061. XIE F, Su M, Qiu W, Zhang M, et al
    Kaempferol Promotes Apoptosis in Human Bladder Cancer Cells by Inducing the Tumor Suppressor, PTEN.
    Int J Mol Sci. 2013;14:21215-21226.
    Abstract     Related articles   

  1062. INOUE K, Ota U, Ishizuka M, Kawada C, et al
    Porphyrins as urinary biomarkers for bladder cancer after 5-aminolevulinic acid (ALA) administration: The potential of photodynamic screening for tumors.
    Photodiagnosis Photodyn Ther. 2013;10:484-9.
    Abstract     Related articles   

  1063. GRAY PJ, Shipley WU, Efstathiou JA
    T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. Con.
    Oncology (Williston Park). 2013;27:873.
    Abstract     Related articles   

  1064. CLARK PE
    T1 high-grade bladder cancer recurring after BCG therapy: radical cystectomy is still the best approach. Pro.
    Oncology (Williston Park). 2013;27:872.
    Abstract     Related articles   

  1065. FAHMY N, Lazo-Langner A, Iansavichene AE, Pautler SE, et al
    Effect of anticoagulants and antiplatelet agents on the efficacy of intravesical BCG treatment of bladder cancer: A systematic review.
    Can Urol Assoc J. 2013;7.
    Abstract     Related articles   

  1066. LIN MY, Lee YR, Chiang SY, Li YZ, et al
    Cortex Moutan Induces Bladder Cancer Cell Death via Apoptosis and Retards Tumor Growth in Mouse Bladders.
    Evid Based Complement Alternat Med. 2013;2013:207279.
    Abstract     Related articles   

  1067. KIM K, Punj V, Choi J, Heo K, et al
    Gene dysregulation by histone variant H2A.Z in bladder cancer.
    Epigenetics Chromatin. 2013;6:34.
    Abstract     Related articles   

  1068. GIERTH M, Burger M
    Bladder cancer: Progress in defining progression in NMIBC.
    Nat Rev Urol. 2013 Nov 26. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1069. PAN JG, Luo RQ, Zhou X, Han RF, et al
    Potent antitumor activity of the combination of HSV-TK and endostatin by adeno-associated virus vector for bladder cancer in vivo.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  1070. PAN JG, Luo RQ, Zhou X, Han RF, et al
    Suppression of bladder cancer growth by adeno-associated virus vector-mediated combination of HSV-TK and endostatin in vitro.
    Clin Lab. 2013;59.
    Abstract     Related articles   

  1071. TAYLOR CF, Platt FM, Hurst CD, Thygesen HH, et al
    Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumor grade and stage and inversely related to chromosomal copy number changes.
    Hum Mol Genet. 2013.
    Abstract     Related articles   

  1072. MARTINI T, Mayr R, Wehrberger C, Dechet C, et al
    Comparison of radical cystectomy with conservative treatment in geriatric (>/=80) patients with muscle-invasive bladder cancer.
    Int Braz J Urol. 2013;39:622-30.
    Abstract     Related articles   

  1073. LIU C, Yin Q, Li L, Jiao G, et al
    XRCC1 Arg194Trp and Arg280His Polymorphisms in Bladder Cancer Susceptibility: A Meta-Analysis.
    Crit Rev Eukaryot Gene Expr. 2013;23:339-54.
    Abstract     Related articles   

  1074. XU F, Zhang Q, Cheng W, Zhang Z, et al
    Effect of miR-29b-1* and miR-29c knockdown on cell growth of the bladder cancer cell line T24.
    J Int Med Res. 2013;41:1803-10.
    Abstract     Related articles   

  1075. TAKEUCHI M, Sasaki S, Naiki T, Kawai N, et al
    MR imaging of urinary bladder cancer for T-staging: A review and a pictorial essay of diffusion-weighted imaging.
    J Magn Reson Imaging. 2013 Nov 21. doi: 10.1002/jmri.24227.
    Abstract     Related articles   

  1076. WANG Y, Li Z, Liu N, Zhang G, et al
    Association between CCND1 and XPC polymorphisms and bladder cancer risk: a meta-analysis based on 15 case-control studies.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1077. SASAKI Y, Oi H, Oyama T, Kagawa J, et al
    [Non-Muscle Invasive Bladder Cancer with Multiple Bone Metastasis without Local Invasion : A Case Report].
    Hinyokika Kiyo. 2013;59:669-72.
    Abstract     Related articles   

  1078. YANG J, Yu H, Shen M, Wei W, et al
    GC7 Sensitizes Bladder Cancer Cells to Doxorubicin by Preventing EMT via Inhibiting eIF5A2 Activation.
    Cancer Sci. 2013 Nov 22. doi: 10.1111/cas.12328.
    Abstract     Related articles   

  1079. MIGITA K, Miyashita T, Mizuno A, Jiuchi Y, et al
    IgG4-related epididymo-orchitis associated with bladder cancer: possible involvement of BAFF/BAFF-R interaction in IgG4-related urogenital disease.
    Mod Rheumatol. 2014;24:188-94.
    Abstract     Related articles   

  1080. NISHIOKA K, Shimizu S, Shinohara N, Ito YM, et al
    Prospective Phase II Study of Image-guided Local Boost Using a Real-time Tumor-tracking Radiotherapy (RTRT) System for Locally Advanced Bladder Cancer.
    Jpn J Clin Oncol. 2013.
    Abstract     Related articles   

  1081. WU J, Liu J, Jia R, Song H, et al
    Nur77 inhibits androgen-induced bladder cancer growth.
    Cancer Invest. 2013;31:654-60.
    Abstract     Related articles   

  1082. BEHARI A, Kapoor VK
    Incidental gall bladder cancer.
    Adv Surg. 2013;47:227-49.
    Abstract     Related articles   

  1083. ZABOLOTNEVA AA, Zhavoronkov AA, Shegay PV, Gaifullin NM, et al
    A systematic experimental evaluation of microRNA markers of human bladder cancer.
    Front Genet. 2013;4:247.
    Abstract     Related articles   

  1084. MELAK D, Ferreccio C, Kalman D, Parra R, et al
    Arsenic Methylation and Lung and Bladder Cancer in a Case-control Study in Northern Chile.
    Toxicol Appl Pharmacol. 2013 Nov 29. pii: S0041-008X(13)00528.
    Abstract     Related articles   

  1085. PARK HS, Han MH, Kim GY, Moon SK, et al
    Sulforaphane induces reactive oxygen species-mediated mitotic arrest and subsequent apoptosis in human bladder cancer 5637 cells.
    Food Chem Toxicol. 2013 Nov 29. pii: S0278-6915(13)00796.
    Abstract     Related articles   

  1086. CAMARGO EA, da Silva GN, Gobette CP, Marcondes JP, et al
    No Relationship between the Amount of DNA Damage and the Level of hMLH1 and RASSF1A Gene Expression in Bladder Cancer Cells Treated with Cisplatin and Gemcitabine.
    Asian Pac J Cancer Prev. 2013;14:5941-8.
    Abstract     Related articles   

  1087. JANCKE G, Rosell J, Jahnson S
    Impact of surgical experience on recurrence and progression after transurethral resection of bladder tumour in non-muscle-invasive bladder cancer.
    Scand J Urol. 2013.
    Abstract     Related articles   

  1088. KIM MS, Kim JE, Lim DY, Huang Z, et al
    Naproxen induces cell cycle arrest and apoptosis in human urinary bladder cancer cell lines and chemically induced cancers by targeting PI3-K.
    Cancer Prev Res (Phila). 2013.
    Abstract     Related articles   

  1089. KASMAN L, Voelkel-Johnson C
    An orthotopic bladder cancer model for gene delivery studies.
    J Vis Exp. 2013;.
    Abstract     Related articles   

  1090. GARCIA-GARCIA P, Laguna-Del-Estal P, Gonzalez-Lois C, Brea-Alvarez B, et al
    Facial paralysis secondary to single metastasis to the temporal bone from bladder cancer.
    Acta Otorrinolaringol Esp. 2013 Dec 7. pii: S0001-6519(13)00187.
    Abstract     Related articles   

  1091. TURNER RM, Kwok CS, Chen-Turner C, Maduakor CA, et al
    Thiazolidinediones and associated risk of Bladder Cancer: a Systematic Review and Meta-analysis.
    Br J Clin Pharmacol. 2013 Dec 10. doi: 10.1111/bcp.12306.
    Abstract     Related articles   

  1092. HADDAD A, Lotan Y
    Bladder cancer in 2013: From genomics to imaging-advances along the care continuum.
    Nat Rev Urol. 2013 Dec 10. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1093. GONDO T, Ohno Y, Nakashima J, Hashimoto T, et al
    Factors predicting incisional surgical site infection in patients undergoing open radical cystectomy for bladder cancer.
    Int J Clin Oncol. 2013.
    Abstract     Related articles   

  1094. BASMA HA, Kobeissi LH, Jabbour ME, Moussa MA, et al
    and genotypes and bladder cancer risk in a Lebanese population.
    Int J Mol Epidemiol Genet. 2013;4:207-217.
    Abstract     Related articles   

  1095. ANDREOTTI G, Karami S, Pfeiffer RM, Hurwitz L, et al
    methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants.
    Epigenetics. 2013;9.
    Abstract     Related articles   

  1096. DU HF, Ou LP, Yang X, Song XD, et al
    A new PKCalpha/beta/TBX3/E-cadherin pathway is involved in PLCepsilon-regulated invasion and migration in human bladder cancer cells.
    Cell Signal. 2013 Dec 5. pii: S0898-6568(13)00346.
    Abstract     Related articles   

  1097. HUANG ZM, Chen HA, Chiang YT, Shen CH, et al
    Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
    J Chin Med Assoc. 2013 Dec 4. pii: S1726-4901(13)00272.
    Abstract     Related articles   

  1098. CHANG L, Shi R, Yang T, Li F, et al
    Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.
    J Exp Clin Cancer Res. 2013;32:101.
    Abstract     Related articles   

  1099. SHIN DY, Kim GY, Hwang HJ, Kim WJ, et al
    Diallyl trisulfide-induced apoptosis of bladder cancer cells is caspase-dependent and regulated by PI3K/Akt and JNK pathways.
    Environ Toxicol Pharmacol. 2013;37:74-83.
    Abstract     Related articles   

  1100. SHAKHSSALIM N, Houshmand M, Kamalidehghan B, Faraji A, et al
    The mitochondrial C16069T polymorphism, not mitochondrial D310 (D-loop) mononucleotide sequence variations, is associated with bladder cancer.
    Cancer Cell Int. 2013;13:120.
    Abstract     Related articles   

  1101. HSU JW, Yin PN, Wood R, Messing J, et al
    1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guerin immunotherapy of bladder cancer.
    Oncotarget. 2013.
    Abstract     Related articles   

  1102. ZHANG T, Guo P, Zhang Y, Xiong H, et al
    The antidiabetic drug metformin inhibits the proliferation of bladder cancer cells in vitro and in vivo.
    Int J Mol Sci. 2013;14:24603-18.
    Abstract     Related articles   

  1103. GUO G, Xu Y, Gong M, Cao Y, et al
    USP28 is a potential prognostic marker for bladder cancer.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1104. LI SX, Dai QS, Chen SX, Zhang SD, et al
    Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1105. DUENAS M, Martinez-Fernandez M, Garcia-Escudero R, Villacampa F, et al
    PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors.
    Mol Carcinog. 2013 Dec 18. doi: 10.1002/mc.22125.
    Abstract     Related articles   

  1106. WADHWA N, Mathew BB, Jatawa SK, Tiwari A, et al
    Genetic instability in urinary bladder cancer: An evolving hallmark.
    J Postgrad Med. 2013;59:284-8.
    Abstract     Related articles   

  1107. NICASTRO HL, Grubbs CJ, Juliana MM, Bode AM, et al
    Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
    Cancer Prev Res (Phila). 2013.
    Abstract     Related articles   

  1108. GANDAGLIA G, Sun M
    Bladder cancer: Conditional survival after radical cystectomy.
    Nat Rev Urol. 2013 Dec 17. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1109. OUZZANE A, Colin P
    Bladder cancer: Tumour recurrence after radical nephroureterectomy for UTUC.
    Nat Rev Urol. 2013 Dec 17. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1110. VON RUNDSTEDT FC, Lerner SP
    Bladder cancer: Always consider extravesical sites when BCG fails.
    Nat Rev Urol. 2013 Dec 17. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1111. KOULOULIAS V, Mosa E, Tolia M, Kantzou I, et al
    Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy schedules in localised muscle invasive bladder cancer.
    J BUON. 2013;18:942-8.
    Abstract     Related articles   

  1112. NETTO GJ
    Molecular genetics and genomics progress in urothelial bladder cancer.
    Semin Diagn Pathol. 2013;30:313-20.
    Abstract     Related articles   

  1113. TURATI F, Pelucchi C, Galeone C, Decarli A, et al
    Personal hair dye use and bladder cancer: a meta-analysis.
    Ann Epidemiol. 2013 Nov 14. pii: S1047-2797(13)00419.
    Abstract     Related articles   

  1114. JAISWAL PK, Singh V, Mittal RD
    Polymorphism at P21 codon 31 and dinucleotide polymorphism of P73 gene and susceptibility to bladder cancer in individuals from North India.
    Indian J Hum Genet. 2013;19:293-300.
    Abstract     Related articles   

  1115. HAGGAG R, Farag K, Abu-Taleb F, Shamaa S, et al
    Low-dose versus standard-dose gemcitabine infusion and cisplatin for patients with advanced bladder cancer: a randomized phase II trial-an update.
    Med Oncol. 2014;31:811.
    Abstract     Related articles   

  1116. CHO TM, Kim WJ, Moon SK
    AKT signaling is involved in fucoidan-induced inhibition of growth and migration of human bladder cancer cells.
    Food Chem Toxicol. 2013 Dec 11. pii: S0278-6915(13)00831.
    Abstract     Related articles   

  1117. RITTER R, Hennenlotter J, Kuhs U, Hofmann U, et al
    Evaluation of a new quantitative point-of-care test platform for urine-based detection of bladder cancer.
    Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00404.
    Abstract     Related articles   

  1118. BURGESS EF
    Individualized management of advanced bladder cancer: Where do we stand?
    Urol Oncol. 2013 Dec 11. pii: S1078-1439(13)00399.
    Abstract     Related articles   

  1119. NUMAKURA S, Morikawa T, Ushiku T, Toyoshima T, et al
    Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guerin therapy.
    Pathol Res Pract. 2013 Nov 22. pii: S0344-0338(13)00373.
    Abstract     Related articles   

  1120. KARL A, Adejoro O, Saigal C, Konety B, et al
    General Adherence to Guideline Recommendations on Initial Diagnosis of Bladder Cancer in the United States and Influencing Factors.
    Clin Genitourin Cancer. 2013 Nov 14. pii: S1558-7673(13)00274.
    Abstract     Related articles   

  1121. MAY M, Burger M, Brookman-May S, Stief CG, et al
    EORTC Progression Score Identifies Patients at High Risk of Cancer-Specific Mortality After Radical Cystectomy for Secondary Muscle-Invasive Bladder Cancer.
    Clin Genitourin Cancer. 2013 Nov 13. pii: S1558-7673(13)00285.
    Abstract     Related articles   

  1122. BORGHESI M, Brunocilla E, Schiavina R, Martorana G, et al
    Lymphovascular Invasion in High Grade T1 Bladder Cancer: Are More Aggressive Treatments Needed?
    Clin Genitourin Cancer. 2013 Nov 13. pii: S1558-7673(13)00270.
    Abstract     Related articles   

  1123. JITAO W, Jinchen H, Qingzuo L, Li C, et al
    Androgen receptor inducing bladder cancer progression by promoting an epithelial-mesenchymal transition.
    Andrologia. 2013 Dec 16. doi: 10.1111/and.12203.
    Abstract     Related articles   

  1124. HE H, Shui B
    Folate intake and risk of bladder cancer: a meta-analysis of epidemiological studies.
    Int J Food Sci Nutr. 2013.
    Abstract     Related articles   

  1125. ELLIS CL, Chang AG, Cimino-Mathews A, Argani P, et al
    GATA-3 immunohistochemistry in the differential diagnosis of adenocarcinoma of the urinary bladder.
    Am J Surg Pathol. 2013;37:1756-60.
    Abstract     Related articles   

  1126. HOLLINGSWORTH JM, Rogers MA, Krein SL, Hickner A, et al
    Determining the noninfectious complications of indwelling urethral catheters: a systematic review and meta-analysis.
    Ann Intern Med. 2013;159:401-10.
    Abstract     Related articles   

  1127. TSUI KH, Wang SW, Chung LC, Feng TH, et al
    Mechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells.
    Biomed Res Int. 2013;2013:791212.
    Abstract     Related articles   

  1128. PU C, Yuan H, Li J, Tang Y, et al
    [Research progress of common mode in urinary diversion after radical cystectomy].
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2013;27:492-5.
    Abstract     Related articles   

  1129. PENG CC, Chyau CC, Wang HE, Chang CH, et al
    Cytotoxicity of ferulic Acid on T24 cell line differentiated by different microenvironments.
    Biomed Res Int. 2013;2013:579859.
    Abstract     Related articles   

  1130. HAN C, Hao L, Chen M, Hu J, et al
    Target expression of Staphylococcus enterotoxin A from an oncolytic adenovirus suppresses mouse bladder tumor growth and recruits CD3+ T cell.
    Tumour Biol. 2013;34:2863-9.
    Abstract     Related articles   

  1131. CHERIF M, Ktari K, Ben Slama MR, Bouzouita A, et al
    [Cavernous hemangioma: a cause of hematuria in children].
    Tunis Med. 2013;91:289-91.
    Abstract     Related articles   

  1132. GAO X, Wang HF, Li Y, Peng S, et al
    Treatment of bladder invasive adenosquamous carcinoma of the prostate: radical cystoprostatectomy.
    Chin Med J (Engl). 2013;126:1998.
    Abstract     Related articles   

  1133. SARI A, Ermete M, Sadullahoglu C, Bal K, et al
    Large cell neuroendocrine carcinoma of urinary bladder; case presentation.
    Turk Patoloji Derg. 2013;29:138-42.
    Abstract     Related articles   

  1134. ARANTES-RODRIGUES R, Pinto-Leite R, da Costa RG, Colaco A, et al
    Cytogenetic characterization of an N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse papillary urothelial carcinoma.
    Tumour Biol. 2013;34:2691-6.
    Abstract     Related articles   

  1135. MACAK J, Dundr P, Dvorackova J, Buzrla P, et al
    [Primary large cell neuroendocrine carcinoma of the urinary bladder].
    Cesk Patol. 2013;49:80-3.
    Abstract     Related articles   

  1136. VERWILST P, David CC, Leen V, Hofkens J, et al
    Synthesis and in vitro evaluation of a PDT active BODIPY-NLS conjugate.
    Bioorg Med Chem Lett. 2013;23:3204-7.
    Abstract     Related articles   

  1137. DEES-RIBBERS HM, Pos FJ, Betgen A, Bex A, et al
    Fusion of planning CT and cystoscopy images for bladder tumor delineation: a feasibility study.
    Med Phys. 2013;40:051713.
    Abstract     Related articles   

  1138. GALIA A, Amico P, Emmanuele C, Tranchina MG, et al
    Primary invasive urothelial carcinoma of the bladder resembling invasive lobular carcinoma of the breast: a potential diagnostic pitfall of an unusual high-grade bladder neoplasia.
    Pathol Res Pract. 2013;209:327-9.
    Abstract     Related articles   

  1139. BEILAN J, Lawton A, Hajdenberg J, Rosser CJ, et al
    Locally advanced paraganglioma of the urinary bladder: a case report.
    BMC Res Notes. 2013;6:156.
    Abstract     Related articles   

  1140. QUINTA A, Carvalho AP, Oliveira M, Oliveira C, et al
    [Bladder adenocarcinoma 41 years after augmentation enterocystoplasty for tuberculosis].
    Arch Esp Urol. 2013;66:231-3.
    Abstract     Related articles   

  1141. SHAMS TM, Metawea M, Salim EI
    c-KIT positive schistosomal urinary bladder carcinoma are frequent but lack KIT gene mutations.
    Asian Pac J Cancer Prev. 2013;14:15-20.
    Abstract     Related articles   

  1142. VLAHOU A
    Network views for personalized medicine.
    Proteomics Clin Appl. 2013;7.
    Abstract     Related articles   

  1143. CEKANOVA M, Uddin MJ, Bartges JW, Callens A, et al
    Molecular imaging of cyclooxygenase-2 in canine transitional cell carcinomas in vitro and in vivo.
    Cancer Prev Res (Phila). 2013;6:466-76.
    Abstract     Related articles   

  1144. DRAKAKI A, McDermott DF
    Novel immunotherapies in GU malignancies.
    Curr Oncol Rep. 2013;15:224-31.
    Abstract     Related articles   

  1145. XU Y, Zhang NZ, Chen J, Yuan HQ, et al
    Biomarkers in urothelial carcinoma of the bladder: the potential cross-talk between transforming growth factor-beta1 and estrogen receptor beta/androgen receptor pathways.
    Med Hypotheses. 2013;80:716-8.
    Abstract     Related articles   

  1146. XIANG ST, Wang SS, Zhou JF, Gan S, et al
    Endoscopic surgical strategy of non-functional urinary bladder paraganglioma in children.
    Chin Med J (Engl). 2013;126:999-1000.
    Abstract     Related articles   

  1147. PESCHETOLA V, Laurent VM, Duperray A, Michel R, et al
    Time-dependent traction force microscopy for cancer cells as a measure of invasiveness.
    Cytoskeleton (Hoboken). 2013;70:201-14.
    Abstract     Related articles   

  1148. HU T, Andrew AS, Karagas MR, Moore JH, et al
    Statistical epistasis networks reduce the computational complexity of searching three-locus genetic models.
    Pac Symp Biocomput. 2013.
    Abstract     Related articles   

  1149. ONG K, Herdiman O, Johnson L, Lawrentschuk N, et al
    Orthotopic bladder substitution (neobladder): part I: indications, patient selection, preoperative education, and counseling.
    J Wound Ostomy Continence Nurs. 2013;40:73-82.
    Abstract     Related articles   

  1150. BOYER AC , Jafri SZ, Jafri SM, Amin MB, et al
    Neuroendocrine carcinoma of the urinary bladder: a retrospective study of CT findings.
    Abdom Imaging. 2012.
    Abstract     Related articles   

  1151. BARRIO MUNOZ M, Garcia Rojo D, Gonzalez Sala JL, Prats Lopez J, et al
    [Urinary schistosomiasis: description of 8 cases].
    Med Clin (Barc). 2013;140:476-7.
    Abstract     Related articles   

  1152. GOLDMAN RE, Bajo A, MacLachlan LS, Pickens R, et al
    Design and performance evaluation of a minimally invasive telerobotic platform for transurethral surveillance and intervention.
    IEEE Trans Biomed Eng. 2013;60:918-25.
    Abstract     Related articles   

  1153. KECK B, Wach S, Kunath F, Bertz S, et al
    Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder.
    Ann Surg Oncol. 2013;20:2440-5.
    Abstract     Related articles   

  1154. SUN L, Kang F
    An additive-multiplicative rates model for recurrent event data with informative terminal event.
    Lifetime Data Anal. 2013;19:117-37.
    Abstract     Related articles   

  1155. GOSNELL H, Kasman LM, Potta T, Vu L, et al
    Polymer-Enhanced Delivery Increases Adenoviral Gene Expression in an Orthotopic Model of Bladder Cancer.
    J Control Release. 2013 Dec 23. pii: S0168-3659(13)00954.
    Abstract     Related articles   

  1156. ARANTES-RODRIGUES R, Pinto-Leite R, Fidalgo-Goncalves L, Palmeira C, et al
    Synergistic Effect between Cisplatin and Sunitinib Malate on Human Urinary Bladder-Cancer Cell Lines.
    Biomed Res Int. 2013;2013:791406.
    Abstract     Related articles   

  1157. CARREON T, Hein MJ, Hanley KW, Viet SM, et al
    Bladder cancer incidence among workers exposed to o-toluidine, aniline and nitrobenzene at a rubber chemical manufacturing plant.
    Occup Environ Med. 2013 Dec 24. doi: 10.1136/oemed-2013-101873.
    Abstract     Related articles   

  1158. LIANG Z, Fei Y, Lizhi N, Jianying Z, et al
    Percutaneous cryotherapy for metastatic bladder cancer: experience with 23 patients.
    Cryobiology. 2013 Dec 21. pii: S0011-2240(13)00430.
    Abstract     Related articles   

  1159. AZRIA D, Riou O, Rebillard X, Thezenas S, et al
    Combined Chemoradiation Therapy With Twice-Weekly Gemcitabine and Cisplatin for Organ Preservation in Muscle-Invasive Bladder Cancer: Long-Term Results of a Phase 1 Trial.
    Int J Radiat Oncol Biol Phys. 2013 Dec 21. pii: S0360-3016(13)03319.
    Abstract     Related articles   

  1160. YANG X, Li P, Yang X, Qin C, et al
    TSP-1-1223 A/G Polymorphism as a Potential Predictor of the Recurrence Risk of Bladder Cancer in a Chinese Population.
    Int J Genomics. 2013;2013:473242.
    Abstract     Related articles   

  1161. NEUTSCH L, Eggenreich B, Herwig E, Marchetti-Deschmann M, et al
    Biomimetic Delivery Strategies at the Urothelium: Targeted Cytoinvasion in Bladder Cancer Cells via Lectin Bioconjugates.
    Pharm Res. 2013.
    Abstract     Related articles   

  1162. LUO ZG, Li ZG, Gui SL, Chi BJ, et al
    Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.
    J Int Med Res. 2013.
    Abstract     Related articles   

  1163. CLYNE M
    Bladder cancer: The difference between men and women.
    Nat Rev Urol. 2013 Dec 24. doi: 10.1038/nrurol.2013.
    Abstract     Related articles   

  1164. GUAN Z, Zeng J, Wang Z, Xie H, et al
    Urine tenascinC is an independent risk factor for bladder cancer patients.
    Mol Med Rep. 2013 Dec 18. doi: 10.3892/mmr.2013.1873.
    Abstract     Related articles   

  1165. ZHANG K, Zhou B, Zhang P, Zhang Z, et al
    Genetic variants in NAMPT predict bladder cancer risk and prognosis in individuals from southwest Chinese Han group.
    Tumour Biol. 2013.
    Abstract     Related articles   

  1166. KAUSHIK D, Frank I, Eisenberg MS, Cheville JC, et al
    Gender-specific survival following radical cystectomy for pT4 bladder cancer.
    World J Urol. 2013.
    Abstract     Related articles   

  1167. BERTRAND J, Siegler N, Murez T, Poinas G, et al
    Impact of preoperative immunonutrition on morbidity following cystectomy for bladder cancer: a case-control pilot study.
    World J Urol. 2013.
    Abstract     Related articles   

  1168. ABERN MR, Owusu R, Inman BA
    Clinical performance and utility of a DNA methylation urine test for bladder cancer.
    Urol Oncol. 2014;32:51.
    Abstract     Related articles   

  1169. DING W, Gou Y, Sun C, Xia G, et al
    Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.
    Urol Oncol. 2014;32:42.
    Abstract     Related articles   

  1170. DANCIK GM, Theodorescu D
    Pharmacogenomics in bladder cancer.
    Urol Oncol. 2014;32:16-22.
    Abstract     Related articles   

  1171. DANCIK GM, Owens CR, Iczkowski KA, Theodorescu D, et al
    A cell of origin gene signature indicates human bladder cancer has distinct cellular progenitors.
    Stem Cells. 2013 Dec 19. doi: 10.1002/stem.1625.
    Abstract     Related articles   

  1172. SONPAVDE G, Galsky MD, Latini D, Chen GJ, et al
    Cisplatin-Ineligible and Chemotherapy-Ineligible Patients Should Be the Focus of New Drug Development in Patients With Advanced Bladder Cancer.
    Clin Genitourin Cancer. 2013 Nov 14. pii: S1558-7673(13)00287.
    Abstract     Related articles   

  1173. NOMURA S, Suzuki Y, Takahashi R, Terasaki M, et al
    Snail expression and outcome in T1 high-grade and T2 bladder cancer: a retrospective immunohistochemical analysis.
    BMC Urol. 2013;13:73.
    Abstract     Related articles   

  1174. LOTAN Y, Daudon M, Bruyere F, Talaska G, et al
    Impact of fluid intake in the prevention of urinary system diseases: a brief review.
    Curr Opin Nephrol Hypertens. 2013;22 Suppl 1:S1-10.
    Abstract     Related articles   

  1175. TERADA T
    Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carc
    Int J Clin Exp Pathol. 2013;6:1150-6.
    Abstract     Related articles   

  1176. KRAVCHICK S, Lobik L, Paz A, Stepnov E, et al
    Radical cystectomy with W-shaped orthotopic ileal neobladder constructed with non-absorbable titanium staples-long term follow-up.
    Int Braz J Urol. 2013;39:167-72.
    Abstract     Related articles   

  1177. SCHREMPP DR, Childress MO, Stewart JC, Leach TN, et al
    Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma.
    J Am Vet Med Assoc. 2013;242:1534-8.
    Abstract     Related articles   

  1178. FERREIRA JA, Videira PA, Lima L, Pereira S, et al
    Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.
    Mol Oncol. 2013;7:719-31.
    Abstract     Related articles   

  1179. SHAKER OG, Hammam OA, Wishahi MM
    Is there a correlation between HPV and urinary bladder carcinoma?
    Biomed Pharmacother. 2013;67:183-91.
    Abstract     Related articles   

  1180. UBRIG B, Kories C, Roth S
    [Follow-up after surgical replacement of the urinary bladder (urinary diversion)].
    Aktuelle Urol. 2013;44:55-67.
    Abstract     Related articles   

  1181. XU C, Zeng Q, Xu W, Jiao L, et al
    miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR.
    Mol Cancer Ther. 2013;12:207-19.
    Abstract     Related articles   

  1182. HAN SS , Rosenberg PS, Garcia-Closas M, Figueroa JD, et al
    Likelihood ratio test for detecting gene (G)-environment (E) interactions under an additive risk model exploiting G-E independence for case-control data.
    Am J Epidemiol. 2012;176:1060-7.
    Abstract     Related articles   

  1183. HSU LI , Chen GS, Lee CH, Yang TY, et al
    Use of arsenic-induced palmoplantar hyperkeratosis and skin cancers to predict risk of subsequent internal malignancy.
    Am J Epidemiol. 2013;177:202-12.
    Abstract     Related articles   

  1184. SALAS LA , Cantor KP, Tardon A, Serra C, et al
    Biological and Statistical Approaches for Modeling Exposure to Specific Trihalomethanes and Bladder Cancer Risk.
    Am J Epidemiol. 2013.
    Abstract     Related articles   

  1185. KE HL , Tu HP, Lin HH, Chai CY, et al
    Cyclooxygenase-2 (COX-2) up-regulation is a prognostic marker for poor clinical outcome of upper tract urothelial cancer.
    Anticancer Res. 2012;32:4111-6.
    Abstract     Related articles   

  1186. CULINE S , Sellam Z, Bouaita L, Assaf E, et al
    Combining paclitaxel and lapatinib as second-line treatment for patients with metastatic transitional cell carcinoma: a case series.
    Anticancer Res. 2012;32:3949-52.
    Abstract     Related articles   

  1187. HAUSER S , Kogej M, Fechner G, VON Pezold J, et al
    Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study.
    Anticancer Res. 2013;33:779-84.
    Abstract     Related articles   

  1188. LI QQ , Wang G, Liang H, Li JM, et al
    beta-Elemene Promotes Cisplatin-induced Cell Death in Human Bladder Cancer and Other Carcinomas.
    Anticancer Res. 2013;33:1421-8.
    Abstract     Related articles   

  1189. ARANTES-RODRIGUES R , Colaco A, Pinto-Leite R, Oliveira PA, et al
    In vitro and in vivo experimental models as tools to investigate the efficacy of antineoplastic drugs on urinary bladder cancer.
    Anticancer Res. 2013;33:1273-96.
    Abstract     Related articles   

  1190. LAH K , Desai D, Hadway P, Perry-Keene J, et al
    Primary vesical clear cell adenocarcinoma arising in endometriosis: a rare case of mullerian origin.
    Anticancer Res. 2013;33:615-7.
    Abstract     Related articles   

  1191. DEN OTTER W , VAN Moorselaar RJ, Jacobs JJ, Haar RT, et al
    Role of Marker Lesion when Applying Intravesical Instillations of IL-2 for Non-muscle-invasive Bladder Cancer Comparison of the Therapeutic Effects in Two Pilot Studies.
    Anticancer Res. 2013;33:2099-105.
    Abstract     Related articles   

  1192. ZHANG N , Ye L, Wu L, Deng X, et al
    Expression of Bone Morphogenetic Protein-10 (BMP10) in Human Urothelial Cancer of the Bladder and its Effects on the Aggressiveness of Bladder Cancer Cells In Vitro.
    Anticancer Res. 2013;33:1917-25.
    Abstract     Related articles   

  1193. LEE YC , Wu WJ, Li WM, Lin HH, et al
    Prognostic value of p53 protein overexpression in upper tract urothelial carcinomas in Taiwan.
    Anticancer Res. 2013;33:1091-8.
    Abstract     Related articles   

  1194. WU CE , Lin YC, Hong JH, Chuang CK, et al
    Prognostic Value of Complete Response in Patients with Muscle-invasive Bladder Cancer Undergoing Concurrent Chemoradiotherapy.
    Anticancer Res. 2013;33:2605-10.
    Abstract     Related articles   

  1195. KOPPARAPU PK , Boorjian SA, Robinson BD, Downes M, et al
    Expression of VEGF and Its receptors VEGFR1/VEGFR2 Is Associated with Invasiveness of Bladder Cancer.
    Anticancer Res. 2013;33:2381-90.
    Abstract     Related articles   

  1196. SCHMID SC , Schuster T, Horn T, Gschwend J, et al
    Utility of ATP7B in Prediction of Response to Platinum-based Chemotherapy in Urothelial Bladder Cancer.
    Anticancer Res. 2013;33:3731-7.
    Abstract     Related articles   

  1197. BURCZYNSKA B , Booth MJ, Iles RK, Shah A, et al
    Stable Knockdown of hCGbeta mRNA Expression in Bladder Cancer Cells Results in Significant Growth Inhibition.
    Anticancer Res. 2013;33:3611-4.
    Abstract     Related articles   

  1198. KITAGAWA Y , Izumi K, Miwa S, Kadono Y, et al
    Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Anticancer Res. 2013;33:4497-503.
    Abstract     Related articles   

  1199. JUHEM A , Boumendjel A, Touquet B, Guillot A, et al
    AG11, A Novel Dichloroflavanone Derivative with Anti-mitotic Activity Towards Human Bladder Cancer Cells.
    Anticancer Res. 2013;33:4445-52.
    Abstract     Related articles   

  1200. CHANG WS, Tsai CW, Ji HX, Wu HC, et al
    Associations of Cyclooxygenase 2 Polymorphic Genotypes with Bladder Cancer Risk in Taiwan.
    Anticancer Res. 2013;33:5401-5405.
    Abstract     Related articles   

  1201. KOPPARAPU PK, Boorjian SA, Robinson BD, Downes M, et al
    Expression of cyclin d1 and its association with disease characteristics in bladder cancer.
    Anticancer Res. 2013;33:5235-42.
    Abstract     Related articles   

  1202. SAMMON JD , Morgan M, Djahangirian O, Trinh QD, et al
    Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
    BJU Int. 2012;110:1301-9.
    Abstract     Related articles   

  1203. SAITO K , Urakami S, Komai Y, Yasuda Y, et al
    Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin.
    BJU Int. 2012;110:1478-84.
    Abstract     Related articles   

  1204. YUAN JB , Zu XB, Miao JG, Wang J, et al
    Laparoscopic pelvic lymph node dissection system based on preoperative primary tumour stage (T stage) by computed tomography in urothelial bladder cancer: results of a single-institution prospective study.
    BJU Int. 2013 Jan 16. doi: 10.1111/j.1464-410X.2012.11650.
    Abstract     Related articles   

  1205. HENNING A , Wehrberger M, Madersbacher S, Pycha A, et al
    Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer?
    BJU Int. 2013 Jan 15. doi: 10.1111/j.1464-410X.2012.11661.
    Abstract     Related articles   

  1206. SMITH ZL , Christodouleas JP, Keefe SM, Malkowicz SB, et al
    Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.
    BJU Int. 2013 Jan 29. doi: 10.1111/j.1464-410X.2012.11762.
    Abstract     Related articles   

  1207. HERR HW , Dalbagni G
    Intravesical bacille Calmette-Guerin (BCG) in immunologically compromised patients with bladder cancer.
    BJU Int. 2013 Jan 25. doi: 10.1111/j.1464-410X.2012.11778.
    Abstract     Related articles   

  1208. BONBERG N , Taeger D, Gawrych K, Johnen G, et al
    Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
    BJU Int. 2013 Jan 25. doi: 10.1111/j.1464-410X.2012.11666.
    Abstract     Related articles   

  1209. SAPRE N , Anderson P, Foroudi F
    Management of local recurrences in the irradiated bladder: a systematic review.
    BJU Int. 2012;110 Suppl 4:51-7.
    Abstract     Related articles   

  1210. SAPRE N , Bugeja P, Hayes E, Corcoran NM, et al
    Nurse-led flexible cystoscopy in Australia: initial experience and early results.
    BJU Int. 2012;110 Suppl 4:46-50.
    Abstract     Related articles   

  1211. MEEKS JJ , Taylor JM, Matsushita K, Herr HW, et al
    Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer.
    BJU Int. 2013 Feb 5. doi: 10.1111/j.1464-410X.2012.11751.
    Abstract     Related articles   

  1212. HASHAD MM , Atta M, Elabbady A, Elfiky S, et al
    Safety of no bowel preparation before ileal urinary diversion.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1213. KORKOLOPOULOU P , Levidou G, Trigka EA, Prekete N, et al
    A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1214. LAVALLEE LT , Fergusson D, Dahm P, Scales CD Jr, et al
    Diagnostic tests in urology: urine cytology.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1215. HOUNSOME LS , Abel GA, Verne J, Neal DE, et al
    Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer: data from a pilot study of 1756 cases 2004-2011.
    BJU Int. 2013 Feb 6. doi: 10.1111/j.1464-410X.2012.11644.
    Abstract     Related articles   

  1216. CUTRESS ML , Stewart GD, Wells-Cole S, Phipps S, et al
    Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    BJU Int. 2012;110:1608-17.
    Abstract     Related articles   

  1217. GRASSO M , Fishman AI, Cohen J, Alexander B, et al
    Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients.
    BJU Int. 2012;110:1618-26.
    Abstract     Related articles   

  1218. ALI-EL-DEIN B , Sooriakumaran P, Trinh QD, Barakat TS, et al
    Construction of predictive models for recurrence and progression in >1000 patients with non-muscle-invasive bladder cancer (NMIBC) from a single centre.
    BJU Int. 2013 Feb 27. doi: 10.1111/bju.12026.
    Abstract     Related articles   

  1219. BRYAN RT , Zeegers MP, van Roekel EH, Bird D, et al
    A comparison of patient and tumour characteristics in two UK bladder cancer cohorts separated by 20 years.
    BJU Int. 2013 Mar 4. doi: 10.1111/bju.12032.
    Abstract     Related articles   

  1220. WITJES JA , Palou J, Soloway M, Lamm D, et al
    Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guerin (BCG): results of an international individual patient data survey (IPDS).
    BJU Int. 2013 Mar 1. doi: 10.1111/bju.12012.
    Abstract     Related articles   

  1221. KIM SP , Shah ND, Weight CJ, Thompson RH, et al
    Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer.
    BJU Int. 2013 Mar 1. doi: 10.1111/j.1464-410X.2012.11508.
    Abstract     Related articles   

  1222. LINDEN M , Segersten U, Runeson M, Wester K, et al
    Tumour expression of bladder cancer-associated urinary proteins.
    BJU Int. 2013 Mar 7. doi: 10.1111/j.1464-410X.2012.11653.
    Abstract     Related articles   

  1223. RINK M , Hansen J, Cha EK, Green DA, et al
    Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
    BJU Int. 2013;111:74-84.
    Abstract     Related articles   

  1224. ABERN MR , Freedland SJ, Inman BA
    Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    BJU Int. 2013;111:187-8.
    Abstract     Related articles   

  1225. CHROMECKI TF , Cha EK, Fajkovic H, Rink M, et al
    Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    BJU Int. 2013;111:249-55.
    Abstract     Related articles   

  1226. TAKADA N , Abe T, Shinohara N, Sazawa A, et al
    Peri-operative morbidity and mortality related to radical cystectomy: a multi-institutional retrospective study in Japan.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1227. BRUINS HM , Wopat R, Mitra AP, Cai J, et al
    Long-term outcomes of salvage radical cystectomy for recurrent urothelial carcinoma of the bladder following partial cystectomy.
    BJU Int. 2013;111.
    Abstract     Related articles   

  1228. GREEN DA , Rink M, Cha EK, Xylinas E, et al
    Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
    BJU Int. 2013;111.
    Abstract     Related articles   

  1229. RINK M , Lee DJ, Kent M, Xylinas E, et al
    Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
    BJU Int. 2013;111.
    Abstract     Related articles   

  1230. ANING J , Dunn J, Daugherty M, Mason R, et al
    Towards bloodless cystectomy: a 10-year experience of intra-operative cell salvage during radical cystectomy.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1231. AHMAD S , Aboumarzouk O, Somani B, Nabi G, et al
    Oral 5-aminolevulinic acid in simultaneous photodynamic diagnosis of upper and lower urinary tract transitional cell carcinoma - a prospective audit.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1232. LEE EK , Herr HW, Dickstein RJ, Kassouf W, et al
    Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1233. EL-ASSMY A , Abou-El-Ghar ME, Refaie HF, Mosbah A, et al
    Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1234. TODENHOFER T , Renninger M, Schwentner C, Stenzl A, et al
    A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    BJU Int. 2012;110.
    Abstract     Related articles   

  1235. HOROVITZ D , Turker P, Bostrom PJ, Mirtti T, et al
    Does patient age affect survival after radical cystectomy?
    BJU Int. 2012;110.
    Abstract     Related articles   

  1236. MAURICE MJ , Ponsky LE
    En bloc transurethral resection of bladder lesions: a trick to retrieve specimens up to 4.5 cm.
    BJU Int. 2013;111:E15-6.
    Abstract     Related articles   

  1237. GREEN DA , Rink M, Hansen J, Cha EK, et al
    Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    BJU Int. 2013;111:404-11.
    Abstract     Related articles   

  1238. DE LA PENA E , Hernandez V, Blazquez C, Martin MD, et al
    Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
    BJU Int. 2013;111.
    Abstract     Related articles   

  1239. GOEL A , Prakash J, Sharma P
    Weight of the resected specimen after transurethral resection as a new predictive variable for recurrence of non-muscle-invasive bladder tumour.
    BJU Int. 2013;111:E138.
    Abstract     Related articles   

  1240. LLORENTE C
    Reply.
    BJU Int. 2013;111:E138.
    Abstract     Related articles   

  1241. EHDAIE B , Furberg H, Zabor EC, Ostroff JS, et al
    Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma.
    BJU Int. 2013;111:589-95.
    Abstract     Related articles   

  1242. CRIVELLI JJ , Xylinas E, Kluth LA, da Silva RD, et al
    Effect of statin use on outcomes of non-muscle-invasive bladder cancer.
    BJU Int. 2013;112:E4-E12.
    Abstract     Related articles   

  1243. GALUSTIAN C
    Tools to investigate biomarker expression in bladder cancer progression.
    BJU Int. 2013;112:404-6.
    Abstract     Related articles   

  1244. KIM JH , Kim SJ, Lee KM, Chang IH, et al
    Human beta-defensin 2 may inhibit internalisation of bacillus Calmette-Guerin (BCG) in bladder cancer cells.
    BJU Int. 2013 Jul 2. doi: 10.1111/bju.12196.
    Abstract     Related articles   

  1245. WIECZOREK E , Reszka E, Jablonowski Z, Jablonska E, et al
    Genetic polymorphisms in matrix metalloproteinases (MMPs) and tissue inhibitors of MPs (TIMPs), and bladder cancer susceptibility.
    BJU Int. 2013 May 14. doi: 10.1111/bju.12230.
    Abstract     Related articles   

  1246. WONG KA , Zisengwe G, Athanasiou T, O'Brien T, et al
    Outpatient laser ablation of non-muscle-invasive bladder cancer: is it safe, tolerable and cost-effective?
    BJU Int. 2013 May 9. doi: 10.1111/bju.12216.
    Abstract     Related articles   

  1247. MATSUYAMA H , Ikemoto K, Eguchi S, Oga A, et al
    Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC).
    BJU Int. 2013 May 14. doi: 10.1111/bju.12232.
    Abstract     Related articles   

  1248. NEHEMAN A , Schulman C, Yossepowitch O
    Novel anti-biofilm mechanism for wireless capsule endoscopy in the urinary tract: preliminary study in a sheep model.
    BJU Int. 2013;111:1156-60.
    Abstract     Related articles   

  1249. MARSHALL SJ , Hayn MH, Stegemann AP, Agarwal PK, et al
    Impact of surgeon and volume on extended lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium (IRCC).
    BJU Int. 2013;111:1075-80.
    Abstract     Related articles   

  1250. NEUZILLET Y , Soulie M, Larre S, Roupret M, et al
    Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control study.
    BJU Int. 2013;111:1253-60.
    Abstract     Related articles   

  1251. DJALADAT H , Bruins HM, Miranda G, Cai J, et al
    The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer.
    BJU Int. 2013 Jul 26. doi: 10.1111/bju.12240.
    Abstract     Related articles   

  1252. PHILIPPOU Y , Hadjipavlou M, Khan S, Rane A, et al
    Complementary and alternative medicine (CAM) in prostate and bladder cancer.
    BJU Int. 2013 Mar 13. doi: 10.1111/bju.12062.
    Abstract     Related articles   

  1253. ZEHNDER P , Studer UE, Skinner EC, Thalmann GN, et al
    Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades.
    BJU Int. 2013;112:E51-8.
    Abstract     Related articles   

  1254. XIAO Z , Mak A, Koch K, Moore RB, et al
    A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
    BJU Int. 2013;112:E201-10.
    Abstract     Related articles   

  1255. SAPRE N , Corcoran NM
    Modulating the immune response to Bacillus Calmette-Guerin (BCG): a novel way to increase the immunotherapeutic effect of BCG for treatment of bladder cancer?
    BJU Int. 2013;112:852-3.
    Abstract     Related articles   

  1256. GOH V , Cook G
    Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
    BJU Int. 2013;112:709.
    Abstract     Related articles   

  1257. RIEKEN M , Xylinas E, Kluth L, Crivelli JJ, et al
    Association of Diabetes Mellitus and Metformin Use with Oncological Outcomes of Patients with non-muscle invasive Bladder Cancer.
    BJU Int. 2013 Sep 5. doi: 10.1111/bju.12448.
    Abstract     Related articles   

  1258. MERTENS LS , Meijer RP, Meinhardt W, van der Poel HG, et al
    occult lymph node metastases in patients with muscle invasive bladder cancer: incidence after neoadjuvant chemotherapy and cystectomy versus cystectomy alone.
    BJU Int. 2013 Sep 5. doi: 10.1111/bju.12447.
    Abstract     Related articles   

  1259. FAN X , Huang H, Bi L, Li K, et al
    Extended versus Non-extended Pelvic Lymph Node Dissection and Their Influence on Recurrence-free Survival in Patients Undergoing Radical Cystectomy for Bladder Cancer: A systematic Review and Meta-analysis of Comparative Studies.
    BJU Int. 2013 Jul 19. doi: 10.1111/bju.12371.
    Abstract     Related articles   

  1260. DESCOTES F , Dessen P, Bringuier PP, Decaussin M, et al
    Microarray gene expression profiling and analysis of bladder cancer supports the sub classification of the T1 tumours in T1a and T1b stages.
    BJU Int. 2013 Jul 12. doi: 10.1111/bju.12364.
    Abstract     Related articles   

  1261. O'BRIEN T , Ray E, Chatterton K, Khan S, et al
    A prospective randomised trial of Hexylaminolevulinate (HEXVIX (R)) photodynamic assisted transurethral resection (TURBT) plus single shot intravesical MitomycinC versus conventional white-light TURBT plus MitomycinC in newly presenting non-muscle inv
    BJU Int. 2013 Jul 8. doi: 10.1111/bju.12355.
    Abstract     Related articles   

  1262. ZEHNDER P , Studer UE, Daneshmand S, Birkhauser FD, et al
    Outcome with Radical Cystectomy and Extended Lymphadenectomy Alone in Lymph Node Positive Bladder Cancer Patients Unfit for or Declining Adjuvant Chemotherapy.
    BJU Int. 2013 Oct 16. doi: 10.1111/bju.12520.
    Abstract     Related articles   

  1263. KIM PH , Sukhu R, Cordon BH, Sfakianos JP, et al
    Reflex fluorescence in situ hybridization assay for suspicious urinary cytology in bladder cancer patients with negative surveillance cystoscopy.
    BJU Int. 2013 Oct 15. doi: 10.1111/bju.12516.
    Abstract     Related articles   

  1264. TRACEY E , Watt H, Currow D, Young J, et al
    Investigation of poorer bladder cancer survival in women than men in NSW Australia: A data linkage study.
    BJU Int. 2013 Oct 15. doi: 10.1111/bju.12496.
    Abstract     Related articles   

  1265. KNOEDLER JJ , Boorjian SA, Tollefson MK, Cheville JC, et al
    Urothelial Carcinoma Involving the Prostate: the Association of Revised Tumor Stage and Coexistent Bladder Cancer with Survival Following Radical Cystectomy.
    BJU Int. 2013 Oct 7. doi: 10.1111/bju.12486.
    Abstract     Related articles   

  1266. LIEW MS , Azad A, Tafreshi A, Eapen R, et al
    USANZ: Time-trends in use and impact on outcomes of perioperative chemotherapy in patients treated with radical cystectomy for urothelial bladder cancer.
    BJU Int. 2013;112 Suppl 2:74-82.
    Abstract     Related articles   

  1267. AL-DAGHMIN A , Kauffman EC, Shi Y, Badani K, et al
    Efficacy of Robot-assisted Radical Cystectomy in Advanced Bladder Cancer: Results from the International Radical Cystectomy Consortium (IRCC).
    BJU Int. 2013 Nov 13. doi: 10.1111/bju.12569.
    Abstract     Related articles   

  1268. MANSOUR AM
    A real-life snapshot of the current trends of urinary diversion.
    BJU Int. 2013;112:428-9.
    Abstract     Related articles   

  1269. SMITH AB , Pruthi RS
    Phase II study of everolimus in metastatic urothelial cancer.
    BJU Int. 2013;112:427-8.
    Abstract     Related articles   

  1270. KADER AK , Richards KA, Krane LS, Pettus JA, et al
    Robot-assisted laparoscopic vs open radical cystectomy: comparison of complications and perioperative oncological outcomes in 200 patients.
    BJU Int. 2013;112:E290-4.
    Abstract     Related articles   

  1271. LUO HL , Kang CH, Chen YT, Chuang YC, et al
    Severity of hydronephrosis correlates with tumour invasiveness and urinary bladder recurrence of ureteric cancer.
    BJU Int. 2013;112:489-94.
    Abstract     Related articles   

  1272. MILOWSKY MI , Iyer G, Regazzi AM, Al-Ahmadie H, et al
    Phase II study of everolimus in metastatic urothelial cancer.
    BJU Int. 2013;112:462-70.
    Abstract     Related articles   

  1273. MERTENS LS , Fioole-Bruining A, Vegt E, Vogel WV, et al
    Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    BJU Int. 2013;112:729-34.
    Abstract     Related articles   

  1274. CRESSWELL J
    Diabetes mellitus and non-muscle-invasive bladder cancer: not just a coincidence?
    BJU Int. 2013;112:1055-6.
    Abstract     Related articles   

  1275. JOHNSON DC, Nielsen ME, Matthews J, Woods ME, et al
    Neoadjuvant Chemotherapy for Bladder Cancer Does Not Increase Risk of Perioperative Morbidity.
    BJU Int. 2013 Nov 26. doi: 10.1111/bju.12585.
    Abstract     Related articles   

  1276. SMITH AB, Deal AM, Woods ME, Wallen EM, et al
    Muscle-Invasive Bladder Cancer: Evaluating Treatment and Survival in the National Cancer Data Base.
    BJU Int. 2013 Dec 11. doi: 10.1111/bju.12601.
    Abstract     Related articles   

  1277. LAMMERS RJ, Palou J, Witjes WP, Janzing-Pastors MH, et al
    Comparison of expected treatment outcome provided by risk models and international guidelines with observed treatment outcome in a cohort of Dutch non-muscle-invasive bladder cancer patients treated with intravesical chemotherapy.
    BJU Int. 2013 Oct 15. doi: 10.1111/bju.12495.
    Abstract     Related articles   

  1278. GOODFELLOW H, Viney Z, Hughes P, Rankin S, et al
    Role of Fdg Pet-Ct in the Staging of Bladder Cancer.
    BJU Int. 2013 Dec 16. doi: 10.1111/bju.12608.
    Abstract     Related articles   

  1279. LEE RK, Abol-Enein H, Artibani W, Bochner B, et al
    Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes.
    BJU Int. 2014;113:11-23.
    Abstract     Related articles   

  1280. CLOUSTON D, Lawrentschuk N
    Metaplastic conditions of the bladder.
    BJU Int. 2013;112 Suppl 2:27-31.
    Abstract     Related articles   

  1281. DE LA ROSETTE J
    No one of us is as smart as all of us.
    BJU Int. 2013;112:881-2.
    Abstract     Related articles   

  1282. GAN C, Patel A, Fowler S, Catto J, et al
    Snapshot of transurethral resection of bladder tumours in the United Kingdom Audit (STUKA).
    BJU Int. 2013;112:930-5.
    Abstract     Related articles   

  1283. RANASINGHE WK, Attia J, Oldmeadow C, Lawrentschuk N, et al
    Bladder carcinoma in situ (CIS) in Australia: a rising incidence for an under-reported malignancy.
    BJU Int. 2013;112 Suppl 2:46-52.
    Abstract     Related articles   

  1284. ROSENBERG E, Baniel J, Spector Y, Faerman A, et al
    Predicting progression of bladder urothelial carcinoma using microRNA expression.
    BJU Int. 2013;112:1027-34.
    Abstract     Related articles   

  1285. WAGENER N , Bulkescher J, Macher-Goeppinger S, Karapanagiotou-Schenkel I, et al
    Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients.
    Br J Cancer. 2013 Jan 8. doi: 10.1038/bjc.2012.
    Abstract     Related articles   

  1286. XYLINAS E , Cha EK, Sun M, Rink M, et al
    Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling.
    Br J Cancer. 2012;107:1826-32.
    Abstract     Related articles   

  1287. ISHIOKA J , Saito K, Sakura M, Yokoyama M, et al
    Development of a nomogram incorporating serum C-reactive protein level to predict overall survival of patients with advanced urothelial carcinoma and its evaluation by decision curve analysis.
    Br J Cancer. 2012;107:1031-6.
    Abstract     Related articles   

  1288. NOON AP , Albertsen PC, Thomas F, Rosario DJ, et al
    Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients.
    Br J Cancer. 2013 Mar 12. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1289. TONG ZT , Wei JH, Zhang JX, Liang CZ, et al
    AIB1 predicts bladder cancer outcome and promotes bladder cancer cell proliferation through AKT and E2F1.
    Br J Cancer. 2013 Mar 19. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1290. WANG J , Wu X, Kamat A, Barton Grossman H, et al
    Fluid intake, genetic variants of UDP-glucuronosyltransferases, and bladder cancer risk.
    Br J Cancer. 2013 Apr 30. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1291. BOMAN K , Larsson AH, Segersten U, Kuteeva E, et al
    Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.
    Br J Cancer. 2013 May 7. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1292. MORO FD , Rossi A, Zattoni F
    Does age really matter in the choice of treatment for bladder cancer?
    Br J Cancer. 2013 May 14. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1293. BLICK C , Ramachandran A, Wigfield S, McCormick R, et al
    Hypoxia regulates FGFR3 expression via HIF-1alpha and miR-100 and contributes to cell survival in non-muscle invasive bladder cancer.
    Br J Cancer. 2013 Jun 18. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1294. SHIMWELL NJ , Bryan RT, Wei W, James ND, et al
    Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma.
    Br J Cancer. 2013;108:1854-61.
    Abstract     Related articles   

  1295. SERONT E , Pinto A, Bouzin C, Bertrand L, et al
    PTEN deficiency is associated with reduced sensitivity to mTOR inhibitor in human bladder cancer through the unhampered feedback loop driving PI3K/Akt activation.
    Br J Cancer. 2013 Aug 29. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1296. ALCARAZ A , Gonzalez-Lopez R, Morote J, de la Piedra C, et al
    Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAMO study.
    Br J Cancer. 2013;109:121-30.
    Abstract     Related articles   

  1297. SANTONI M , Amantini C, Morelli MB, Liberati S, et al
    Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells.
    Br J Cancer. 2013;109:1040-50.
    Abstract     Related articles   

  1298. BRYAN RT, Shimwell NJ, Wei W, Devall AJ, et al
    Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential.
    Br J Cancer. 2013 Nov 28. doi: 10.1038/bjc.2013.
    Abstract     Related articles   

  1299. MITRA AP , Castelao JE, Hawes D, Tsao-Wei DD, et al
    Combination of molecular alterations and smoking intensity predicts bladder cancer outcome: A report from the Los Angeles Cancer Surveillance Program.
    Cancer. 2013 Jan 14. doi: 10.1002/cncr.27763.
    Abstract     Related articles   

  1300. GALSKY MD , Hendricks R, Svatek R, Bangs R, et al
    Critical analysis of contemporary clinical research in muscle-invasive and metastatic urothelial cancer: A report from the Bladder Cancer Advocacy Network Clinical Trials Working Group.
    Cancer. 2013 Mar 1. doi: 10.1002/cncr.27973.
    Abstract     Related articles   

  1301. SIEFKER-RADTKE AO , Dinney CP, Shen Y, Williams DL, et al
    A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.
    Cancer. 2013;119:540-7.
    Abstract     Related articles   

  1302. LEE EK , Ye Y, Kamat AM, Wu X, et al
    Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancer.
    Cancer. 2013 Mar 25. doi: 10.1002/cncr.27871.
    Abstract     Related articles   

  1303. CHAMIE K , Litwin MS, Bassett JC, Daskivich TJ, et al
    Recurrence of high-risk bladder cancer: A population-based analysis.
    Cancer. 2013 Jun 4. doi: 10.1002/cncr.28147.
    Abstract     Related articles   

  1304. WYSZYNSKI A , Tanyos SA, Rees JR, Marsit CJ, et al
    Body mass and smoking are modifiable risk factors for recurrent bladder cancer.
    Cancer. 2013 Oct 10. doi: 10.1002/cncr.28394.
    Abstract     Related articles   

  1305. BAROCAS DA, Alvarez J, Koyama T, Anderson CB, et al
    Racial variation in the quality of surgical care for bladder cancer.
    Cancer. 2013 Dec 11. doi: 10.1002/cncr.28520.
    Abstract     Related articles   

  1306. KANG MR , Yang G, Place RF, Charisse K, et al
    Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth.
    Cancer Res. 2012;72:5069-79.
    Abstract     Related articles   

  1307. QIAO B , Kerr M, Groselj B, Teo MT, et al
    Imatinib radiosensitises bladder cancer by targeting homologous recombination.
    Cancer Res. 2013.
    Abstract     Related articles   

  1308. REDELMAN-SIDI G , Iyer G, Solit DB, Glickman MS, et al
    Oncogenic Activation of Pak1-Dependent Pathway of Macropinocytosis Determines BCG Entry into Bladder Cancer Cells.
    Cancer Res. 2013;73:1156-67.
    Abstract     Related articles   

  1309. DU X , Wang QR, Chan E, Merchant M, et al
    FGFR3 stimulates stearoyl CoA desaturase 1 activity to promote bladder tumor growth.
    Cancer Res. 2012;72:5843-55.
    Abstract     Related articles   

  1310. GARCIA-CLOSAS M , Rothman N, Figueroa JD, Prokunina-Olsson L, et al
    Common Genetic Polymorphisms Modify the Effect of Smoking on Absolute Risk of Bladder Cancer.
    Cancer Res. 2013.
    Abstract     Related articles   

  1311. YUAN X , Yu L, Li J, Xie G, et al
    ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton.
    Cancer Res. 2013.
    Abstract     Related articles   

  1312. ALLEN M, Luong P, Hudson C, Leyton J, et al
    Prognostic and therapeutic impact of argininosuccinate synthase-1 control in bladder cancer as monitored longitudinally by PET imaging.
    Cancer Res. 2013.
    Abstract     Related articles   

  1313. LIN C, Yin Y, Stemler K, Humphrey P, et al
    Constitutive beta-catenin activation induces male-specific tumorigenesis in the bladder urothelium.
    Cancer Res. 2013;73:5914-25.
    Abstract     Related articles   

  1314. KE HL , Chen M, Ye Y, Hildebrandt MA, et al
    Genetic variations in microRNA-biogenesis genes and clinical outcomes in non-muscle invasive bladder cancer.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1315. SINGH SV , Singh K
    Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research.
    Carcinogenesis. 2012;33:1833-42.
    Abstract     Related articles   

  1316. LA MAESTRA S , Micale RT, De Flora S, D'Agostini F, et al
    DNA damage in exfoliated cells and histopathological alterations in the urinary tract of mice exposed to cigarette smoke and treated with chemopreventive agents.
    Carcinogenesis. 2013;34:183-9.
    Abstract     Related articles   

  1317. ZHANG JX , Wei J, Lu J, Tong Z, et al
    Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3beta/Snail signaling.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1318. CHOUDHARY S , Hegde P, Pruitt JR, Sielecki TM, et al
    Macrophage Migratory Inhibitory Factor (MIF) promotes bladder cancer progression via increasing proliferation and angiogenesis.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1319. BHATTACHARYA A , Li Y, Shi Y, Zhang Y, et al
    Enhanced inhibition of urinary bladder cancer growth and muscle invasion by allyl isothiocyanate and celecoxib in combination.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1320. FERNANDEZ MI , Gong Y, Ye Y, Lin J, et al
    Gamma-H2AX Level in Peripheral Blood Lymphocytes as a Risk Predictor for Bladder Cancer.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1321. HSU I , Chuang KL, Slavin S, da J, et al
    Suppression of ERbeta signaling via ERbeta knockout or ERbeta antagonist protects against bladder cancer development.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1322. ROSE M, Gaisa NT, Antony P, Fiedler D, et al
    Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high grade urothelial tumours.
    Carcinogenesis. 2013.
    Abstract     Related articles   

  1323. ZHOU N , Singh K, Mir MC, Parker Y, et al
    The investigational Aurora kinase A inhibitor MLN8237 induces defects in cell viability and cell cycle progression in bladder cancer cells in vitro and in vivo.
    Clin Cancer Res. 2013.
    Abstract     Related articles   

  1324. SHIMADA K , Fujii T, Tsujikawa K, Anai S, et al
    ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak/Fn14/VEGF signals.
    Clin Cancer Res. 2012;18:5247-55.
    Abstract     Related articles   


  1325. Retraction: Functional Characterization of the Bladder Cancer Marker, BLCA-4.
    Clin Cancer Res. 2013.
    Abstract     Related articles   

  1326. EUSTACE A , Mani N, Span PN, Irlam JJ, et al
    A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
    Clin Cancer Res. 2013.
    Abstract     Related articles   

  1327. KANDIMALLA R , Masius R, Beukers W, Bangma CH, et al
    A 3-plex methylation assay combined with the FGFR3 mutation assay sensitively detects recurrent bladder cancer in voided urine.
    Clin Cancer Res. 2013.
    Abstract     Related articles   

  1328. ERUSLANOV E , Stoffs T, Kim WJ, Daurkin I, et al
    Expansion of CCR8(+) inflammatory myeloid cells in cancer patients with urothelial and renal carcinomas.
    Clin Cancer Res. 2013;19:1670-80.
    Abstract     Related articles   

  1329. POCH MA , Raza J, Nyquist J, Guru KA, et al
    Tips and tricks to robot-assisted radical cystectomy and intracorporeal diversion.
    Curr Opin Urol. 2013;23:65-71.
    Abstract     Related articles   

  1330. GRAY PJ , Shipley WU, Efstathiou JA, Zietman AL, et al
    Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2013.
    Abstract     Related articles   

  1331. COLLINS JW , Wiklund PN, Desai MM, Goh AC, et al
    Total intracorporeal robotic cystectomy: are we there yet?
    Curr Opin Urol. 2013;23:135-40.
    Abstract     Related articles   

  1332. ZEHNDER P , Thalmann GN
    Timing and outcomes for radical cystectomy in nonmuscle invasive bladder cancer.
    Curr Opin Urol. 2013.
    Abstract     Related articles   

  1333. WILLIS DL , Porten SP, Kamat AM
    Should histologic variants alter definitive treatment of bladder cancer?
    Curr Opin Urol. 2013.
    Abstract     Related articles   

  1334. BAMBURY RM , Rosenberg JE
    Actionable mutations in muscle-invasive bladder cancer.
    Curr Opin Urol. 2013;23:472-8.
    Abstract     Related articles   

  1335. MORGAN R , Bryan RT, Javed S, Launchbury F, et al
    Expression of Engrailed-2 (EN2) protein in bladder cancer and its potential utility as a urinary diagnostic biomarker.
    Eur J Cancer. 2013 Feb 21. pii: S0959-8049(13)00081.
    Abstract     Related articles   

  1336. ROS MM , Bueno-de-Mesquita HB, Kampman E, Buchner FL, et al
    Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition.
    Eur J Cancer. 2012;48:3267-77.
    Abstract     Related articles   

  1337. TRIANTAFYLLOU M , Studer UE, Birkhauser FD, Fleischmann A, et al
    Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer.
    Eur J Cancer. 2013;49:616-24.
    Abstract     Related articles   

  1338. TSAI YC , Yeh CH, Tzen KY, Ho PY, et al
    Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma.
    Eur J Cancer. 2013;49:1458-66.
    Abstract     Related articles   

  1339. KANG HW , Song PH, Ha YS, Kim WT, et al
    Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility and outcomes in muscle invasive bladder cancer patients.
    Eur J Cancer. 2013 Jun 26. pii: S0959-8049(13)00427.
    Abstract     Related articles   

  1340. XYLINAS E , Rink M, Robinson BD, Lotan Y, et al
    Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    Eur J Cancer. 2013;49:1889-97.
    Abstract     Related articles   

  1341. FORTUIN AS , Barentsz JO
    Comments on Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer, Triantafyllou et al., European Journal of Cancer, published onli
    Eur J Cancer. 2013;49:1789-90.
    Abstract     Related articles   

  1342. THOENY HC , Froehlich JM, Bains LJ, Studer UE, et al
    Response to the letter to the editor from Ansje S. Fortuin and Jelle O. Barentsz--Harriet C. Thoeny for the authors.
    Eur J Cancer. 2013;49:1787-8.
    Abstract     Related articles   

  1343. RAGHAVAN D
    Cells, sieves, positive and negative attraction: But...slow progress in bladder cancer.
    Eur J Cancer. 2013 Jul 8. pii: S0959-8049(13)00482.
    Abstract     Related articles   

  1344. BIRKHAHN M , Mitra AP, Williams AJ, Barr NJ, et al
    A novel precision-engineered microfiltration device for capture and characterisation of bladder cancer cells in urine.
    Eur J Cancer. 2013 Jul 9. pii: S0959-8049(13)00481.
    Abstract     Related articles   

  1345. ISMAILI N
    Re: Siobhan P. Lynch, Yu Shen, Ashish Kamat, et al. neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center. Eur Urol. In pres
    Eur Urol. 2012;62:e65-6.
    Abstract     Related articles   

  1346. BLACK PC
    Radical Locoregional Therapy for Bladder Cancer: Underutilized, or Unsuitable in Many?
    Eur Urol. 2013 Jan 9. pii: S0302-2838(13)00002.
    Abstract     Related articles   

  1347. LARRE S , Catto JW, Cookson MS, Messing EM, et al
    Screening for Bladder Cancer: Rationale, Limitations, Whom to Target, and Perspectives.
    Eur Urol. 2013 Jan 8. pii: S0302-2838(13)00003.
    Abstract     Related articles   

  1348. WEIBULL CE , Eloranta S, Altman D, Johansson AL, et al
    Childbearing and the Risk of Bladder Cancer: A Nationwide Population-based Cohort Study.
    Eur Urol. 2013 Jan 11. pii: S0302-2838(13)00008.
    Abstract     Related articles   

  1349. BAGRODIA A , Lotan Y
    Re: Radiotherapy With or Without Chemotherapy in Muscle-invasive Bladder Cancer.
    Eur Urol. 2013;63:580-1.
    Abstract     Related articles   

  1350. SAGALOWSKY AI
    Re: A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
    Eur Urol. 2013;63:579-80.
    Abstract     Related articles   

  1351. KHAN MS , Elhage O, Challacombe B, Murphy D, et al
    Long-term Outcomes of Robot-assisted Radical Cystectomy for Bladder Cancer.
    Eur Urol. 2013 Jan 11. pii: S0302-2838(13)00009.
    Abstract     Related articles   

  1352. SINGH BP , Dhakad U
    Re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.
    Eur Urol. 2012;62:e79.
    Abstract     Related articles   

  1353. LIEDBERG F , Lauss M, Patschan O, Aine M, et al
    The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading.
    Eur Urol. 2012;62:620-3.
    Abstract     Related articles   

  1354. BRUINS HM , Dorin RP, Rubino B, Miranda G, et al
    Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Eur Urol. 2012;62:671-6.
    Abstract     Related articles   

  1355. MAYR R , May M, Martini T, Lodde M, et al
    Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
    Eur Urol. 2012;62:662-70.
    Abstract     Related articles   

  1356. RINK M , Ehdaie B, Cha EK, Green DA, et al
    Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery.
    Eur Urol. 2012;62:677-84.
    Abstract     Related articles   

  1357. XYLINAS E , Roupret M, Kluth L, Scherr DS, et al
    Collaborative research networks as a platform for virtual multidisciplinary, international approach to managing difficult clinical cases: an example from the Upper Tract Urothelial Carcinoma Collaboration.
    Eur Urol. 2012;62:943-5.
    Abstract     Related articles   

  1358. GOH AC , Gill IS, Lee DJ, de Castro Abreu AL, et al
    Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles.
    Eur Urol. 2012;62:891-901.
    Abstract     Related articles   

  1359. YUH BE , Nazmy M, Ruel NH, Jankowski JT, et al
    Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.
    Eur Urol. 2012;62:806-13.
    Abstract     Related articles   

  1360. BANGMA CH , Loeb S, Busstra M, Zhu X, et al
    Outcomes of a Bladder Cancer Screening Program Using Home Hematuria Testing and Molecular Markers.
    Eur Urol. 2013 Mar 4. pii: S0302-2838(13)00219.
    Abstract     Related articles   

  1361. INMAN BA , Abern MR
    Interpreting a Study on Bladder Cancer Screening.
    Eur Urol. 2013 Apr 11. pii: S0302-2838(13)00301.
    Abstract     Related articles   

  1362. BURGER M , Grossman HB, Droller M, Schmidbauer J, et al
    Photodynamic Diagnosis of Non-muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data.
    Eur Urol. 2013 Apr 8. pii: S0302-2838(13)00353.
    Abstract     Related articles   

  1363. ROOBOL MJ , Bangma CH, Steyerberg EW
    Reply from Authors re: Brant A. Inman, Michael R. Abern. Interpreting a Study on Bladder Cancer Screening. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.03.047: The Goal of Cancer Screening: Early Evaluation of Screening for Bladder Canc
    Eur Urol. 2013 Apr 19. pii: S0302-2838(13)00384.
    Abstract     Related articles   

  1364. TILKI D , Brausi M, Colombo R, Evans CP, et al
    Lymphadenectomy for Bladder Cancer at the Time of Radical Cystectomy.
    Eur Urol. 2013 Apr 29. pii: S0302-2838(13)00421.
    Abstract     Related articles   

  1365. EHDAIE B , Sylvester R, Herr HW
    Maintenance Bacillus Calmette-Guerin Treatment of Non-muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence.
    Eur Urol. 2013 May 18. pii: S0302-2838(13)00493.
    Abstract     Related articles   

  1366. SELINSKI S , Ovsiannikov D, Hengstler JG, Golka K, et al
    Re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the Risk of Bladder Cancer: A Nationwide Population-based Cohort Study. Eur Urol 2013;63:733-8.
    Eur Urol. 2013 May 14. pii: S0302-2838(13)00485.
    Abstract     Related articles   

  1367. WEIBULL CE , Eloranta S, Johansson AL, Altman D, et al
    Reply to Silvia Selinski, Daniel Ovsiannikov, Jan G. Hengstler and Klaus Golka's Letter to the Editor re: Caroline E. Weibull, Sandra Eloranta, Daniel Altman, Anna L.V. Johansson, Mats Lambe. Childbearing and the Risk of Bladder Cancer: A Nationwide P
    Eur Urol. 2013 May 29. pii: S0302-2838(13)00508.
    Abstract     Related articles   

  1368. GALOSI AB , Cheng L, Lopez-Beltran A, Montorsi F, et al
    Precise Morphologic Documentation with Large-format Histology of Clinical Findings in a Bladder Cancer Patient.
    Eur Urol. 2013 Jun 12. pii: S0302-2838(13)00599.
    Abstract     Related articles   

  1369. NIEGISCH G , Lorch A, Droller MJ, Lavery HJ, et al
    Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit?
    Eur Urol. 2013 Jun 12. pii: S0302-2838(13)00600.
    Abstract     Related articles   

  1370. MAYR R , May M, Fritsche HM
    Reply to Michael Froehner, Rainer Koch and Manfred P. Wirth's letter to the editor re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortal
    Eur Urol. 2013;63:e10.
    Abstract     Related articles   

  1371. FROEHNER M , Koch R, Wirth MP
    Re: Roman Mayr, Matthias May, Thomas Martini, et al. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder. Eur Urol 2012
    Eur Urol. 2013;63:e9.
    Abstract     Related articles   

  1372. PERLIS N , Zlotta AR, Beyene J, Finelli A, et al
    Immediate Post-Transurethral Resection of Bladder Tumor Intravesical Chemotherapy Prevents Non-Muscle-invasive Bladder Cancer Recurrences: An Updated Meta-analysis on 2548 Patients and Quality-of-Evidence Review.
    Eur Urol. 2013 Jun 19. pii: S0302-2838(13)00607.
    Abstract     Related articles   

  1373. SAYLOR PJ , Armstrong AJ, Fizazi K, Freedland S, et al
    New and emerging therapies for bone metastases in genitourinary cancers.
    Eur Urol. 2013;63:309-20.
    Abstract     Related articles   

  1374. ALVAREZ-MUGICA M , Fernandez-Gomez JM, Cebrian V, Fresno F, et al
    Polyamine-modulated factor-1 methylation predicts Bacillus Calmette-Guerin response in patients with high-grade non-muscle-invasive bladder carcinoma.
    Eur Urol. 2013;63:364-70.
    Abstract     Related articles   

  1375. EISENBERG MS , Leibovich BC, Kim SP
    Re: Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al. Use of Potentially Curative Therapies for Muscle-invasive Bladder Cancer in the United States: Results from the National Cancer Data Base. Eur Urol 2013;63:823-9.
    Eur Urol. 2013 Jul 2. pii: S0302-2838(13)00654.
    Abstract     Related articles   

  1376. PETRELLI F , Coinu A, Cabiddu M, Ghilardi M, et al
    Correlation of Pathologic Complete Response with Survival After Neoadjuvant Chemotherapy in Bladder Cancer Treated with Cystectomy: A Meta-analysis.
    Eur Urol. 2013 Jul 3. pii: S0302-2838(13)00664.
    Abstract     Related articles   

  1377. ODDENS J , Brausi M, Sylvester R, Bono A, et al
    Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintena
    Eur Urol. 2013;63:462-72.
    Abstract     Related articles   

  1378. MAFFEZZINI M
    Feeding hungry patients, even those well nourished.
    Eur Urol. 2013;63:483-5.
    Abstract     Related articles   

  1379. ROTH B , Birkhauser FD, Zehnder P, Thalmann GN, et al
    Parenteral nutrition does not improve postoperative recovery from radical cystectomy: results of a prospective randomised trial.
    Eur Urol. 2013;63:475-82.
    Abstract     Related articles   

  1380. RINK M , Babjuk M, Catto JW, Jichlinski P, et al
    Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature.
    Eur Urol. 2013 Jul 19. pii: S0302-2838(13)00722.
    Abstract     Related articles   

  1381. BLACK P , Kassouf W
    Re: Gunter Niegisch, Anja Lorch, Michael J. Droller, Hugh J. Lavery, Kristian D. Stensland, Peter Albers. Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit? Eur Urol 2013;64:355-7.
    Eur Urol. 2013 Aug 17. pii: S0302-2838(13)00844.
    Abstract     Related articles   

  1382. COLLINS JW , Wiklund NP
    A totally intracorporeal approach will improve patient choice.
    Eur Urol. 2013;63:644-5.
    Abstract     Related articles   

  1383. AZZOUNI FS , Din R, Rehman S, Khan A, et al
    The first 100 consecutive, robot-assisted, intracorporeal ileal conduits: evolution of technique and 90-day outcomes.
    Eur Urol. 2013;63:637-43.
    Abstract     Related articles   

  1384. FRITSCHE HM , May M, Denzinger S, Otto W, et al
    Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
    Eur Urol. 2013;63:739-44.
    Abstract     Related articles   

  1385. ALLORY Y , Beukers W, Sagrera A, Flandez M, et al
    Telomerase Reverse Transcriptase Promoter Mutations in Bladder Cancer: High Frequency Across Stages, Detection in Urine, and Lack of Association with Outcome.
    Eur Urol. 2013 Sep 6. pii: S0302-2838(13)00904.
    Abstract     Related articles   

  1386. LEOW JJ , Martin-Doyle W, Rajagopal PS, Patel CG, et al
    Adjuvant Chemotherapy for Invasive Bladder Cancer: A 2013 Updated Systematic Review and Meta-Analysis of Randomized Trials.
    Eur Urol. 2013 Aug 28. pii: S0302-2838(13)00861.
    Abstract     Related articles   

  1387. SNOW-LISY DC , Campbell SC, Gill IS, Hernandez AV, et al
    Robotic and Laparoscopic Radical Cystectomy for Bladder Cancer: Long-term Oncologic Outcomes.
    Eur Urol. 2013 Aug 20. pii: S0302-2838(13)00849.
    Abstract     Related articles   

  1388. HURST CD , Platt FM, Knowles MA
    Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine.
    Eur Urol. 2013 Sep 3. pii: S0302-2838(13)00926.
    Abstract     Related articles   

  1389. THALMANN GN
    To transfuse or not to transfuse: is it really a question?
    Eur Urol. 2013;63:846-7.
    Abstract     Related articles   

  1390. LINDER BJ , Frank I, Cheville JC, Tollefson MK, et al
    The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Eur Urol. 2013;63:839-45.
    Abstract     Related articles   

  1391. BRAUSI M , Siracusano S
    Collateral activity of immunotherapy with bacillus Calmette-Guerin for the treatment of non-muscle-invasive transitional cell carcinoma of the bladder: new insights.
    Eur Urol. 2013;63:836-7.
    Abstract     Related articles   

  1392. EHDAIE B , Sylvester R, Herr HW
    Reply to Donald L. Lamm and Nilay M. Gandhi's Letter to the Editor re: Behfar Ehdaiea, Richard Sylvester, Harry W. Herr. Maintenance Bacillus Calmette-Guerin Treatment of Non-muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence. Eur U
    Eur Urol. 2013 Oct 3. pii: S0302-2838(13)01025.
    Abstract     Related articles   

  1393. LAMM DL , Gandhi NM
    Re: Behfar Ehdaie, Richard Sylvester, Harry W. Herr. Maintenance Bacillus Calmette-Guerin Treatment of Non-Muscle-invasive Bladder Cancer: A Critical Evaluation of the Evidence. Eur Urol 2013;64:579-85.
    Eur Urol. 2013 Oct 4. pii: S0302-2838(13)01026.
    Abstract     Related articles   

  1394. PLOUSSARD G , Shariat SF, Dragomir A, Kluth LA, et al
    Conditional Survival After Radical Cystectomy for Bladder Cancer: Evidence for a Patient Changing Risk Profile over Time.
    Eur Urol. 2013 Oct 9. pii: S0302-2838(13)01053.
    Abstract     Related articles   

  1395. THEODORESCU D , Cech TR
    Telomerase in Bladder Cancer: Back to a Better Future?
    Eur Urol. 2013 Oct 28. pii: S0302-2838(13)01092.
    Abstract     Related articles   

  1396. KAMAT AM , Porten S
    Myths and Mysteries Surrounding Bacillus Calmette-Guerin Therapy for Bladder Cancer.
    Eur Urol. 2013 Oct 26. pii: S0302-2838(13)01089.
    Abstract     Related articles   

  1397. COLOMBEL M, Heidenreich A, Martinez-Pineiro L, Babjuk M, et al
    Perioperative Chemotherapy in Muscle-invasive Bladder Cancer: Overview and the Unmet Clinical Need for Alternative Adjuvant Therapy as Studied in the MAGNOLIA Trial.
    Eur Urol. 2013 Nov 11. pii: S0302-2838(13)01194.
    Abstract     Related articles   

  1398. KIEMENEY LA
    Geographical and Temporal Trends in Bladder Cancer Occurrence: So What?
    Eur Urol. 2013 Dec 2. pii: S0302-2838(13)01301.
    Abstract     Related articles   

  1399. DAUGHERTY SE , Laceyjr JV, Pfeiffer RM, Park Y, et al
    Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.
    Int J Cancer. 2013 Jan 15. doi: 10.1002/ijc.28022.
    Abstract     Related articles   

  1400. ROBLES C , Viscidi R, Malats N, Silverman DT, et al
    Bladder cancer and seroreactivity to BK, JC and merkel cell polyomaviruses: The spanish bladder cancer study.
    Int J Cancer. 2013 Jan 25. doi: 10.1002/ijc.28053.
    Abstract     Related articles   

  1401. ALLEN NE , Appleby PN, Key TJ, Bueno-de-Mesquita HB, et al
    Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition.
    Int J Cancer. 2013;132:635-44.
    Abstract     Related articles   

  1402. KIM YJ , Yoon HY, Kim JS, Kang HW, et al
    HOXA9, ISL1, and ALDH1A3 methylation patterns as prognostic markers for non-muscle invasive bladder cancer: Array-based DNA methylation and expression profiling.
    Int J Cancer. 2013 Feb 22. doi: 10.1002/ijc.28121.
    Abstract     Related articles   

  1403. SACERDOTE C , Guarrera S, Ricceri F, Pardini B, et al
    Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.
    Int J Cancer. 2013 Mar 30. doi: 10.1002/ijc.28186.
    Abstract     Related articles   

  1404. HORN T , Grab J, Schusdziarra J, Schmid S, et al
    Antitumor T cell responses in bladder cancer are directed against a limited set of antigens and are modulated by regulatory T cells and routine treatment approaches.
    Int J Cancer. 2013 Apr 27. doi: 10.1002/ijc.28233.
    Abstract     Related articles   

  1405. MENGUS C , Schultz-Thater E, Coulot J, Kastelan Z, et al
    MAGE-A10 cancer/testis antigen is highly expressed in high grade non muscle invasive bladder carcinomas.
    Int J Cancer. 2012 Nov 5. doi: 10.1002/ijc.27914.
    Abstract     Related articles   

  1406. MENGUAL L , Lozano JJ, Ingelmo-Torres M, Gazquez C, et al
    Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
    Int J Cancer. 2013 May 17. doi: 10.1002/ijc.28274.
    Abstract     Related articles   

  1407. LORENZI T , Lorenzi M, Altobelli E, Marzioni D, et al
    HtrA1 in human urothelial bladder cancer: A secreted protein and a potential novel biomarker.
    Int J Cancer. 2013 May 27. doi: 10.1002/ijc.28280.
    Abstract     Related articles   

  1408. KOUTROS S , Baris D, Fischer A, Tang W, et al
    Differential urinary specific gravity as a molecular phenotype of the bladder cancer genetic association in the urea transporter gene, SLC14A1.
    Int J Cancer. 2013 Jun 10. doi: 10.1002/ijc.28325.
    Abstract     Related articles   

  1409. CATSBURG CE , Gago-Dominguez M, Yuan JM, Castelao JE, et al
    Dietary sources of N-nitroso compounds and bladder cancer risk: Findings from the Los Angeles bladder cancer study.
    Int J Cancer. 2013 Jun 18. doi: 10.1002/ijc.28331.
    Abstract     Related articles   

  1410. VAN ROEKEL EH , Cheng KK, James ND, Wallace DM, et al
    Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis.
    Int J Cancer. 2013;133:446-54.
    Abstract     Related articles   

  1411. BOWMAN KJ , Al-Moneef MM, Sherwood BT, Colquhoun AJ, et al
    Comet assay measures of DNA damage are predictive of bladder cancer cell treatment sensitivity in vitro and outcome in vivo.
    Int J Cancer. 2013 Aug 19. doi: 10.1002/ijc.28437.
    Abstract     Related articles   

  1412. BUCKLAND G , Ros MM, Roswall N, Bueno-de-Mesquita HB, et al
    Adherence to the Mediterranean diet and risk of bladder cancer in the EPIC cohort study.
    Int J Cancer. 2013 Oct 31. doi: 10.1002/ijc.28573.
    Abstract     Related articles   

  1413. TAKAGI S , Oh-Hara T, Sato S, Gong B, et al
    Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis.
    Int J Cancer. 2013 Nov 13. doi: 10.1002/ijc.28602.
    Abstract     Related articles   

  1414. YU CC , Ko FY, Yu CS, Lin CC, et al
    Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Int J Oncol. 2012;41:1050-60.
    Abstract     Related articles   

  1415. LIN C , Tsai SC, Tseng MT, Peng SF, et al
    AKT serine/threonine protein kinase modulates baicalin-triggered autophagy in human bladder cancer T24 cells.
    Int J Oncol. 2013;42:993-1000.
    Abstract     Related articles   

  1416. ZHU Z , Zhu Z, Pang Z, Xing Y, et al
    Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
    Int J Oncol. 2013 Feb 5. doi: 10.3892/ijo.2013.1807.
    Abstract     Related articles   

  1417. DU P , Ye L, Yang Y, Jiang WG, et al
    Candidate of metastasis 1 regulates in vitro growth and invasion of bladder cancer cells.
    Int J Oncol. 2013;42:1249-56.
    Abstract     Related articles   

  1418. SHINNOH M , Horinaka M, Yasuda T, Yoshikawa S, et al
    Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8.
    Int J Oncol. 2013;42:903-11.
    Abstract     Related articles   

  1419. AZUMA H , Inamoto T, Takahara K, Nomi H, et al
    A great option for elderly patients with locally invasive bladder cancer, BOAI-CDDP-radiation (OMC regimen).
    Int J Oncol. 2013;43:1087-94.
    Abstract     Related articles   

  1420. BIAN J , Li B, Zeng X, Hu H, et al
    Mutation of TGF-beta receptor II facilitates human bladder cancer progression through altered TGF-beta1 signaling pathway.
    Int J Oncol. 2013 Aug 20. doi: 10.3892/ijo.2013.2065.
    Abstract     Related articles   

  1421. HONG SH , Kim GY, Chang YC, Moon SK, et al
    Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions.
    Int J Oncol. 2013;42:277-86.
    Abstract     Related articles   

  1422. GUAN Z, Ding C, Du Y, Zhang K, et al
    HAF drives the switch of HIF-1alpha to HIF-2alpha by activating the NF-kappaB pathway, leading to malignant behavior of T24 bladder cancer cells.
    Int J Oncol. 2013 Dec 6. doi: 10.3892/ijo.2013.2210.
    Abstract     Related articles   

  1423. CHIBA S, Tsuchiya N, Horikawa Y, Narita S, et al
    Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer.
    Int J Oncol. 2013 Dec 20. doi: 10.3892/ijo.2013.2221.
    Abstract     Related articles   

  1424. HITIER-BERTHAULT M , Ansquer C, Branchereau J, Renaudin K, et al
    (18) F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study.
    Int J Urol. 2012 Dec 20. doi: 10.1111/iju.12045.
    Abstract     Related articles   

  1425. LODDE M
    Editorial Comment to (18) F-fluorodeoxyglucose positron emission tomography-computed tomography for preoperative lymph node staging in patients undergoing radical cystectomy for bladder cancer: A prospective study.
    Int J Urol. 2013 Jan 17. doi: 10.1111/iju.12087.
    Abstract     Related articles   

  1426. ABT D , Bywater M, Engeler DS, Schmid HP, et al
    Therapeutic options for intractable hematuria in advanced bladder cancer.
    Int J Urol. 2013 Feb 6. doi: 10.1111/iju.12113.
    Abstract     Related articles   

  1427. SEJIMA T , Morizane S, Yao A, Isoyama T, et al
    Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy.
    Int J Urol. 2013 May 27. doi: 10.1111/iju.12161.
    Abstract     Related articles   

  1428. GAKIS G
    Editorial Comment to CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder.
    Int J Urol. 2013;20:256-7.
    Abstract     Related articles   

  1429. CHOI JW , Kim Y, Lee JH, Kim YS, et al
    CD74 expression is increased in high-grade, invasive urothelial carcinoma of the bladder.
    Int J Urol. 2013;20:251-5.
    Abstract     Related articles   

  1430. SAITO K , Kihara K
    Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Int J Urol. 2013;20:161-71.
    Abstract     Related articles   

  1431. OHYAMA C , Hatakeyama S, Yoneyama T, Koie T, et al
    Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.
    Int J Urol. 2013 Aug 22. doi: 10.1111/iju.12230.
    Abstract     Related articles   

  1432. YU CC , Lee FY, Li JR
    Recurrent pseudotumor of the urinary bladder managed by revision hip arthroplasty.
    Int J Urol. 2013;20:455-6.
    Abstract     Related articles   

  1433. KITAMURA H
    Editorial comment to stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Int J Urol. 2013;20:398.
    Abstract     Related articles   

  1434. GRECO KA , Flanigan RC, Quek ML
    Acute acalculous cholecystitis after radical cystectomy: a report of two cases.
    Int J Urol. 2013;20:453-4.
    Abstract     Related articles   

  1435. SIMONE G , Papalia R, Ferriero M, Guaglianone S, et al
    Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Int J Urol. 2013;20:390-7.
    Abstract     Related articles   

  1436. VEENBOER PW , de Kort LM
    Bladder carcinoma in a 31-year-old female spina bifida patient with an auto-augmented bladder.
    Int Urol Nephrol. 2012;44:1027-30.
    Abstract     Related articles   

  1437. DINCEL C , Kara C, Balci U, Ozer K, et al
    Comparison of microscopic (pT3a) and gross extravesical extension (pT3b) in pathological staging of bladder cancer: analysis of patient outcomes.
    Int Urol Nephrol. 2013.
    Abstract     Related articles   

  1438. PICOZZI SC , Ricci C, Gaeta M, Casellato S, et al
    Is it oncologically safe performing simultaneous transurethral resection of the bladder and prostate? A meta-analysis on 1,234 patients.
    Int Urol Nephrol. 2012;44:1325-33.
    Abstract     Related articles   

  1439. LIU R , Tian Z, Wang J, Zhang Z, et al
    Evaluation of acridine orange fluorescence in exfoliative urinary cytology for diagnosing bladder carcinoma.
    Int Urol Nephrol. 2012;44:1375-82.
    Abstract     Related articles   

  1440. BRUNOCILLA E , Pernetti R, Schiavina R, Borghesi M, et al
    The number of nodes removed as well as the template of the dissection is independently correlated to cancer-specific survival after radical cystectomy for muscle-invasive bladder cancer.
    Int Urol Nephrol. 2013.
    Abstract     Related articles   

  1441. XIE HY , Zhu Y, Yao XD, Zhang SL, et al
    Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy.
    Int Urol Nephrol. 2012;44:1711-9.
    Abstract     Related articles   

  1442. ALSINNAWI M , Loftus B, Flynn R, McDermott T, et al
    The incidence and relevance of prostate cancer in radical cystoprostatectomy specimens.
    Int Urol Nephrol. 2012;44:1705-10.
    Abstract     Related articles   

  1443. WEISBACH L , Dahlem R, Simone G, Hansen J, et al
    Lymph node dissection during radical cystectomy for bladder cancer treatment: considerations on relevance and extent.
    Int Urol Nephrol. 2013.
    Abstract     Related articles   

  1444. MORIZANE S , Iwamoto H, Masago T, Yao A, et al
    Preoperative prognostic factors after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Int Urol Nephrol. 2013;45:99-106.
    Abstract     Related articles   

  1445. ZHANG H , Jiang H, Wu Z, Fang Z, et al
    Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases.
    Int Urol Nephrol. 2013;45:107-11.
    Abstract     Related articles   

  1446. LIU JY , Zhang Q, Ye YL, Li J, et al
    Prognostic significance of tumor location and superficial urothelial bladder carcinoma history in patients with ureteral urothelial carcinoma treated with radical nephroureterectomy.
    Int Urol Nephrol. 2013;45:395-404.
    Abstract     Related articles   

  1447. GKRITSIOS P , Hatzimouratidis K, Kazantzidis S, Dimitriadis G, et al
    Hexaminolevulinate-guided transurethral resection of non-muscle-invasive bladder cancer does not reduce the recurrence rates after a 2-year follow-up: a prospective randomized trial.
    Int Urol Nephrol. 2013.
    Abstract     Related articles   

  1448. PARK DS, Gong IH, Choi DK, Hwang JH, et al
    A feasibility study of peritoneum preservation in radical cystectomy with extraperitonealization of orthotopic neobladder for invasive high-grade bladder cancer: a preliminary analysis.
    Int Urol Nephrol. 2013.
    Abstract     Related articles   

  1449. CULINE S
    Cetuximab in Advanced Bladder Cancer.
    J Clin Oncol. 2013.
    Abstract     Related articles   

  1450. VOGELZANG NJ
    Antiangiogenic agents, chemotherapy, and the treatment of metastatic transitional cell carcinoma.
    J Clin Oncol. 2013;31:670-5.
    Abstract     Related articles   

  1451. ITO A , Shintaku I, Satoh M, Ioritani N, et al
    Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group Trial
    J Clin Oncol. 2013;31:1422-7.
    Abstract     Related articles   

  1452. WONG YN , Plimack ER, Litwin S, Vaughn D, et al
    Reply to S. Buti and S. Culine.
    J Clin Oncol. 2013;31:1615-6.
    Abstract     Related articles   

  1453. BUTI S
    Does the cetuximab plus paclitaxel combination deserve to be studied in a phase III trial?
    J Clin Oncol. 2013;31:1613-4.
    Abstract     Related articles   

  1454. IYER G , Al-Ahmadie H, Schultz N, Hanrahan AJ, et al
    Prevalence and Co-Occurrence of Actionable Genomic Alterations in High-Grade Bladder Cancer.
    J Clin Oncol. 2013.
    Abstract     Related articles   

  1455. LUCIONI M , Nicola M, Riboni R, Croci GA, et al
    Antibiotic Therapy-Induced Remission of Bladder Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma Carrying t(11;18)(q21;q21) Apoptosis Inhibitor 2-MALT1.
    J Clin Oncol. 2013.
    Abstract     Related articles   

  1456. DIP N , Reis ST, Timoszczuk LS, Viana NI, et al
    Stage, grade and behavior of bladder urothelial carcinoma defined by the microRNA expression profile.
    J Urol. 2012;188:1951-6.
    Abstract     Related articles   

  1457. ZAREI S , Frank I, Boorjian SA, Thompson RH, et al
    Prognostic significance of measured depth of invasion of urothelial carcinoma of the bladder compared to the 2010 American Joint Committee on Cancer pT2 and pT3 classifications.
    J Urol. 2012;188:1706-11.
    Abstract     Related articles   

  1458. KOWALSKI M , Guindon J, Brazas L, Moore C, et al
    A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guerin.
    J Urol. 2012;188:1712-8.
    Abstract     Related articles   

  1459. URQUIDI V , Goodison S, Rosser CJ
    Diagnostic Potential of Urinary <alpha>1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer.
    J Urol. 2013 Jan 12. pii: S0022-5347(13)00051-7. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1460. DIZDAR O , Rahatli S, Ozcan MF
    Diagnostic Potential of Urinary <alpha>1-Antitrypsin and Apolipoprotein E in the Detection of Bladder Cancer.
    J Urol. 2013 Jan 12. pii: S0022-5347(13)00052-9. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1461. BOORJIAN SA , Kim SP, Tollefson MK, Carrasco A, et al
    Comparative Performance of Comorbidity Indices for Estimating Perioperative and 5-Year All-Cause Mortality Following Radical Cystectomy for Bladder Cancer.
    J Urol. 2013 Jan 9. pii: S0022-5347(13)00026-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1462. LEE S , Yoon CY, Byun SS, Lee E, et al
    The role of cellular FLICE-inhibitory protein (c-FLIP) in cisplatin resistance of human bladder cancer cells.
    J Urol. 2013 Jan 9. pii: S0022-5347(13)00015-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1463. WOOD DP
    Re: Extracapsular Extension But Not the Tumour Burden of Lymph Node Metastases is an Independent Adverse Risk Factor in Lymph Node-Positive Bladder Cancer.
    J Urol. 2013;189:484.
    Abstract     Related articles   

  1464. WOOD DP
    Re: Intracutaneous and Intravesical Immunotherapy with Keyhole Limpet Hemocyanin Compared with Intravesical Mitomycin in Patients with Non-Muscle-Invasive Bladder Cancer: Results from a Prospective Randomized Phase III Trial.
    J Urol. 2013;189:483-4.
    Abstract     Related articles   

  1465. SENGIKU A , Ito M, Miyazaki Y, Sawazaki H, et al
    A prospective comparative study of intravesical Bacillus Calmette-Guerin therapy with the Tokyo or Connaught strains for non-muscle invasive bladder cancer.
    J Urol. 2013 Jan 30. pii: S0022-5347(13)00224-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1466. WOOD DP
    Re: interobserver variability limits exact preoperative staging by computed tomography in bladder cancer.
    J Urol. 2013;189:843-4.
    Abstract     Related articles   

  1467. WOOD DP
    Diagnostic Efficacy of ([11C])Choline Positron Emission Tomography/Computed Tomography Compared with Conventional Computed Tomography in Lymph Node Staging of Patients with Bladder Cancer prior to Radical Cystectomy.
    J Urol. 2013;189:843.
    Abstract     Related articles   

  1468. MANDAL S , Goel A
    Re: Gender and body mass index as risk factors for bladder perforation during primary transurethral resection of bladder tumors: K. Herkommer, C. Hofer, J. E. Gschwend, M. Kron and U. Treiber J Urol 2012; 187: 1566-1570.
    J Urol. 2013;189:389.
    Abstract     Related articles   


  1469. Reply by authors.
    J Urol. 2013;189:389-90.
    Abstract     Related articles   

  1470. YANG HY , Wang JD, Lo TC, Chen PC, et al
    Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.
    J Urol. 2013;189:48-52.
    Abstract     Related articles   

  1471. PATEL AR , Cohn JA, Abd El Latif A, Miocinovic R, et al
    Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.
    J Urol. 2013;189:53-8.
    Abstract     Related articles   

  1472. LANDRIGAN PJ
    Editorial comment.
    J Urol. 2013;189:52.
    Abstract     Related articles   

  1473. GORIN MA , Sagalowsky AI, Soloway MS
    Re: Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients.
    J Urol. 2013 Feb 11. pii: S0022-5347(13)00274-7. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1474. PICOZZI S , Ricci C, Carmignani L
    Reply to Michael A. Gorin, Arthur I. Sagalowsky and Mark S. Soloway's Letter to the Editor re: S. Picozzi, C. Ricci, M. Gaeta et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J
    J Urol. 2013 Feb 11. pii: S0022-5347(13)00273-5. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1475. GARCIA-BAQUERO R , Puerta P, Beltran M, Alvarez M, et al
    Methylation of a Novel Panel of Tumor Suppressor Genes in Urine Moves Forward Non-Invasive Diagnosis and Prognosis in Bladder Cancer: A Two Center Prospective Study.
    J Urol. 2013 Feb 25. pii: S0022-5347(13)00346-7. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1476. JOHNSON B , Abouassaly R, Ghiculete D, Stewart RJ, et al
    Evaluating the Effectiveness of a Smoking Warning Label on Raising Patient Awareness of Smoking and Bladder Cancer.
    J Urol. 2013 Mar 6. pii: S0022-5347(13)03526-X. doi: 10.1016/j.juro.2013.02.3196
    Abstract     Related articles   

  1477. DINNEY CP , Fisher MB, Navai N, O'Donnell MA, et al
    Phase I Trial of Intravesical Recombinant Adenovirus-Mediated Interferon-alpha2b Formulated in Syn3 for BCG failures in Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2013 Mar 15. pii: S0022-5347(13)03676-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1478. JAGER W , Horiguchi Y, Shah J, Hayashi T, et al
    Hiding in plain view: Genetic profiling reveals decades old cross-contamination of bladder cancer cell line KU7 with HeLa.
    J Urol. 2013 Mar 7. pii: S0022-5347(13)03643-4. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1479. GONTERO P , Oderda M, Mehnert A, Gurioli A, et al
    The impact of intravesical Gemcitabine and 1/3 dose Bacillus Calmette Guerin instillation therapy on the quality of life in non-muscle-invasive bladder cancer patients: results of a prospective, randomised phase II trial.
    J Urol. 2013 Mar 29. pii: S0022-5347(13)03890-1. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1480. WOOD DP
    Re: Loss of the Urothelial Differentiation Marker FOXA1 is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation.
    J Urol. 2013;189:1597.
    Abstract     Related articles   

  1481. ANTHONY A
    Re: potential role of hsp90 inhibitors in overcoming Cisplatin resistance of bladder cancer-initiating cells.
    J Urol. 2013;189:1596.
    Abstract     Related articles   

  1482. ATALA A
    Re: cancer stem-like cells contribute to Cisplatin resistance and progression in bladder cancer.
    J Urol. 2013;189:1595-6.
    Abstract     Related articles   

  1483. WOOD DP
    Re: metabolomics study on the biochemical profiles of odor elements in urine of human with bladder cancer.
    J Urol. 2013;189:1288.
    Abstract     Related articles   

  1484. WOOD DP
    Re: a phase 2 cancer chemoprevention biomarker trial of isoflavone g-2535 (genistein) in presurgical bladder cancer patients.
    J Urol. 2013;189:1287-8.
    Abstract     Related articles   

  1485. MANO R , Shoshany O, Baniel J, Yossepowitch O, et al
    Resection of ureteral orifice during transurethral resection of bladder tumor: functional and oncologic implications.
    J Urol. 2012;188:2129-33.
    Abstract     Related articles   

  1486. MORGAN TM , Barocas DA, Keegan KA, Cookson MS, et al
    Volume outcomes of cystectomy--is it the surgeon or the setting?
    J Urol. 2012;188:2139-44.
    Abstract     Related articles   

  1487. OLUMI AF
    Editorial comment.
    J Urol. 2012;188:2107.
    Abstract     Related articles   

  1488. MORGAN TM
    Editorial comment.
    J Urol. 2012;188:2127-8.
    Abstract     Related articles   

  1489. JACOBS BL , Miller DC
    The volume outcome relationship in urology: moving the field forward.
    J Urol. 2012;188:2037-8.
    Abstract     Related articles   

  1490. SKINNER EC , Goldman B, Sakr WA, Petrylak DP, et al
    SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Non-Muscle Invasive Bladder Cancer Who Recurred Following at Least Two Prior Courses of Intravesical BCG.
    J Urol. 2013 Apr 15. pii: S0022-5347(13)04077-9. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1491. ZHOU HL , Zheng YJ, Cheng XZ, Lv YS, et al
    Intercellular transfer of P-glycoprotein from the drug-resistant human bladder cancer cell line BIU-87 does not require cell-to-cell contact.
    J Urol. 2013 Apr 22. pii: S0022-5347(13)04105-0. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1492. LEE JY , Diaz RR, Cho KS, Lim MS, et al
    Efficacy and safety of photodynamic therapy in recurrent high-grade non-muscle-invasive bladder cancer refractory or intolerant to bacille Calmette-Guerin immunotherapy.
    J Urol. 2013 May 3. pii: S0022-5347(13)04262-6. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1493. WANG Q , Luo C, Wu X, Du H, et al
    HepaCAM and p-mTOR are closely correlated in transitional cell carcinoma of bladder and expression of hepaCAM inhibits proliferation via an AMPK/mTOR-dependent pathway in human bladder cancer cells.
    J Urol. 2013 May 10. pii: S0022-5347(13)04348-6. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1494. STERNBERG IA , Dalbagni G, Chen LY, Donat SM, et al
    Intravesical gemcitabine for high-risk non-muscle-invasive bladder cancer after bacillus Calmette-Guerin treatment failure.
    J Urol. 2013 May 7. pii: S0022-5347(13)04309-7. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1495. WOOD DP
    Re: association of polymorphisms in oxidative stress genes with clinical outcomes for bladder cancer treated with bacillus calmette-guerin.
    J Urol. 2013;189:2091.
    Abstract     Related articles   

  1496. STERNBERG IA , Paz GE, Chen LY, Herr HW, et al
    Upper tract imaging surveillance is not effective in diagnosing upper tract recurrences in patients followed for non-muscle-invasive bladder cancer.
    J Urol. 2013 May 13. pii: S0022-5347(13)04356-5. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1497. LINDER BJ , Boorjian SA, Cheville JC, Sukov WR, et al
    The Impact Of Histologic Reclassification During Pathology Re-Review: Evidence Of A Will Rogers Effect In Bladder Cancer?
    J Urol. 2013 May 23. pii: S0022-5347(13)04381-4. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1498. STROPE SA , Chang SH, Chen L, Sandhu G, et al
    Survival Impact of Follow-up Care after Radical Cystectomy for Bladder Cancer.
    J Urol. 2013 May 29. pii: S0022-5347(13)04416-9. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1499. CHEN F , Zhang G, Cao Y, Wakim B, et al
    A synthetic polyvalent ligand for alpha5beta1 integrin activates components of the urothelial carcinoma cell response to bacillus Calmette-Guerin.
    J Urol. 2013;189:1104-9.
    Abstract     Related articles   

  1500. EISENBERG MS , Boorjian SA, Cheville JC, Thompson RH, et al
    The SPARC (Survival Prediction After Radical Cystectomy) Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer.
    J Urol. 2013 Jun 13. pii: S0022-5347(13)04610-7. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1501. ROSSER CJ , Ross S, Chang M, Dai Y, et al
    Multiplex Protein Signature for the Detection of Bladder Cancer in Voided Urine Samples.
    J Urol. 2013 Jun 10. pii: S0022-5347(13)04581-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1502. HANSEL DE
    Editorial comment.
    J Urol. 2013;189:1660-1.
    Abstract     Related articles   

  1503. AHMADI H , Skinner EC, Simma-Chiang V, Miranda G, et al
    Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients.
    J Urol. 2013;189:1782-8.
    Abstract     Related articles   

  1504. DAYYANI F , Czerniak BA, Sircar K, Munsell MF, et al
    Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.
    J Urol. 2013;189:1656-61.
    Abstract     Related articles   

  1505. LINDER BJ , Frank I, Cheville JC, Thompson RH, et al
    Outcomes following radical cystectomy for nested variant of urothelial carcinoma: a matched cohort analysis.
    J Urol. 2013;189:1670-5.
    Abstract     Related articles   

  1506. BAROCAS DA , Liu A, Burks FN, Suh RS, et al
    Practice-based collaboration to improve the use of immediate intravesical therapy after resection for non-muscle-invasive bladder cancer.
    J Urol. 2013 Jun 17. pii: S0022-5347(13)04620-X. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1507. LOTAN Y
    The Challenge of Bacillus Calmette-Guerin Failure in Nonmuscle Invasive Bladder Cancer-What is the Next Step in Management?
    J Urol. 2013 Jun 17. pii: S0022-5347(13)04627-2. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1508. HOFNER T , Macher-Goeppinger S, Klein C, Rigo-Watermeier T, et al
    Development and characteristics of preclinical experimental models for the research of rare neuroendocrine bladder cancer.
    J Urol. 2013 Jun 29. pii: S0022-5347(13)04670-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1509. STEERS WD
    Upper Tract Imaging Surveillance for Nonmuscle Invasive Bladder Cancer recurrence.
    J Urol. 2013 Jul 8. pii: S0022-5347(13)04863-5. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1510. ATALA A
    Re: NMR-Based Metabolomics Study of Canine Bladder Cancer.
    J Urol. 2013;190:808.
    Abstract     Related articles   

  1511. WOOD DP
    Re: Long-Term Results of Two Prospective Bladder-Sparing Trimodality Approaches for Invasive Bladder Cancer: Neoadjuvant Chemotherapy and Concurrent Radio-Chemotherapy.
    J Urol. 2013;190:495.
    Abstract     Related articles   

  1512. MENGUAL L , Ribal MJ, Lozano JJ, Ingelmo-Torres M, et al
    Validation study of a non-invasive urine test for diagnosis and prognosis assessment of bladder cancer. Evidence for improved models.
    J Urol. 2013 Jul 2. pii: S0022-5347(13)04825-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1513. HUMPHREY PA
    Sarcomatoid carcinoma of the bladder.
    J Urol. 2013;189:1534-5.
    Abstract     Related articles   


  1514. Reply by authors.
    J Urol. 2013;189:774.
    Abstract     Related articles   

  1515. JOHNSON MH , Nepple KG, Peck V, Trinkaus K, et al
    Randomized controlled trial of oxybutynin extended release versus placebo for urinary symptoms during intravesical Bacillus Calmette-Guerin treatment.
    J Urol. 2013;189:1268-74.
    Abstract     Related articles   

  1516. NAKAGAWA T , Hara T, Kawahara T, Ogata Y, et al
    Prognostic risk stratification of patients with urothelial carcinoma of the bladder with recurrence after radical cystectomy.
    J Urol. 2013;189:1275-81.
    Abstract     Related articles   

  1517. MEEKS JJ , Herr HW, Bernstein M, Al-Ahmadie HA, et al
    Preoperative accuracy of diagnostic evaluation of the urachal mass.
    J Urol. 2013;189:1260-2.
    Abstract     Related articles   

  1518. GREEN DA , Rink M, Xylinas E, Matin SF, et al
    Urothelial carcinoma of the bladder and the upper tract: disparate twins.
    J Urol. 2013;189:1214-21.
    Abstract     Related articles   

  1519. PAREKH DJ , Messer J, Fitzgerald J, Ercole B, et al
    Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy.
    J Urol. 2013;189:474-9.
    Abstract     Related articles   

  1520. THACHIL J
    Re: half of visible and half of recurrent visible hematuria cases have underlying pathology: prospective large cohort study with long-term followup: S. F. Mishriki, R. Vint and B. K. Somani J Urol 2012;187:1561-1565.
    J Urol. 2013;189:773-4.
    Abstract     Related articles   

  1521. SECANELLA-FANDOS S , Luquin M, Julian E
    Connaught and Russian strains showed the highest direct antitumor effects of different Bacillus Calmette-Guerin substrains.
    J Urol. 2013;189:711-8.
    Abstract     Related articles   


  1522. Reply by authors.
    J Urol. 2013;189:2394-5.
    Abstract     Related articles   

  1523. LIU X , Ji J, Forsti A, Sundquist K, et al
    Autoimmune disease and subsequent urological cancer.
    J Urol. 2013;189:2262-8.
    Abstract     Related articles   

  1524. HERTZIG LL , Iwaszko MR, Rangel LJ, Patterson DE, et al
    Urolithiasis after ileal conduit urinary diversion: a comparison of minimally invasive therapies.
    J Urol. 2013;189:2152-7.
    Abstract     Related articles   

  1525. KRYVENKO ON , Epstein JI
    Pseudocarcinomatous urothelial hyperplasia of the bladder: clinical findings and followup of 70 patients.
    J Urol. 2013;189:2083-6.
    Abstract     Related articles   

  1526. ROUPRET M , Seisen T, Comperat E, Larre S, et al
    Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    J Urol. 2013;189:2069-76.
    Abstract     Related articles   

  1527. MOHAMED NE , Chaoprang Herrera P, Hudson S, Revenson TA, et al
    Muscle invasive bladder cancer: Examining survivors' burden and unmet needs.
    J Urol. 2013 Jul 30. pii: S0022-5347(13)05011-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1528. GRIEBLING T
    Re: evaluation of acute toxicity and symptoms palliation in a hypofractionated weekly schedule of external radiotherapy for elderly patients with muscular invasive bladder cancer.
    J Urol. 2013;190:865-6.
    Abstract     Related articles   

  1529. KARL A , Buchner A, Becker A, Staehler M, et al
    A new concept for Early Recovery After Surgery in patients undergoing radical cystectomy for bladder cancer - results of a prospective randomized study.
    J Urol. 2013 Aug 19. pii: S0022-5347(13)05139-2. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   


  1530. Reply by authors.
    J Urol. 2013;190:361-2.
    Abstract     Related articles   

  1531. WITJES JA
    Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? Yes.
    J Urol. 2013;190:19-20.
    Abstract     Related articles   

  1532. O'BRIEN T
    Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? No (a difficult task).
    J Urol. 2013;190:20-1.
    Abstract     Related articles   

  1533. SCHAFAUER C , Ettori D, Roupret M, Phe V, et al
    Detection of bladder urothelial carcinoma using in vivo noncontact, ultraviolet excited autofluorescence measurements converted into simple color coded images: a feasibility study.
    J Urol. 2013;190:271-7.
    Abstract     Related articles   

  1534. BEUKERS W , Hercegovac A, Vermeij M, Kandimalla R, et al
    Hypermethylation of the polycomb group target gene PCDH7 in bladder tumors from patients of all ages.
    J Urol. 2013;190:311-6.
    Abstract     Related articles   

  1535. OKUYAMA H , Yoshida T, Endo H, Nakayama M, et al
    Involvement of heregulin/HER3 in the primary culture of human urothelial cancer.
    J Urol. 2013;190:302-10.
    Abstract     Related articles   

  1536. LAMM D , Persad R, Brausi M, Buckley R, et al
    Defining Progression in Non-Muscle Invasive Bladder Cancer (NMIBC): It's Time for a New, Standard Definition.
    J Urol. 2013 Aug 22. pii: S0022-5347(13)05149-5. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1537. SFAKIANOS JP , Kim PH, Hakimi AA, Herr HW, et al
    The effect of restaging transurethral resection on recurrence and progression rates in patients with non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin.
    J Urol. 2013 Aug 20. pii: S0022-5347(13)05142-2. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1538. MINANA B , Cozar JM, Palou J, Unda Urzaiz M, et al
    Bladder Cancer in Spain 2011. A Population-Based Study.
    J Urol. 2013 Aug 28. pii: S0022-5347(13)05276-2. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1539. ATALA A
    Re: Downregulation of Ral GTPase-Activating Protein Promotes Tumor Invasion and Metastasis of Bladder Cancer.
    J Urol. 2013;190:1437.
    Abstract     Related articles   

  1540. FOREMAN KE , Jesse JN 3rd, Kuo PC, Gupta GN, et al
    Emetine Dihydrochloride: A Novel Therapy for Bladder Cancer.
    J Urol. 2013 Sep 14. pii: S0022-5347(13)05443-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1541. WOOD DP
    Re: inhibition of bladder cancer by broccoli isothiocyanates sulforaphane and erucin: characterization, metabolism, and interconversion.
    J Urol. 2013;190:1956.
    Abstract     Related articles   

  1542. SCHAEFFER EM
    Re: outpatient urological procedures in antibiotic-naive patients with bladder cancer with asymptomatic bacteriuria.
    J Urol. 2013;190:1776-7.
    Abstract     Related articles   

  1543. WOOD DP
    Re: combination of molecular alterations and smoking intensity predicts bladder cancer outcome: a report from the los angeles cancer surveillance program.
    J Urol. 2013;190:1714.
    Abstract     Related articles   

  1544. WOOD DP
    Re: Prospective Evaluation of MRI, (11)C-Acetate PET/CT and Contrast-Enhanced CT for Staging of Bladder Cancer.
    J Urol. 2013;190:1713-4.
    Abstract     Related articles   

  1545. KLATTE T , Shariat SF
    Novel Urinary Markers for Detection of Bladder Cancer: Why Are We Failing?
    J Urol. 2013 Oct 16. pii: S0022-5347(13)05665-6. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1546. BENNER C , Greenberg M, Shepard N, Meng MV, et al
    The Natural History of Symptoms and Distress for Patients and Families following Cystectomy for Treatment of Muscle-Invasive Bladder Cancer.
    J Urol. 2013 Oct 29. pii: S0022-5347(13)05840-0. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1547. HEMDAN T , Johansson R, Jahnson S, Hellstrom P, et al
    Five year outcome of a randomized prospective study comparing bacillus Calmette-Guerin with epirubicin and interferon alpha 2b in patients with T1 bladder cancer.
    J Urol. 2013 Nov 11. pii: S0022-5347(13)05899-0. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1548. STEERS WD
    Early Recovery after Radical Cystectomy for Bladder Cancer.
    J Urol. 2013 Nov 11. pii: S0022-5347(13)05902-8. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1549. ATALA A
    Re: Long Non-Coding RNA H19 Increases Bladder Cancer Metastasis by Associating with EZH2 and Inhibiting E-Cadherin Expression.
    J Urol. 2013;190:2306.
    Abstract     Related articles   


  1550. Reply by authors.
    J Urol. 2013;190:812.
    Abstract     Related articles   

  1551. KIRKALI Z
    Can we change patient behaviors to improve urological health?
    J Urol. 2013;190:383-4.
    Abstract     Related articles   

  1552. ROGHMANN F , Ravi P, Sun M, Noldus J, et al
    Re: perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy: D. J. Parekh, J. Messer, J. Fitzgerald. B. Ercole and R. Svatek J Urol 2013; 189: 474-479.
    J Urol. 2013;190:811-2.
    Abstract     Related articles   

  1553. DA SILVA RD , Xylinas E, Kluth L, Crivelli JJ, et al
    Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
    J Urol. 2013;190:487-92.
    Abstract     Related articles   

  1554. KLUTH LA , Xylinas E, Crivelli JJ, Passoni N, et al
    Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
    J Urol. 2013;190:480-6.
    Abstract     Related articles   

  1555. FRANCOIS A , Salvadori A, Bressenot A, Bezdetnaya L, et al
    How to avoid local side effects of bladder photodynamic therapy: impact of the fluence rate.
    J Urol. 2013;190:731-6.
    Abstract     Related articles   

  1556. GOSALBEZ M, Hupe MC, Lokeshwar SD, Yates TJ, et al
    Differential Expression Of Stroma Derived Factor-1 Isoforms In Bladder Cancer.
    J Urol. 2013 Nov 26. pii: S0022-5347(13)06007-2. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1557. MERTENS LS, Meijer RP, de Vries RR, Nieuwenhuijzen JA, et al
    Prostate Sparing Cystectomy for Bladder Cancer: 20 Years Single Center Experience.
    J Urol. 2013 Nov 25. pii: S0022-5347(13)05984-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1558. GOFRIT ON, Benjamin S, Halachmi S, Leibovitch I, et al
    DNA Based Therapy with DTA-BC-819: A Phase 2b "Marker Lesion" Trial in Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer.
    J Urol. 2013 Dec 13. pii: S0022-5347(13)06105-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1559. KLATTE T, Xylinas E, Rieken M, Kluth LA, et al
    Impact of ABO blood type on outcomes of patients with primary non-muscle-invasive bladder cancer.
    J Urol. 2013 Dec 10. pii: S0022-5347(13)06081-3. doi: 10.1016/j.juro.2013.
    Abstract     Related articles   

  1560. KAPLAN SA
    Re: Benign Prostatic Hyperplasia is a Significant Risk Factor for Bladder Cancer in Diabetic Patients: A Population-Based Cohort Study Using the National Health Insurance in Taiwan.
    J Urol. 2014;191:58-9.
    Abstract     Related articles   

  1561. WOOD DP
    Re: Standardized analysis of frequency and severity of complications after robot-assisted radical cystectomy.
    J Urol. 2013;190:1206.
    Abstract     Related articles   

  1562. GHOSH PM
    Editorial comment.
    J Urol. 2013;190:1697.
    Abstract     Related articles   


  1563. Reply by authors.
    J Urol. 2013;190:1697.
    Abstract     Related articles   

  1564. ATALA A
    Re: PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.
    J Urol. 2013;190:1131.
    Abstract     Related articles   

  1565. PENSON DF
    Re: Nurse-led flexible cystoscopy in Australia: initial experience and early results.
    J Urol. 2013;190:977-8.
    Abstract     Related articles   

  1566. ERICKSON BA
    What is the role of cost-effectiveness analysis in clinical practice?
    J Urol. 2013;190:1163-4.
    Abstract     Related articles   

  1567. TSUI JF, Weinberger JM, Kashan M, Weiss JP, et al
    Bladder lipoma.
    J Urol. 2013;190:1387-8.
    Abstract     Related articles   

  1568. DANESHMAND S
    Editorial comment.
    J Urol. 2013;190:927.
    Abstract     Related articles   

  1569. STROPE SA
    Editorial comment.
    J Urol. 2013;190:922.
    Abstract     Related articles   

  1570. BRUINS HM, Djaladat H, Ahmadi H, Sherrod A, et al
    Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1,476 radical cystoprostatectomy specimens.
    J Urol. 2013;190:1704-9.
    Abstract     Related articles   

  1571. GAYED BA, Seideman C, Lotan Y
    Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma.
    J Urol. 2013;190:1181-6.
    Abstract     Related articles   

  1572. XU K, Liu CX, Zheng SB, Li HL, et al
    Orthotopic detaenial sigmoid neobladder after radical cystectomy: technical considerations, complications and functional outcomes.
    J Urol. 2013;190:928-34.
    Abstract     Related articles   

  1573. GILBERT SM, Lai J, Saigal CS, Gore JL, et al
    Downstream complications following urinary diversion.
    J Urol. 2013;190:916-22.
    Abstract     Related articles   

  1574. LARGE MC, Cohn JA, Kiriluk KJ, Dangle P, et al
    The impact of running versus interrupted anastomosis on ureterointestinal stricture rate after radical cystectomy.
    J Urol. 2013;190:923-7.
    Abstract     Related articles   

  1575. ZHANG G, Chen F, Cao Y, Amos JV, et al
    HMGB1 release by urothelial carcinoma cells in response to Bacillus Calmette-Guerin functions as a paracrine factor to potentiate the direct cellular effects of Bacillus Calmette-Guerin.
    J Urol. 2013;190:1076-82.
    Abstract     Related articles   

  1576. YU L , Yuan X, Wang D, Barakat B, et al
    Selective regulation of p38beta protein and signaling by integrin-linked kinase mediates bladder cancer cell migration.
    Oncogene. 2013 Feb 25. doi: 10.1038/onc.2013.
    Abstract     Related articles   

  1577. ROSS RL , Askham JM, Knowles MA
    PIK3CA mutation spectrum in urothelial carcinoma reflects cell context-dependent signaling and phenotypic outputs.
    Oncogene. 2013;32:768-76.
    Abstract     Related articles   

  1578. CHELL V , Balmanno K, Little AS, Wilson M, et al
    Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.
    Oncogene. 2013;32:3059-70.
    Abstract     Related articles   

  1579. SU SF , Chang YW, Andreu-Vieyra C, Fang JY, et al
    miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.
    Oncogene. 2013;32:4694-701.
    Abstract     Related articles   

  1580. KAUFFMAN EC , Robinson BD, Downes M, Marcinkiewicz K, et al
    Estrogen receptor-beta expression and pharmacological targeting in bladder cancer.
    Oncol Rep. 2013 Apr 23. doi: 10.3892/or.2013.2416.
    Abstract     Related articles   

  1581. ZARAVINOS A , Volanis D, Lambrou GI, Delakas D, et al
    Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder.
    Oncol Rep. 2012;28:1159-66.
    Abstract     Related articles   

  1582. YOSHII H , Ito K, Asano T, Horiguchi A, et al
    Increased expression of alpha-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer.
    Oncol Rep. 2013 Jul 1. doi: 10.3892/or.2013.2577.
    Abstract     Related articles   

  1583. LIU XL , Xiao K, Xue B, Yang D, et al
    Dual role of TGFBR3 in bladder cancer.
    Oncol Rep. 2013 Jul 8. doi: 10.3892/or.2013.2599.
    Abstract     Related articles   

  1584. TOLLE A , Jung M, Rabenhorst S, Kilic E, et al
    Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
    Oncol Rep. 2013 Jul 18. doi: 10.3892/or.2013.2621.
    Abstract     Related articles   

  1585. HSIEH TF , Chen CC, Ma WL, Chuang WM, et al
    Epidermal growth factor enhances androgen receptormediated bladder cancer progression and invasion via potentiation of AR transactivation.
    Oncol Rep. 2013 Oct 10. doi: 10.3892/or.2013.2792.
    Abstract     Related articles   

  1586. ZHU D, Wan X, Huang H, Chen X, et al
    Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells.
    Oncol Rep. 2013 Dec 13. doi: 10.3892/or.2013.2919.
    Abstract     Related articles   

  1587. MASSON-LECOMTE A , Vordos D, de la Taille A, Neuzillet Y, et al
    [Update on FGFR3 mutation and multiple regional epigenetic silencing (MRES) phenotype in urothelial carcinogenesis].
    Prog Urol. 2013;23:96-8.
    Abstract     Related articles   

  1588. NOEL N , Couteau J, Maillet G, Gobet F, et al
    [Preliminary study of p53 and FGFR3 gene mutations in the urine for bladder tumors].
    Prog Urol. 2013;23:29-35.
    Abstract     Related articles   

  1589. FERRE A , Cordonnier C, Demailly M, Hakami F, et al
    [Bladder tumor targeting by Hexvix((R)) fluorescence: 4 years results after prospective monocentric evaluation].
    Prog Urol. 2013;23:195-202.
    Abstract     Related articles   

  1590. COMPERAT E , Camparo P, Larre S, Roupret M, et al
    [Urothelial carcinoma in patients under 40 years. Review of the cancer committee of the French Association of Urology].
    Prog Urol. 2013;23:171-5.
    Abstract     Related articles   

  1591. CHAMPY CM , Phe V, Drouin SJ, Comperat E, et al
    [Prognostic influence of prostate gland invasion by bladder tumour and/or prostate cancer in cystoprostatectomy specimen: A review].
    Prog Urol. 2013;23:165-70.
    Abstract     Related articles   

  1592. MICHAUD S , Kuntz A, Dupas D, Campion L, et al
    [Multicentric evaluation of a self-screening questionnaire for occupational bladder cancer.]
    Prog Urol. 2013;23:977-985.
    Abstract     Related articles   

  1593. GALLIOT I , Le Gall S, Rigaud J, Saint F, et al
    [Bacillus Calmette-Guerin maintenance treatment in non-invasive bladder tumors: 1 year follow-up results of multicenter URO-BCG-4 trial].
    Prog Urol. 2013;23:336-46.
    Abstract     Related articles   

  1594. SEISEN T , Roupret M
    [Transurethral bladder resection of non muscle invasive bladder cancer with Hexvix((R))].
    Prog Urol. 2013;23:1177-80.
    Abstract     Related articles   

  1595. HIRANO D , Okada Y, Nagane Y, Satoh K, et al
    Intravesical recurrence after surgical management of urothelial carcinoma of the upper urinary tract.
    Urol Int. 2012;89:71-7.
    Abstract     Related articles   

  1596. ODERDA M , Ricceri F, Pisano F, Fiorito C, et al
    Prognostic Factors Including Ki-67 and p53 in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
    Urol Int. 2013.
    Abstract     Related articles   

  1597. ABOUMARZOUK OM , Drewa T, Olejniczak P, Chlosta PL, et al
    Laparoscopic versus Open Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Single Institute Comparative Analysis.
    Urol Int. 2013.
    Abstract     Related articles   

  1598. GOLABEK T , Darewicz B, Borawska M, Socha K, et al
    Copper, zinc, and Cu/Zn ratio in transitional cell carcinoma of the bladder.
    Urol Int. 2012;89:342-7.
    Abstract     Related articles   

  1599. DRAGA RO , Grimbergen MC, Kok ET, Jonges TN, et al
    The quality of 5-aminolevulinic acid-induced photodynamic diagnosis and transurethral resection of bladder tumors: does the urologist play a role?.
    Urol Int. 2012;89:326-31.
    Abstract     Related articles   

  1600. HUANG J , Fu J, Zhan H, Xie K, et al
    Analysis of the absence of the detrusor muscle in initial transurethral resected specimens and the presence of residual tumor tissue.
    Urol Int. 2012;89:319-25.
    Abstract     Related articles   

  1601. MACEK P , Sanchez-Salas R, Rozet F, Barret E, et al
    Prostate-Sparing Radical Cystectomy for Selected Patients with Bladder Cancer.
    Urol Int. 2013.
    Abstract     Related articles   

  1602. FRIEDRICH-FREKSA M , Schulz E, Nitzke T, Wenzel O, et al
    Performing Radical Cystectomy and Urinary Diversion in Regional Anesthesia: Potential Risk Reduction in the Treatment of Bladder Cancer.
    Urol Int. 2013.
    Abstract     Related articles   

  1603. AZIZ A , Gierth M, Fritsche HM, May M, et al
    Oncological Outcome of Primary versus Secondary Muscle-Invasive Bladder Cancer Is Comparable after Radical Cystectomy.
    Urol Int. 2013.
    Abstract     Related articles   

  1604. MARTINI T , Mayr R, Lodde M, Seitz C, et al
    Validation of RiskCheck Bladder Cancer (c), Version 5.0 for Risk-Adapted Screening of Bladder Cancer.
    Urol Int. 2013.
    Abstract     Related articles   

  1605. YANG H , Li H, Wang Z, Gao J, et al
    Is Urinary Soluble Fas an Independent Predictor of Non-Muscle-Invasive Bladder Cancer? A Prospective Chart Study.
    Urol Int. 2013.
    Abstract     Related articles   

  1606. GONTERO P , Gillo A, Fiorito C, Oderda M, et al
    Prognostic Factors of 'High-Grade' Ta Bladder Cancers according to the WHO 2004 Classification: Are These Equivalent to 'High-Risk' Non-Muscle-Invasive Bladder Cancer?
    Urol Int. 2013.
    Abstract     Related articles   

  1607. NOVOTNY V , Hakenberg OW, Froehner M, Zastrow S, et al
    Systematic assessment of complications and outcome of radical cystectomy undertaken with curative intent in patients with comorbidity and over 75 years of age.
    Urol Int. 2013;90:195-201.
    Abstract     Related articles   

  1608. LIN YL , He ZK, Li ZG, Guan TY, et al
    Downregulation of CDH13 expression promotes invasiveness of bladder transitional cell carcinoma.
    Urol Int. 2013;90:225-32.
    Abstract     Related articles   

  1609. LIN YL , Li ZG, Guan TY
    The clinical significance of PCDH10 promoter methylation in patients with bladder transitional cell carcinoma.
    Urol Int. 2013;90:219-24.
    Abstract     Related articles   

  1610. LOESER A , Katzenberger T, Vergho DC, Kocot A, et al
    Frozen Section Analysis of Ureteral Margins in Patients Undergoing Radical Cystectomy for Bladder Cancer: Differential Impact of Carcinoma in situ in the Bladder on Reliability and Impact on Tumour Recurrence in the Upper Urinary Tract.
    Urol Int. 2013.
    Abstract     Related articles   

  1611. AKIN Y , Celik O, Ates M, Nuhoglu B, et al
    Evaluation of open and laparoscopic radical cystoprostatectomy combined with orthotopic neobladder: a single-surgeon experience.
    Urol Int. 2013;90:348-53.
    Abstract     Related articles   

  1612. SOOHOO JR , Gonzalez MO, Siomos VJ, Durairaj VD, et al
    Urothelial carcinoma with orbital metastasis.
    Urology. 2012;80:e45-6.
    Abstract     Related articles   

  1613. PRABHARASUTH D , Moses KA, Bernstein M, Dalbagni G, et al
    Management of Bladder Cancer After Renal Transplantation.
    Urology. 2013 Jan 3. pii: S0090-4295(12)01455.
    Abstract     Related articles   

  1614. KAPLAN AL , Margolis DJ, Said J, Chin AI, et al
    Primary carcinoid tumor of urinary bladder discovered on pelvic magnetic resonance imaging.
    Urology. 2012;80:e55-7.
    Abstract     Related articles   

  1615. SUER E , Gulpinar O, Mermerkaya M, Burgu B, et al
    Inflammatory myofibroblastic tumor of the bladder in a 10-year-old girl.
    Urology. 2012;80:1138-40.
    Abstract     Related articles   

  1616. BONNAL JL , Rock A Jr, Gagnat A, Papadopoulos S, et al
    Confocal laser endomicroscopy of bladder tumors associated with photodynamic diagnosis: an ex vivo pilot study.
    Urology. 2012;80:1162.
    Abstract     Related articles   

  1617. GHOUSHEH AI , Durkee CT, Groth TW
    Advanced transitional cell carcinoma of the bladder in a 16-year-old girl with Hinman syndrome.
    Urology. 2012;80:1141-3.
    Abstract     Related articles   

  1618. LAMBERT JW , Ingham M, Gibbs BB, Given RW, et al
    Using Preoperative Albumin Levels As a Surrogate Marker for Outcomes After Radical Cystectomy for Bladder Cancer.
    Urology. 2013 Jan 24. pii: S0090-4295(12)01466.
    Abstract     Related articles   

  1619. GOTOH A , Nagaya H, Kanno T, Tagawa M, et al
    Fiber-substituted Conditionally Replicating Adenovirus Ad5F35 Induces Oncolysis of Human Bladder Cancer Cells in In Vitro Analysis.
    Urology. 2013 Feb 7. pii: S0090-4295(12)01567.
    Abstract     Related articles   

  1620. BALTACI S
    Editorial comment.
    Urology. 2012;80:1318.
    Abstract     Related articles   

  1621. CHAUX A , Comperat E, Varinot J, Hicks J, et al
    High levels of phosphatase and tensin homolog expression are associated with tumor progression, tumor recurrence, and systemic metastases in pT1 urothelial carcinoma of the bladder: a tissue microarray study of 156 patients treated by transurethral re
    Urology. 2013;81:116-22.
    Abstract     Related articles   

  1622. LARGE MC , Reichard C, Williams JT, Chang C, et al
    Incidence, risk factors, and complications of postoperative delirium in elderly patients undergoing radical cystectomy.
    Urology. 2013;81:123-8.
    Abstract     Related articles   

  1623. SHIKANOV S
    Editorial comment.
    Urology. 2013;81:128-9.
    Abstract     Related articles   

  1624. HAN Y , Liu Y, Nie L, Gui Y, et al
    Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Urology. 2013;81:209.
    Abstract     Related articles   

  1625. LIPSKY MJ , Badalato GM, Motamedinia P, Hruby GW, et al
    The Effect of Fibrin Clot Inhibitors on the Immunomodulatory Efficacy of Bacillus Calmette-Guerin Therapy for Non-muscle-invasive Bladder Cancer.
    Urology. 2013 Mar 22. pii: S0090-4295(12)01481.
    Abstract     Related articles   

  1626. YANG DR , Lin SJ, Ding XF, Miyamoto H, et al
    Higher Expression of Peroxisome Proliferator-activated Receptor gamma or Its Activation by Agonist Thiazolidinedione-rosiglitazone Promotes Bladder Cancer Cell Migration and Invasion.
    Urology. 2013 Mar 19. pii: S0090-4295(12)01571.
    Abstract     Related articles   

  1627. HANSEL DE , Miller JS, Cookson MS, Chang SS, et al
    Challenges in the Pathology of Non-Muscle-invasive Bladder Cancer: A Dialogue Between the Urologic Surgeon and the Pathologist.
    Urology. 2013 Mar 19. pii: S0090-4295(13)00088.
    Abstract     Related articles   

  1628. KURU TH , Roethke MC, Nyarangi-Dix J, Okouoyo S, et al
    Pediatric case report on magnetic resonance imaging/transrectal ultrasound-fusion biopsy of rhabdomyosarcoma of the bladder/prostate: a new tool to reduce therapy-associated morbidity?
    Urology. 2013;81:417-20.
    Abstract     Related articles   

  1629. DAVIES JD , Simons CM, Ruhotina N, Barocas DA, et al
    Anatomic basis for lymph node counts as measure of lymph node dissection extent: a cadaveric study.
    Urology. 2013;81:358-63.
    Abstract     Related articles   

  1630. BASSETT JC
    Editorial comment.
    Urology. 2013;81:281.
    Abstract     Related articles   

  1631. SERRETTA V , Altieri V, Morgia G, Di Lallo A, et al
    Cigarette smoking status at diagnosis and recurrence in intermediate-risk non-muscle-invasive bladder carcinoma.
    Urology. 2013;81:277-81.
    Abstract     Related articles   

  1632. TOMASZEWSKI JJ , Smaldone MC
    Editorial comment.
    Urology. 2013;81:592.
    Abstract     Related articles   

  1633. CAMPODONICO F , Parodi D
    Re: Lambert et al.: Using Preoperative Albumin Levels as a Surrogate Marker for Outcomes After Radical Cystectomy for Bladder Cancer (Urology 2013;81:587-592).
    Urology. 2013;81:1382.
    Abstract     Related articles   

  1634. XU T , Zhu Z, Zhang X, Wang X, et al
    Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models.
    Urology. 2013 Jun 8. pii: S0090-4295(13)00454.
    Abstract     Related articles   

  1635. DOHAN A , Ferlicot S, Bessede T, Soyer P, et al
    Low-grade mucinous cystic tumor mimicking urinary bladder tumor: imaging-pathologic correlation.
    Urology. 2013;81:e33-4.
    Abstract     Related articles   

  1636. ZHU YP , Ye DW, Yao XD, Zhang SL, et al
    Defining good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases.
    Urology. 2013;81:820-4.
    Abstract     Related articles   

  1637. ELLIMOOTTIL C , Quek ML, Ellimoottil C
    Editorial comment.
    Urology. 2013;81:824-5.
    Abstract     Related articles   

  1638. NEOGI S , Kariholu PL, Dhakre G, Gupta V, et al
    Malignant urothelial carcinoma of urinary bladder in a young child: a rare case report.
    Urology. 2013;81:888-90.
    Abstract     Related articles   

  1639. MAFFEZZINI M , Campodonico F, Manuputty EE, Puntoni M, et al
    Systemic Absorption and Pharmacokinetics of Single-dose Early Intravesical Mitomycin C After Transurethral Resection of Non-muscle-invasive Bladder Cancer.
    Urology. 2013 Jun 20. pii: S0090-4295(13)00409.
    Abstract     Related articles   

  1640. DOWNS TM
    Editorial comment.
    Urology. 2013;81:1278.
    Abstract     Related articles   

  1641. GRIVAS PD , Hussain M, Hafez K, Daignault-Newton S, et al
    A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACaG) in patients with locally advanced carcinoma of the bladder.
    Urology. 2013;82:111-7.
    Abstract     Related articles   

  1642. KONG MX , Zhao X, Kheterpal E, Lee P, et al
    Histopathologic and clinical features of vesical diverticula.
    Urology. 2013;82:142-7.
    Abstract     Related articles   

  1643. SHAPIRO DD , Potretzke A, Downs TM
    Leukemoid Reaction: A Rare Paraneoplastic Syndrome in Bladder Cancer Associated With a Grave Prognosis.
    Urology. 2013 Sep 14. pii: S0090-4295(13)00956.
    Abstract     Related articles   

  1644. REHMAN S , Crane A, Din R, Raza SJ, et al
    Understanding Avoidance, Refusal, and Abandonment of Chemotherapy Before and After Cystectomy for Bladder Cancer.
    Urology. 2013 Oct 11. pii: S0090-4295(13)01072.
    Abstract     Related articles   

  1645. ZAID HB , Patel SG, Stimson CJ, Resnick MJ, et al
    Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database.
    Urology. 2013 Nov 11. pii: S0090-4295(13)01173.
    Abstract     Related articles   

  1646. MEIJER RP , Mertens LS, van Rhijn BW, Bex A, et al
    Induction Chemotherapy Followed by Surgery in Node Positive Bladder Cancer.
    Urology. 2013 Nov 15. pii: S0090-4295(13)01254.
    Abstract     Related articles   

  1647. WANG H, Cai Z, Yang F, Luo J, et al
    Enhanced Antitumor Efficacy of Integrin-targeted Oncolytic Adenovirus AxdAdB3-F/RGD on Bladder Cancer.
    Urology. 2013 Dec 5. pii: S0090-4295(13)01369.
    Abstract     Related articles   

  1648. JAROW JP, Lerner SP, Kluetz PG, Liu K, et al
    Clinical Trial Design for the Development of New Therapies for Nonmuscle-invasive Bladder Cancer: Report of a Food and Drug Administration and American Urological Association Public Workshop.
    Urology. 2013 Dec 11. pii: S0090-4295(13)01375.
    Abstract     Related articles   

  1649. PATEL P, Reikie BA, Maxwell JP, Yilmaz A, et al
    Long-term clinical outcome of inverted urothelial papilloma including cases with focal papillary pattern: is continuous surveillance necessary?
    Urology. 2013;82:857-60.
    Abstract     Related articles   

  1650. ZHAO C, Kim MK, Kim HJ, Lee SK, et al
    Comparative safety analysis of surgical smoke from transurethral resection of the bladder tumors and transurethral resection of the prostate.
    Urology. 2013;82:744.
    Abstract     Related articles   

  1651. TSENG CH
    Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.
    BMC Cancer. 2013;13:7.
    Abstract     Related articles   

  1652. CHUNG H , Kim B, Jung SH, Won KJ, et al
    Does phosphorylation of cofilin affect the progression of human bladder cancer?
    BMC Cancer. 2013;13:45.
    Abstract     Related articles   

  1653. KECK B , Wach S, Stoehr R, Kunath F, et al
    Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy.
    BMC Cancer. 2013;13:71.
    Abstract     Related articles   

  1654. CHUNG SD , Tsai MC, Lin CC, Lin HC, et al
    A case-control study on the association between bladder cancer and prior bladder calculus.
    BMC Cancer. 2013;13:117.
    Abstract     Related articles   

  1655. ZHU Z , Wang X, Shen Z, Lu Y, et al
    Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies.
    BMC Cancer. 2013;13:310.
    Abstract     Related articles   

  1656. MIYAKE M , Lawton A, Goodison S, Urquidi V, et al
    Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers.
    BMC Cancer. 2013;13:322.
    Abstract     Related articles   

  1657. ZHU S , Tang Y, Li K, Shang Z, et al
    Optimal schedule of Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer: A meta-analysis of comparative studies.
    BMC Cancer. 2013;13:332.
    Abstract     Related articles   

  1658. HANZE J, Henrici M, Hegele A, Hofmann R, et al
    Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
    BMC Cancer. 2013;13:589.
    Abstract     Related articles   

  1659. LIU JY, Li YH, Lin HX, Liao YJ, et al
    Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder.
    BMC Cancer. 2013;13:349.
    Abstract     Related articles   

  1660. CHIHARA Y, Kanai Y, Fujimoto H, Sugano K, et al
    Diagnostic markers of urothelial cancer based on DNA methylation analysis.
    BMC Cancer. 2013;13:275.
    Abstract     Related articles   

  1661. CORONA E , Chen R, Sikora M, Morgan AA, et al
    Analysis of the genetic basis of disease in the context of worldwide human relationships and migration.
    PLoS Genet. 2013;9:e1003447.
    Abstract     Related articles   

  1662. LIU Y , Han Y, Zhang H, Nie L, et al
    Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells.
    PLoS One. 2012;7:e52280.
    Abstract     Related articles   

  1663. SCHWENDER H , Selinski S, Blaszkewicz M, Marchan R, et al
    Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.
    PLoS One. 2012;7:e51880.
    Abstract     Related articles   

  1664. ANDREW AS , Hu T, Gu J, Gui J, et al
    HSD3B and Gene-Gene Interactions in a Pathway-Based Analysis of Genetic Susceptibility to Bladder Cancer.
    PLoS One. 2012;7:e51301.
    Abstract     Related articles   

  1665. NEUZILLET Y , Paoletti X, Ouerhani S, Mongiat-Artus P, et al
    A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer.
    PLoS One. 2012;7:e48993.
    Abstract     Related articles   

  1666. GRAU L , Luque-Garcia JL, Gonzalez-Peramato P, Theodorescu D, et al
    A Quantitative Proteomic Analysis Uncovers the Relevance of CUL3 in Bladder Cancer Aggressiveness.
    PLoS One. 2013;8:e53328.
    Abstract     Related articles   

  1667. WANG Y , Wang H, Zhang W, Shao C, et al
    Genistein Sensitizes Bladder Cancer Cells to HCPT Treatment In Vitro and In Vivo via ATM/NF-kappaB/IKK Pathway-Induced Apoptosis.
    PLoS One. 2013;8:e50175.
    Abstract     Related articles   

  1668. SHAHAB U , Moinuddin, Ahmad S, Dixit K, et al
    Genotoxic Effect of N-Hydroxy-4-Acetylaminobiphenyl on Human DNA: Implications in Bladder Cancer.
    PLoS One. 2013;8:e53205.
    Abstract     Related articles   

  1669. MANSURE JJ , Nassim R, Chevalier S, Szymanski K, et al
    A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer.
    PLoS One. 2013;8:e55997.
    Abstract     Related articles   

  1670. GENUA M , Xu SQ, Buraschi S, Peiper SC, et al
    Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells.
    PLoS One. 2012;7:e40148.
    Abstract     Related articles   

  1671. RENTSCH CA , Biot C, Gsponer JR, Bachmann A, et al
    BCG-Mediated Bladder Cancer Immunotherapy: Identifying Determinants of Treatment Response Using a Calibrated Mathematical Model.
    PLoS One. 2013;8:e56327.
    Abstract     Related articles   

  1672. ZHU Z , Zhang X, Shen Z, Zhong S, et al
    Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.
    PLoS One. 2013;8:e56662.
    Abstract     Related articles   

  1673. CHENG T , Roth B, Choi W, Black PC, et al
    Fibroblast growth factor receptors-1 and -3 play distinct roles in the regulation of bladder cancer growth and metastasis: implications for therapeutic targeting.
    PLoS One. 2013;8:e57284.
    Abstract     Related articles   

  1674. XU X , Wu J, Mao Y, Zhu Y, et al
    Diabetes mellitus and risk of bladder cancer: a meta-analysis of cohort studies.
    PLoS One. 2013;8:e58079.
    Abstract     Related articles   

  1675. MIYATA Y , Watanabe S, Sagara Y, Mitsunari K, et al
    High Expression of HuR in Cytoplasm, but Not Nuclei, Is Associated with Malignant Aggressiveness and Prognosis in Bladder Cancer.
    PLoS One. 2013;8:e59095.
    Abstract     Related articles   

  1676. JAGER W , Moskalev I, Janssen C, Hayashi T, et al
    Ultrasound-guided intramural inoculation of orthotopic bladder cancer xenografts: a novel high-precision approach.
    PLoS One. 2013;8:e59536.
    Abstract     Related articles   

  1677. CHEN MF , Lin PY, Wu CF, Chen WC, et al
    IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer.
    PLoS One. 2013;8:e61901.
    Abstract     Related articles   

  1678. MANSURE JJ , Nassim R, Chevalier S, Szymanski K, et al
    Correction: A Novel Mechanism of PPAR Gamma Induction via EGFR Signalling Constitutes Rational for Combination Therapy in Bladder Cancer.
    PLoS One. 2013;8.
    Abstract     Related articles   

  1679. WANG W , Liu Z, Qu P, Zhou Z, et al
    Knockdown of Regulator of Cullins-1 (ROC1) Expression Induces Bladder Cancer Cell Cycle Arrest at the G2 Phase and Senescence.
    PLoS One. 2013;8:e62734.
    Abstract     Related articles   

  1680. HECKER N , Stephan C, Mollenkopf HJ, Jung K, et al
    A New Algorithm for Integrated Analysis of miRNA-mRNA Interactions Based on Individual Classification Reveals Insights into Bladder Cancer.
    PLoS One. 2013;8:e64543.
    Abstract     Related articles   

  1681. HURST RE , Hauser PJ, Kyker KD, Heinlen JE, et al
    Suppression and Activation of the Malignant Phenotype by Extracellular Matrix in Xenograft Models of Bladder Cancer: A Model for Tumor Cell "Dormancy"
    PLoS One. 2013;8:e64181.
    Abstract     Related articles   

  1682. HAN MH , Park C, Jin CY, Kim GY, et al
    Apoptosis Induction of Human Bladder Cancer Cells by Sanguinarine through Reactive Oxygen Species-Mediated Up-Regulation of Early Growth Response Gene-1.
    PLoS One. 2013;8:e63425.
    Abstract     Related articles   

  1683. FANG Z , Chen F, Wang X, Yi S, et al
    XRCC1 Arg194Trp and Arg280His Polymorphisms Increase Bladder Cancer Risk in Asian Population: Evidence from a Meta-Analysis.
    PLoS One. 2013;8:e64001.
    Abstract     Related articles   

  1684. ZHUO DX , Zhang XW, Jin B, Zhang Z, et al
    CSTP1, a Novel Protein Phosphatase, Blocks Cell Cycle, Promotes Cell Apoptosis, and Suppresses Tumor Growth of Bladder Cancer by Directly Dephosphorylating Akt at Ser473 Site.
    PLoS One. 2013;8:e65679.
    Abstract     Related articles   

  1685. NASSIM R , Mansure JJ, Chevalier S, Cury F, et al
    Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment.
    PLoS One. 2013;8:e65257.
    Abstract     Related articles   

  1686. MAJID S , Dar AA, Saini S, Deng G, et al
    MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer.
    PLoS One. 2013;8:e67686.
    Abstract     Related articles   

  1687. AGENANT M , Noordmans HJ, Koomen W, Bosch JL, et al
    Real-time bladder lesion registration and navigation: a phantom study.
    PLoS One. 2013;8:e54348.
    Abstract     Related articles   

  1688. KHALID T , White P, De Lacy Costello B, Persad R, et al
    A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace.
    PLoS One. 2013;8:e69602.
    Abstract     Related articles   

  1689. EWALD JA , Downs TM, Cetnar JP, Ricke WA, et al
    Expression microarray meta-analysis identifies genes associated with Ras/MAPK and related pathways in progression of muscle-invasive bladder transition cell carcinoma.
    PLoS One. 2013;8:e55414.
    Abstract     Related articles   

  1690. QI W , White MC, Choi W, Guo C, et al
    Inhibition of inducible heat shock protein-70 (hsp72) enhances bortezomib-induced cell death in human bladder cancer cells.
    PLoS One. 2013;8:e69509.
    Abstract     Related articles   

  1691. ZHANG H , Jiang D, Li X
    Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studies.
    PLoS One. 2013;8:e70008.
    Abstract     Related articles   

  1692. YUAN F , Xu Z, Yang M, Wei Q, et al
    Overexpressed DNA Polymerase Iota Regulated by JNK/c-Jun Contributes to Hypermutagenesis in Bladder Cancer.
    PLoS One. 2013;8:e69317.
    Abstract     Related articles   

  1693. CHEN Z , Lessey E, Berginski ME, Cao L, et al
    Gleevec, an Abl family inhibitor, produces a profound change in cell shape and migration.
    PLoS One. 2013;8:e52233.
    Abstract     Related articles   

  1694. LI P , Gu J, Yang X, Cai H, et al
    Functional Promoter -94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population.
    PLoS One. 2013;8:e71604.
    Abstract     Related articles   

  1695. DJUKIC TI , Savic-Radojevic AR, Pekmezovic TD, Matic MG, et al
    Glutathione s-transferase t1, o1 and o2 polymorphisms are associated with survival in muscle invasive bladder cancer patients.
    PLoS One. 2013;8:e74724.
    Abstract     Related articles   

  1696. LI S , Peng Q, Chen Y, You J, et al
    DNA Repair Gene XRCC1 Polymorphisms, Smoking, and Bladder Cancer Risk: A Meta-Analysis.
    PLoS One. 2013;8:e73448.
    Abstract     Related articles   

  1697. ELSASSER J , Janssen MW, Becker F, Suttmann H, et al
    Antigen-Specific CD4 T Cells Are Induced after Intravesical BCG-Instillation Therapy in Patients with Bladder Cancer and Show Similar Cytokine Profiles as in Active Tuberculosis.
    PLoS One. 2013;8:e69892.
    Abstract     Related articles   

  1698. ISONO T , Chano T, Okabe H, Suzaki M, et al
    Study of global transcriptional changes of N-GlcNAc2 proteins-producing T24 bladder carcinoma cells under glucose deprivation.
    PLoS One. 2013;8:e60397.
    Abstract     Related articles   

  1699. LIU Z , Wang W, Jiang J, Bao E, et al
    Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6.
    PLoS One. 2013;8:e73991.
    Abstract     Related articles   

  1700. WU W , Zhang S, Li X, Xue M, et al
    Ets-2 Regulates Cell Apoptosis via the Akt Pathway, through the Regulation of Urothelial Cancer Associated 1, a Long Non-Coding RNA, in Bladder Cancer Cells.
    PLoS One. 2013;8:e73920.
    Abstract     Related articles   

  1701. YUAN H , Qiu J, Liu L, Zheng S, et al
    Therapeutic outcome of fluorescence cystoscopy guided transurethral resection in patients with non-muscle invasive bladder cancer: a meta-analysis of randomized controlled trials.
    PLoS One. 2013;8:e74142.
    Abstract     Related articles   

  1702. ZHONG X , Isharwal S, Naples JM, Shiff C, et al
    Hypermethylation of Genes Detected in Urine from Ghanaian Adults with Bladder Pathology Associated with Schistosoma haematobium Infection.
    PLoS One. 2013;8:e59089.
    Abstract     Related articles   

  1703. CAI H , Chiorean EG, Chiorean MV, Rex DK, et al
    Elevated phospholipase A2 activities in plasma samples from multiple cancers.
    PLoS One. 2013;8:e57081.
    Abstract     Related articles   

  1704. LI R , Yu C, Jiang F, Gao L, et al
    Overexpression of N-Myc Downstream-Regulated Gene 2 (NDRG2) Regulates the Proliferation and Invasion of Bladder Cancer Cells In Vitro and In Vivo.
    PLoS One. 2013;8:e76689.
    Abstract     Related articles   

  1705. SAINIO A , Nyman M, Lund R, Vuorikoski S, et al
    Lack of decorin expression by human bladder cancer cells offers new tools in the therapy of urothelial malignancies.
    PLoS One. 2013;8:e76190.
    Abstract     Related articles   

  1706. WU S , Ju GQ, Du T, Zhu YJ, et al
    Microvesicles derived from human umbilical cord Wharton's jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo.
    PLoS One. 2013;8:e61366.
    Abstract     Related articles   

  1707. CHEKALUK Y , Wu CL, Rosenberg J, Riester M, et al
    Identification of nine genomic regions of amplification in urothelial carcinoma, correlation with stage, and potential prognostic and therapeutic value.
    PLoS One. 2013;8:e60927.
    Abstract     Related articles   

  1708. NIEDWOROK C , Rock K, Kretschmer I, Freudenberger T, et al
    Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer.
    PLoS One. 2013;8:e80084.
    Abstract     Related articles   

  1709. JEON C , Kim M, Kwak C, Kim HH, et al
    Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis.
    PLoS One. 2013;8:e76719.
    Abstract     Related articles   

  1710. YUAN L, Chu H, Wang M, Gu X, et al
    Genetic Variation in DROSHA 3'UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk.
    PLoS One. 2013;8:e81524.
    Abstract     Related articles   

  1711. GUPTA S, Hau AM, Beach JR, Harwalker J, et al
    Mammalian Target of Rapamycin Complex 2 (mTORC2) Is a Critical Determinant of Bladder Cancer Invasion.
    PLoS One. 2013;8:e81081.
    Abstract     Related articles   

  1712. ROPERTO S, Russo V, Ozkul A, Corteggio A, et al
    Productive infection of bovine papillomavirus type 2 in the urothelial cells of naturally occurring urinary bladder tumors in cattle and water buffaloes.
    PLoS One. 2013;8:e62227.
    Abstract     Related articles   

  1713. BALBAS-MARTINEZ C, Rodriguez-Pinilla M, Casanova A, Dominguez O, et al
    ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.
    PLoS One. 2013;8:e62483.
    Abstract     Related articles   

  1714. OVERDEVEST JB , Knubel KH, Duex JE, Thomas S, et al
    CD24 expression is important in male urothelial tumorigenesis and metastasis in mice and is androgen regulated.
    Proc Natl Acad Sci U S A. 2012;109:E3588-96.
    Abstract     Related articles   

  1715. PIGNON JC , Grisanzio C, Geng Y, Song J, et al
    p63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia.
    Proc Natl Acad Sci U S A. 2013.
    Abstract     Related articles   

  1716. RACHAKONDA PS , Hosen I, de Verdier PJ, Fallah M, et al
    TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
    Proc Natl Acad Sci U S A. 2013.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Pierre Fabre.

Design:


;